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Distinct freshwater and seawater chloride cells have been identified in salmon gills and 
recent studies also suggest that there are specific freshwater (α1a) and seawater (α1b) 
isoforms of the α subunit of Na+K+-ATPase (NKA). Salmon smolts adjust to seawater 
prior to migration and an upregulation of NKAα1b transcription have been seen while the 
smolts were still in freshwater. Studies of mature Pacific salmon (Oncorhynchus spp.) 
suggest that mature salmon adapt to freshwater while still in seawater and may thus loose 
the ability to hypo-osmoregulate. Consequently, maturing salmon kept in net pens may 
suffer from terminal dehydration and this might be a major fish welfare problem in 
aquaculture as many salmon mature before slaughter weight is achieved. 
Thus, the aim of the present study is to detect possible changes in gill NKAα1a and gill 
NKAα1b expression in maturing male salmon kept in fresh- and seawater using Real-
Time RT-qPCR. 
Pre-smolts were exposed to a smolt inducing photoperiod, before half were transferred to 
seawater, while the rest remained in freshwater. The post-smolts were then exposed to 
either continuous light or short day photoperiod to induce high end low incidence of 
mature males, respectively. 
The present study is the first in which changes in salinity specific NKAα1a and NKAα1b 
isoforms is used to detect a possible preparatory adaptation to freshwater in maturing 
male Atlantic salmon. 
Our date coincides with previously seen changes in NKAα1a and NKAα1b in relation to 
smoltification and desmoltification as the expression of NKAα1b increased in smolts 
prior to seawater transfer and NKAα1a expression decreased. Furthermore, an increase in 
NKAα1a was seen in desmolting salmon while NKAα1b expression declined. These 
findings support the hypothesis of NKAα1b as the seawater adaptive isoform and 
NKAα1a as the freshwater isoform. In addition, an increase in NKAα1a were seen in 
maturing male salmon kept in seawater and NKAα1a levels were significantly higher in 
mature males than in immature females. No significant differences in NKAα1b were seen 
between mature males and immature females in seawater, but NKA activity was 
significantly lower in mature males than in immature females in seawater. This suggest 
that mature salmon adapt to freshwater while still in seawater and may consequently die 
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1.1 The lifecycle of Atlantic salmon 
The anadromous Atlantic salmon (Salmo salar L.) is one of the teleosts that show the 
greatest variety in lifecycle strategies (Hutchings and Jones, 1998). Critical events, 
such as smoltification and age at first maturity may vary with several years, between 
and within populations (Hutchings and Jones, 1998, Fleming, 1996). 
The salmon migrate from their river of origin to the ocean as smolts during spring and 
they return in the summer/autumn to spawn, after one to four years at sea 
(McCormick et al., 1998, Hutchings and Jones, 1998). During these migrations, the 
salmon undergo many complex physiological, behavioral, and morphological 
adaptations to survive in these two diverse habitats (McCormick et al., 1998).  
1.2 Smoltification 
As the juvenile salmon goes through smoltification, it will change from stream-
dwelling and aggressive parr, to a pelagic and schooling smolt, perfectly adapted to 
the marine environment (fig. 1) (McCormick et al., 1998, McCormick and Saunders, 
1987, Stefansson et al., 2008, Wedemeyer et al., 1980). To complete the transition 
from freshwater (FW) to seawater (SW), the salmon must change from hyper-
osmoregulation to hypo-osmoregulation prior to and during migration (McCormick et 
al., 1998). 
In most of the distribution range, smoltification takes place in April to May, with light 
and temperature as the two main triggering factors (McCormick et al., 1998). The 
increased day length is registered by the pineal gland and retina, which send signals to 
the hypothalamus through neurons, resulting in the release of growth hormone (GH) 
and thyroid stimulating hormone (TSH) from the pituitary (Ebbesson et al., 2003). 
GH stimulates the hepatic and peripheral insulin-like growth factor (IGF-1) 
production, adrenocorticotropic hormone (ACTH) the release of cortisol from the 
head kidney, while TSH stimulates the production of the thyroid hormones (TH); 
thyroxin (T4) and tri-iodothyronine (T3) (McCormick et al., 1998, Stefansson et al., 
2008). The interaction of these hormones induce structural modifications known to be 
associated with seawater adaptation as they increase the number of SW chloride cells 
and thus Na+K+ATPase (NKA) activity, which is essential for seawater survival 
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(McCormick, 2001, Prunet et al., 1994). The smolt will enter seawater when it is 
behaviorally and psychologically ready. This period is referred to as the “smolt 
window” and is characterized by a high NKA activity and an ability to survive an 
immediate transfer to full strength SW (Stefansson et al., 2008).   
The production of smolt for aquaculture purposes was previously season dependent, 
but methods using artificial light have made it possible to produce “out of season” 
underyearling smolts (Berge et al., 1995). Salmon farmers are now able to transfer 
fish to ocean net pens year round.  
 
Figure 1: Parr-Smolt transformation and its related hormones. Notice the color difference in 
salmon parr and smolt. A normal developing fish is always perfectly adapted to their environment. The 
brown color base and aggressive behavior of the parr is in contrast to the silvery body and schooling 
behavior of the smolt. The graph shows the relative hormone levels of GH, IGF-1, Cortisol, T4 and 
PRL in relation to a natural spring smolting and the smolt window (Nilsen, 2007, McCormick, 2001). 
Illustration modified from (Nilsen, 2007 Phd). 
1.3 Puberty  
Puberty is the developmental period during which an immature animal requires the 
capacity to produce offspring for the first time (Okuzawa, 2002, Taranger et al., 
2010). Puberty in teleosts is associated with rapid gonad growth due to differentiation 
of germ cells, and culminates into the first spermiation or ovulation (Okuzawa, 2002). 
The onset of puberty in Atlantic salmon is triggered through several internal and 
external factors, such as light, temperature and energy stores (Taranger et al., 2010). 
Changes in the photoperiodic cycle stimulates the production and release of the 
neurohormone gonadotropin-releasing hormone (GnRH) from the hypothalamus, 
which then triggers the production of the pituitary gonadotropins: follicle stimulating 
hormone (FSH) and luteinizing hormone (LH) (Schulz et al., 2006, Schulz et al., 
2010, Okuzawa, 2002). LH and FSH will then activate the production of sex steroids 
and germ cells in ovaries and testis (Schulz et al., 2006, Schulz et al., 2010, Okuzawa, 
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2002). The proliferation and maturation of gametes requires energy, more so in 
females than in males (Fleming, 1996). Thus, most female Atlantic salmon are 
anadromous, so they may utilize the rich feeding grounds of the ocean (McCormick et 
al., 1998). Male salmon will either select to spawn as parr or as full-size males after 
one to four years at sea (Hutchings and Jones, 1998). Whether the salmon becomes 
mature after one year at sea or later depends on genetic factors, the energetic factors 
and the overall physiological status of the individual (Thorpe, 1986). When mature, 
the anadromous salmon will return to their river of origin and reproduce (Hutchings 
and Jones, 1998). Some will survive spawning and return to sea, while for others the 
energy cost is to great and death is inevitable (Fleming, 1996).  
1.4 Early puberty and sexual maturation 
Atlantic salmons may become mature as parr, prior to SW migration, after a few 
months in SW, at the “jack” stage and after 1.5 years in SW, at the “grilse” stage or 
after two or more years in SW as multi-sea-winter salmon (Jonsson and Jonsson, 
2007, Taranger et al., 2010). Early puberty and maturation normally occur when food 
is available in sufficient amounts (Fleming, 1996, Hutchings and Jones, 1998) and the 
proportion of males that reach parr, jack and grilse maturation is normally higher than 
in females (Taranger et al., 2010). Because of this lifecycle variation, some farmed 
salmon may reach puberty at an early age, due to enhanced food availability and 
growth conditions in tanks or net pens (Taranger et al., 2010). 
Early puberty in Atlantic salmon is a major economical and welfare problem in the 
aquaculture industry considering the negative impact puberty has on meat quality, 
growth and survival rate (Taranger et al., 2010). Although methods like photoperiodic 
control may delay puberty in salmon (Bromage et al., 2001), the commercial use of 
these methods may be compromised by unpredictable results (Taranger et al., 2010). 
Temperature and other uncontrollable factors may result in a significant number of 
mature fish in spite of the use of inhibitory photoperiod (Taranger et al., 2010). 
Consequently, a better understanding of the onset of puberty and fish welfare 
consequences is needed.  
1.5 Photoperiodic control of sexual maturation 
As mentioned, salmon require a substantial amount of energy for the production of 
gametes and to mature (Fleming, 1996). Thus, an internal biological threshold for 
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entering puberty is present to ensure that each salmon has stored enough energy to 
complete maturation (Fleming, 1996). The biological threshold is based on the 
physiological state of the animal (e.g. size, adiposity and gonad development) and is 
determined by both genetic and phenotypic factors (Taranger et al., 2010). Fast 
growing salmon are more likely to reach the threshold before the “critical window” 
controlled by circannual rhythms closes, than slow growing salmon (Taranger et al., 
2010).  
Advancing photoperiod, by increasing day length in winter or early spring, will 
reduce the proportion of salmon entering puberty as few individuals have reached the 
required threshold so early in the season (fig. 2) (Taranger et al., 1999). However, 
prolonged exposure to long days, or exposure to continuous light after summer 
solstice can have the opposite effect by increasing the number of fish who has reached 
the threshold (fig. 2) (Taranger et al., 2010). This model makes it possible to move 
forward or postpone puberty and sexual maturation (Taranger et al., 2010). Advancing 
puberty is first and foremost useful in an experimental context, making it possible to 
study maturation in smaller fish.  
 
Figure 2: Photoperiodic control of puberty. The dotted line represents the natural photoperiod in the 
northern hemisphere. The arrows illustrates changes in photoperiod that may advance or delay 
circannual rhythms. Long days or continuous light early in the season will advance such rhythms and 
therefore delay puberty. Short days early in the season will delay the rhythm and advance puberty. 
Long days or continuous light after midsummer will postpone circannual rhythms and advance puberty, 





Shifting between FW and SW is challenging as the two environments represent 
completely different osmotic challenges for the fish. In FW a stable plasma 
osmolarity is maintained through absorbing ions across the gill and excrete excess 
water, obtained through passive osmosis, by producing large volumes of dilute urine 
(Perry, 1997). In SW, the fish dinks water to avoid dehydration and ions are actively 
excreted trough the gill and (Evans et al., 2005).  
Chloride cells (CC) play an important role in osmoregulation and adaptation to SW or 
FW in migrating fish species as they are the main site for ion secretion and ion uptake 
allowing maintenance of a stable plasma osmolality (McCormick, 2001, Perry, 1997). 
CC are located in the gill filament s, mainly in the afferent edge of filaments and in 
the interlamellar region (Evans et al., 2005). Distinct FW-type CC and SW-type CC 
are identified based on differences in function, morphology and specific antibodies 
(fig. 3) (Evans et al., 2005, Perry, 1997, McCormick et al., 2009). SW-type CC have 
an extensive tubular system, which is formed by invagination of the basolateral 
membrane (Evans et al., 2005). This tubular system, which almost fills the entire CC, 
have a high abundance of the enzyme Na+K+ATPase (NKA) (Evans et al., 2005). A 
study of Brown trout (Salmo trutta) revealed a correlation between increased NKA 
activity and increased number of SW-type CC after SW transfer (Seidelin et al., 2000) 
and the same is seen in Atlantic salmon (McCormick et al., 2009). In addition, 
multiple studies have shown that a high NKA activity is linked with seawater 
adaption and survival (Berge et al., 1995, Boeuf and Prunet, 1985, McCormick et al., 
1995, Nilsen et al., 2007, Prunet et al., 1989, Stefansson et al., 1998).  
It has been shown that GH and IGF-1 stimulate the differentiation of SWCC and more 
efficiently so in synergy with cortisol (McCormick, 1996, McCormick, 2001). 
Furthermore, TH has an indirect effect on SW adaption through the upregulation of 
corticoid receptors in the gill, which is further enhanced by GH (Shrimpton and 
McCormick, 1998, McCormick, 2001). Thus TH indirectly supports cortisol’s ability 
to increase NKA activity (McCormick, 2001, Shrimpton and McCormick, 1998). In 
addition, prolactin (PRL) is considered the FW adaption hormone as it is antagonistic 
to GH and a reduction in PRL levels is seen in smolting salmon (fig.1) (Prunet et al., 
1989), but there is still some uncertainty about the precise effect of PRL on CC and 
osmoregulation as inconsistent results of PRL exposure are reported (Manzon, 2002). 
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 Apical  
Basolateral 
 
Figure 3: Seawater and freshwater chloride cells. The general morphology of SW CC and FW CC 
differ in several ways. The SW CC, unlike FW CC, form shallow tight junctions with accessory cells, 
are larger in size, have a higher NKA activity and a smooth apical pit (Evans et al., 2005). Illustrations 
modified from McCormick et al 2001. 
NKA is, as mentioned, present in the basolateral membrane of both FWCC and 
SWCC, but in greater number in the latter (Evans et al., 2005). The functional enzyme 
has two essential subunits, α and β, and a FYXD protein (sometimes referred to as the 
γ subunit) (Skou and Esmann, 1992, Blanco and Mercer, 1998, Kaplan, 2002, Hirose 
et al., 2003, Geering, 1990, Geering, 2005, Tipsmark et al., 2008). The α subunit is 
the catalytic component and the binding site for Na+, K+, ouabain and ATP, while the 
β subunit is found to stabilize and support the correct folding of the α subunit and 
regulate the molecules affinity for Na+ and K+ (Blanco and Mercer, 1998, Richards et 
al., 2003, Mobasheri et al., 2000, Skou and Esmann, 1992, Kaplan, 2002).  NKA 
hydrolyzes one molecule of ATP to ADP to exchange three intracellular Na+ ions 
with two extracellular K+ ions and the electrochemical gradient NKA maintain drives 
other Na+ coupled transporters such as ion channels, co-transporters and counter 
transporters (fig. 3) (Blanco and Mercer, 1998, Mobasheri et al., 2000). Four different 
isoforms of the α (α1 - α4) and β (β1 - β4) subunit have been found in mammals 
(Blanco and Mercer, 1998) while five different isoforms of NKA (α1a, α1b, α1c, α2, 
α3) have been found in salmonids (Richards et al., 2003, Gharbi et al., 2005) and all 
except α2 have been found in Atlantic salmon gill tissue (Nilsen et al., 2007).  
Richards et al (2003) discovered that the expression of NKA α1a and α1b isoforms 
change during adaption to SW and FW in rainbow trout. The level of α1a mRNA 
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decreased when the fish was transferred to SW, whereas the amount of α1b mRNA 
increased during SW transfer (Richards et al., 2003). The same has been shown for 
mRNA (Nilsen et al., 2007, Mackie et al., 2005, Madsen et al., 2008) and protein 
(McCormick et al., 2009) abundance in Atlantic salmon. Further, Gill NKAα1b 
mRNA levels increased in the early stages of smolting and remained high after SW 
transfer, while the levels of NKAα1a decreased during smoltification (Nilsen et al., 
2007). The overall increase in NKA activity during smolting may therefore be the 
result of an increase in NKAα1b abundance (Nilsen et al., 2007). This change in 
isoforms indicates the presence of distinct FW and SW isoforms of NKA, which may 
play different roles in salinity acclimation in salmonids (Richards et al., 2003, 
McCormick et al., 2009). Although several studies have looked at NKA isoform 
change in relation to smoltification and SW transfer (Mackie et al., 2005, Madsen et 
al., 1995, Nilsen et al., 2007, Madsen et al., 2008, Richards et al., 2003), there is very 
little research done on isoform change during sexual maturation and FW adaption in 
salmonids (Shrimpton et al., 2005). What is known is that wild caught homing Pacific 
salmon (Oncorhynchus spp.) show a reduction in NKA activity even when kept in SW 
and fail to survive for more than a week in SW while they adapt perfectly to FW 
(Hirano et al., 1990, Uchida et al., 1997, Shrimpton et al., 2005). Additionally, 
decrease in NKAα1a were seen in salmon migrating upstream, which corresponded 
with lowered level of NKA activity (Shrimpton et al., 2005). 
1.7 Motivation  
Based on the findings of Shrimpton et al. (2005) Uchida et al. (Uchida et al., 1997) 
and Hirano et al. (Hirano et al., 1990)it would be interesting to see if NKA activity 
and NKAα1b and NKAα1a isoforms change in a similar manner in maturing Atlantic 
salmon. If mature Atlantic salmon show sings of preparatory acclimation to FW while 
still in SW it might represent a fish welfare problem as the salmon is in danger of 
obtaining a fatally high plasma osmolality caused by reduced hypo-osmoregulating 
ability (Hirano et al., 1990) 
Consequently, it is necessary to get information regarding changes in hypo-
osmoregulatory ability during the maturation cycle, the timing of these alterations and 
the underlying endocrine and molecular mechanisms. 
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Scientists at The Institute of Marine Research discovered that a high water 
temperature (16°C) and continuous light induce a high incidence of male post-smolt 
maturation in Atlantic salmon, a few months after SW transfer (P.G Fjelldal and T 
Hansen, in prep). Using this method will allow us to study an “out of season entry” 
into puberty under highly controlled settings and test a model that will complete the 
whole lifecycle of the Atlantic salmon within a year. 
1.8 Aim of the study 
Atlantic salmon is a major aquaculture species and most stages of the lifecycle have 
been thoroughly researched. The endocrine, physiological and molecular changes 
during the transition from freshwater to seawater during smoltification are well 
understood (Mackie et al., 2005, Nilsen et al., 2003, Sardet et al., 1979, Stefansson et 
al., 1998, Stefansson et al., 2009, Stefansson et al., 2007, Thrush et al., 1994, 
Tipsmark et al., 2008, McCormick, 2001) thus creating a good base for studying 
similar changes during puberty and maturation.  
This experiment was part of a larger study funded by the Norwegian Research 
Council where the main objective is to obtain more information concerning molecular 
and endocrine changes prior to and during early puberty in Atlantic salmon males and 
shed light on possible fish welfare problems associated with such. Hence, the 
hypothesis of this thesis is: 
• There are changes in the expression level of NKAα1b and NKAα1a 
during the sexual maturation in male salmon. 
• There are differences in expression level of NKAα1b and NKAα1a in 
mature males and immature fish (males and females). 
• Salinity will affect NKAα1b and NKAα1a expression. 
To test these hypotheses we will utilize well-established methods of molecular 






2.1 Experimental design 
The samplings took place at Matre Research facility (61° N), which is owned and run 
by the Institute of Marine Research, Bergen. The experiment started the 29th of 
September 2010 with 1600 Atlantic salmon pre-smolt distributed in 16 experimental 
tanks of 500 L with 100 fish in each tank. The fish were kept under continuous light 
(LL) in freshwater until November 5th, when an out of season smoltification regime 
was initiated, in which all tanks received 6 weeks of short day photoperiod (LD 12:12 
09.00-21.00), followed by 4 weeks of LL. Studies show that this light regime will 
induce out of season smoltification and is utilized in commercial fish farming (Berge 
et al., 1995, Arnesen et al., 2003). 
On January 10th, after the completion of smoltification, 8 tanks were moved back to 
LD 12:12 and 8 tanks were kept on LL. The tanks were supplied with either 35 ‰ 
seawater or freshwater, creating four experimental groups with four replicate tanks 
(fig. 4).  
It is expected that LL and LD 12:12 photoperiod will induce high and low incidences 
of male post-smolt maturation, respectively, while females will remain immature and 
thus function as immature controls within each group.  
 
Figure 4: Experimental setup. Eight tanks were kept on LL and eight tanks were kept on LD 12:12 
after completion of smoltification. These two groups will then be divided into seawater (SW) and 




The experiment consisted of a total of eight samplings; four from the smolting phase 
and four from the maturing phase (table 1).  
 
Table 1: Overview of sampling dates and number of fish sampled. 
Sampling nr  Date Fish sampled 
1 29.09.10 20 
2 03.11.10 20 
3 08.12.10 20 
4 05.01.11 20 
5 26.01.11 80 
6 16.02.11 80 
7 09.03.11 80 
8 29.03.11+ 30.03.11 160 
 
For the first four samplings, 20 fish were collected each time. On January 10th, 2 ½ 
weeks prior to sampling 5, the fish were separated into the four treatment groups 
illustrated in figure 4. Twenty fish were sampled from each group, resulting in 80 fish 
in sampling 5, 6 and 7. The number of immature males was limited at the end of the 
experiment. Hence, it was decided to sample 160 fish for the 8th sampling to ensure a 
sufficient number of non-mature males.  
The fish were collected using a dip net and transferred to 15 L buckets containing 
1g of the anesthetic metomidate (Syndel, Victoria, BC, Canada). When the fish were 
sedated, the fork length and total body weight were recorded and 2.5 ml of blood was 
extracted from the caudal vein. The blood was centrifuged (3000 x g, 5 min, 4C°) and 
three plasma aliquots, A, B and C, were collected and put on dry ice. After blood 
sampling, the head was cut off, internal organs removed and gonad weight recorded. 
Several tissue samples such as pituitary, kidney and intestine were taken as this 
experiment provided material for a number of studies, but only gill samples will be 
mentioned further.  
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Figure 5: Gill arches. The image shows a salmon head from above, illustrating the numbering and 
placement of sampled gill arches. Gill arch 1-4 is on the left side, whilst gill arch 5-8 is on the right 
side. Illustration modified from: 
animaldiversity.ummz.umich.edu/site/resources/Grzimek_fish/structure_function/v04_id131_con_gillf
un.jpg/view.html. 
The gill arches were sampled using tweezers and a scissor, cutting the gill arches off 
one by one. The gill arches are numbered 1 to 8 (fig. 5), with 1 being the anterior left 
arch, 4 the posterior left arch, 5 the anterior right arch and 8 the posterior right arch. 
The cartilage was cut off from gill arches 1 and 7 and the soft tissue was put in tubes 
marked G1. Gill arch nr 4 and nr 8 were not used, since there was sufficient amount 
of tissue and the posterior gill arches were often damaged when the head was 
removed. Gill arch 2 was put in tube marked G2. Gill arch 6 was put in tube marked 
G3. Gill arch 3 and 5 was put in tubes marked G4. The gill size increased rapidly and 
in sampling 7 and 8 the content of tubes originally containing two gill aches was 
reduced to one gill arch. Only gill arch 1, 2, 5 and 6 were then used. 
The tubes were marked with following labels, and with the correct number of the 
sampled fish: 
• G1 was frozen on dry ice for Western blots  
• G2 contained 4 % Paraformaldehyde (PF) in 0.1M Sørensen buffer for 
histology. 
• G3 contained SEI buffer for NKA activity  
• G4 contained RNAlater (Ambion, Austin, TX, USA) for RNA isolation. 
Plasma samples, G1 and G3 were kept on dry ice in a Styrofoam box during 
transportation back to UiB. These samples were stored on -80°C. Samples in 
RNAlater and PF were left in a fridge over night. Gill sample from G2 were fixated in 
4% PF, embedded in Tissue-tek (Sakura Finetek, Alphen aan then Rijn, Nederland) 
and stored at -80°C.  
Selected samples from tubes marked G4 were used for quantification of EF1a, 
NKAα1a and NKAα1b gene expression, while samples from G3 were analyzed for 
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NKA activity at Havbruksinstituttet AS, Bergen High Technology Center 
(http://www.hi.no/index.php).  
2.3 Selecting samples 
For gene expression twelve individuals, six immature females and six immature males 
were selected from sampling 1 to 4, giving 48 samples from the smolting phase. The 
individuals from sampling 5 to 8 were selected, post sampling, based on gender and 
gonado-somatix index (GSI) values (see below). Fish with a GIS above 0.05 were 
considered maturing, as elevated levels of 11-ketotestosterone have been observed in 
salmon reaching GSI of 0.05 and above in previous experiments (Andersson, 
Taranger, personal communication). The fish were then separated into three 
gender/maturity groups: maturing males, immature males and immature females. For 
each treatment group, six fish were selected from each gender/maturity group, if there 
were enough representatives. This gave 223 samples from sampling 5 to 8. 
2.4 Condition factor and sexual maturation 
The condition factor was calculated to using equation 1. 
Equation 1: Condition factor 
CF =




To access the degree of maturation was the gonado-somatic index (GSI) was 
calculated using equation 2. 
Equation 2: GSI 
GSI =
Gonad weight (g) x100
Total body weight (g)
 
2.5 RNA isolation in gill tissue 
Gill tissue from sample tubes marked G4 was used to extract mRNA according to the 
following procedure (Chomczynski, 1993). A standardized piece of gill tissue of 
approximately 80 mg were put in pre marked Fast-Prep vials containing 1 ml of TRI-
reagent (Sigma-Aldrich, St. Louis, MO, USA) 0.6 mg of ceramic beads and kept on 
ice for 5 min, before they were put in the Fast-Prep-120 (Thermo scientific, Waltham, 
MA, USA) for 20 sec on speed 4. The homogenized tissue was kept on room 
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temperature for 5 min before 200 μl of chloroform was added. The tubes were 
vortexed for 1 min and put in a pre-cooled (4°C) 5415R centrifuge (Eppendorf, 
Hamburg, Germany) for 15 min at 12000 x g.  
The supernatant containing total RNA was transferred to new pre marked 1.5 ml tubes 
and 500 μl isopropanol were added. The tubes were inverted five times each and left 
at room temperature for 10 min, before centrifugation for 10 min at 12000 x g at 4°C 
The supernatant was removed and the remaining pellet was washed with 500 μl 80 % 
ethanol and centrifuged for 5 min at 7600 x g. The supernatant was decanted, the 
samples flash spun and the last drop of ethanol removed. The pellet was air dried for 
5-10 min and reconstituted in 100 μl sterile nuclease free water. To ensure that the 
pellet was completely dissolved, the tubes were heated up to 55-60°C on a hot plate 
for 2-3 min and vortexed. 
Total RNA quantity and purity was determined using NanoDrop-1000 
spectrophotometer (Thermo Scientific, NC, USA). Overall, the purity of the total 
RNA samples was satisfactory, with 260/280 absorbance ratio being 1.8 or higher. 
However, the 260/230 ratio indicated small residual amounts of organic compounds in 
the sample (See section 5.2 for extended details). Total RNA in samples from 
sampling 1 – 4 were precipitated by adding 10 µl 3M Sodium Acetate, (NaAc, pH 
5.2) and 250 µl ice cold 100% ethanol, as they were to be stored at -80°C for more 
than two weeks. Prior to cDNA synthesis, the precipitated samples were collected 
from -80°C and immediately centrifuged for 30 min, 12000 x g at 4°C. The 
supernatant was decanted and RNA dissolved and quantified as described above. 
2.6 RNA integrity  
The integrity of twelve isolated and precipitated RNA samples was treated with 
Agilent RNA6000 Nano reagents and measured with Agilent 2100 bioanalyzer 
(Agilent technologies, Santa Clara, CA, USA), using the Agilent RNA Nano protocol 
according to the manufacturer’s instructions.  
1 μl of Agilent RNA6000 Nano dye concentrate was added to an aliquot containing 
65 μl of Agilent RNA6000 Nano filtered gel matrix (gel spun through a filtered tube) 
and the tube was vortexed and centrifuged at room temperature for 10 min at 13000 x 
g (Eppendorf, Hamburg, Germany). 9 μl of the Agilent RNA6000 Nano gel-dye 
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solution was added to one well, marked G on the LabChip (Caliper Life Sciences, 
Hopkinton, MA, USA). 
The LabChip was then placed on the Agilent 2100 bioanalyzer chip priming station 
(Agilent technologies, Santa Clara, CA, USA) and a permanently connected syringe 
was placed above the LabChip well to disperse the liquid by applying pressure. 9 μl 
of gel-dye mixture was then added to two other marked wells. 5 μl of Agilent RNA 
6000 Nano marker was applied to all wells without gel-dye. The Agilent RNA 6000 
ladder consisting of six RNA transcripts with lengths of 0.2, 0.5, 1.0, 2.0, 4.0 and 6.0 
kb, was collected from the freezer and heated to 70°C for 2 min along with the 
samples. 1 μl of ladder was added to the ladder well and 1 μl of each sample was 
added to their respective wells. The LabChip was then vortexed for 60 sec at 24000 
rpm in an IKA vortex (IKA, Staufen, Germany) and placed in the Agilent 2100 
Bioanalyzer. Results were obtained using the 2100 expert software (Agilent 
technologies, Santa Clara, CA, USA) and the RNA integrity number (RIN) noted. The 
RIN values showed excellent RNA integrity in all samples (Bustin and Nolan, 2004b). 
2.7 DNase treatment 
The samples were treated with RQ1 RNase free DNase (Promega Cat. No M6101) to 
remove traces of DNA. In a total reaction volume of 10 μl, 6.5 µl of total RNA (5 µg 
RNA), 2.5 μl RQ1 RNase-free DNase and 1 μl reaction buffer was used for the 
DNase treatment (table 2) per sample. The samples were then incubated at 37°C for 
30 min in a PCR machine (Applied Biosystems, Foster city, CA, USA) before the 
DNase reaction were inactivated by adding 1 μl of DNase stop solution followed by 
incubation of samples at 65°C for 10 min. The RNA was then used for cDNA 
synthesis. 
 
Table 2: Components of master mix used in DNase reaction (Promega Cat. No. M6101) 
Component Volume per sample 
10x reaction buffer 1μl 
RQ1 RNase free DNase 1 2.5 μl 
RNA templat X μl (5 μg RNA) 
RNase free H2O to total Volume 10 μl  
Sum 10 μl 
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2.8 cDNA synthesis 
cDNA synthesis was performed using the Reverse Transcription Core kit 
(EUROGENTEC RT-RTCK-05, Liege, Belgium) following the manufactures 
instructions.  
To synthesize cDNA, 23.8 μl of master mix and 1.2 μl DNase treated RNA (500 ng) 
were added to each PCR tube (table 3). The tubes were incubated (PCR 2700, Applied 
biosystems, Foster City, CA, USA) for 10 min at 25°C, then 30 min at 48°C, before 5 
min at 95°C. The cDNA were then stored at -20°C. 
 
Table 3: cDNA syntheses, master mix (Eurogentec Cat. No. RT-RTCK-05, Liege, Belgium) 
Components Volume per sample Final concentration Volume for 22 
samples 
10x Reaction buffer 3 μl 1x 66 μl 
25 mM MgCl2 solution 5 μl 5 mM 110 μl 
2.5 mM dNTP solution 5 μl 500μM each dNTP 110 μl 
Random nonamer 1.5 μl 2.5 μM 33 μl 
RNase inhibitor 0.6 μl 0.4 U/μl 13.2 μl 
H2O 12.95 μl 384.9 µl 284.9 μl 
Euroscript Reverse 
transcriptase 
0.75 μl 1.25 U/μl 16.5 μl 
RNA template 5 μg  1.2 μl   
Total volume 30 μl   
 
2.9 Real time quantitative PCR: quantification of gene expression 
Real-time quantitative PCR (qPCR) was performed to determine the relative 
expression of NKAα1a and NKAα1b levels in the gill tissue, using the Chromo4 
Continuous Fluorescence Detector (Bio-Rad, CA, USA) and MJ Opticon Monitor 
Analysis Software Platform (version 3.1, Bio-Rad). 
2.0 μl of cDNA from the 48 samples obtained from sampling 1 to 4 was collected in 
one tube to get one sample of stock cDNA to be used for dilution series. 50 μl of 
stock cDNA was added to 200 μl of nuclease free water. Then, 40 μl of the 1:5 
diluted cDNA was added to 360 μl of water, giving a dilution of 1:50. This was 
repeated with the 1:50 dilution and then with the 1:500 giving a ten-fold dilution 
series (fig. 7).  
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Figure 7: The figure illustrates how a ten-fold dilution series of cDNA was generated. 
The qPCR reactions were performed in a total volume of 25 μl, with 12.5 μl SYBR 
green (Applied Biosystems, Foster city, CA, USA), 0.5 μl of 10μM specific forward 
and reverse primers (table 4), 6.5 μl of H2O and 5 μl of cDNA template diluted 1:20.  
 
Table 4: Primer sequences. The specific primers used for the RT-qPCR and their respective nucleic 
acids sequence. 




5’- CACACGGCCCACAGGTACA-3’ R 













Each 96-welled plate (Bio-Rad, CA, USA) contained two Non Template Control 
(NTC) samples, followed by triplicates of the dilution series and duplicates of the 
actual samples. The thermal cycling protocol consisted of 10 min at 95 °C, followed 
by 45 cycles at 95 °C for 15 seconds and 60 °C for 1 min. All in all, 271 samples were 
analyzed for each gene, giving 6.5 plates per gene. A threshold of 0.012 was set 
manually for EF1α, and at 0.013 for NKAα1a and NKAα1b. The threshold was 
within the exponential phase and above the background noise for all assays (Bustin, 
2000). 
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The obtained Ct values were imported to Microsoft Excel® and the mean values of the 
sample duplicates were used for quantification of gene expression. The amplification 
efficiency (E) was determined using the slope of the regression line generated by the 
log cDNA input (0.5 μg RNA template) versus Ct values from cDNA dilution series. 
The regression line and slope for each plate was calculated using Sigmaplot version 
12 (Systat Software, San Jose, CA, USA). To reduce the efficiency variation in EF1α 
were the average slope of all plates used for calculation the efficiency. The regression 
lines were used for calculating efficiency in NKAα1a and NKAα1b using the 
following equation (Pfaffl, 2004):  
E = 10(-1/slope) 
To calculate relative expression in NKA1b and NKA1a were the following equation 
used (Pfaffl, 2004): 
 
Where: 
Etarget = Efficiency of the target gene (NKAα1a or NKAα1b) 
Eref = Mean efficiency of the reference gene (EF1α) 
CP sample = Mean Ct values from target gene of a specific individual 
CP sample = Mean Ct values from reference gene of a specific individual 
CP calibrator = Mean Ct value for NKAα1a or NKAα1b from the first sampling  
2.10 Statistical analysis 
All statistical analyzes were performed in Statistica version 10 (StatSoft, Inc, Tulsa, 
OK, USA). As the experiment consisted of two stages, the results and statistical 
analysis were divided in the same manner. A one-way ANOVA was used to test for 
differences in fork length, body weight, GSI, condition factor and gill NKA activity 
between tanks in each sampling to eliminate differences between tanks. A Dunnett’s 




A factorial ANOVA was performed to test differences in fork length, body weight, 
condition factor, GSI, NKA activity, NKAα1a and NKAα1b mRNA expression 
between genders and sampling. Gender and samplings was used as predictor variables 
and all the variables mentioned above were used as response variables. In case of 
significant ANOVAs, A Newman-Keuls post-hoc test was applied to reveal where the 
significant differences were. Samples displaying values that were more than 2 times 
the standard deviation (2 S.D.) of the mean were considered outliers and excluded 
from the dataset (Zar, 1996). The data was tested for homogeneity of variances and 
normality of distributions using Levene’s F-test and Normal probability plot of 
residuals with a Shapiro-Wilk test, respectively. When necessary, data were log 
transformed to better fit the assumptions of ANOVA.  
Maturation stage: 
A factorial ANOVA was performed to test differences in fork length, body weight, 
condition factor, NKA activity, NKAα1a and NKAα1b mRNA expression between 
mature males (MM) and immature females (NF) among each sampling, within each 
photoperiod/salinity group. The response variables were the same as in the smolting 
stage and maturation group and samplings was used as predictor variables. When 
finding differences in GSI between treatments groups were only data from MM used 
and treatment was used as a predictor variable instead of gender. Very few immature 
males (NM) were found after sampling 5, as almost all males became mature. For this 
reason, the NM group is not used for statistical analyzes. However the few NM are 
included in the graphical presentation of the results. Just as for the smolting data, 
samples displaying values that were more than 2 times the standard deviation (2 S.D.) 
of the mean was considered outliers and excluded from the dataset. The data was 
tested for homogeneity of variances and normality of distributions using Levene’s F-
test and Normal probability plot of residuals, respectively. When necessary, data were 









3.1 Smoltification stage 
The results were divided into two categories; the smolting stage (sampling 1 to 4) and 
the maturation stage (sampling 5 to 8). The 16 tanks received the same treatment 
during the smoltification stage and no significant difference in fork length, body 
weight, condition factor and GSI was found between tanks in each sampling. Slightly 
elevated levels of NKA activity were seen in one tank in sampling 1 and one in 
sampling 2. A one-way ANOVA found the two tanks to be significantly different 
(ANOVA p<0.05) from the other tanks in the sampling (appendix III). Although a 
significant difference was found, this was only for one response variable and in only 
two tanks (appendix III). Consequently, all tanks were treated as one group for the 
smolting stage. 
3.1.1 Fork length 
A significant increase in fork length (cm) in males and females was observed during 
smoltification and a factorial ANOVA revealed significant (ANOVA p<0,001) 
differences between samplings (fig. 8, appendix III). The fork length had increased 
significantly in both males and females in relation to the first sampling, but the length 
in sampling 3 did not differ from sampling 4 in neither males nor females. There was 































Figure 8: Fork length of Atlantic salmon males and females during smoltification stage. Asterisks 
(*) indicate significant differences in time within gender group in relation to the first sampling date. 
Data is presented as mean ± s.e.m. Females: n = 8 – 10 for each sampling, Males: n = 10 – 12 for each 
sampling. 
3.1.2 Body weight  
The body weight of both males and females increased significantly (ANOVA 
p<0.001) (fig.9, appendix III) throughout the smolting stage, as observed for fork 
length. The weight remained stable between sampling 3 and 4 and no significant 



























Figure 9: Body weight of male and female Atlantic salmon during smoltification. Asterisks (*) 
indicates difference in time within gender group in relation to first sampling. Data are presented as 
mean ± s.e.m. Females: n = 8 – 10 for each sampling, Males: n = 10 – 12 for each sampling. 
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3.1.3 Condition factor 
The condition factor remained steady for the first three samplings but dropped 
significantly (ANOVA p<0.001) between sampling 3 and 4 (fig. 10, appendix III). 
However, both males and females follow the same pattern and no significant 
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Figure 10: Condition factor of Atlantic salmon males and females during smoltification. No 
significant difference between males and females was found. Data is presented as mean ± s.e.m. 
Females: n = 8 – 10 for each sampling, Males: n = 10 – 12 for each sampling. 
3.1.4 Gonadosomatic Index 
The gonadosomatic index (GSI) remained stable in females and showed a slight 
increase in males throughout the smolting stage, and the GSI in males in sampling 3 
and 4 was significantly higher compared to sampling 1 (fig. 11, AVOVA p<0.05) 
(appendix III). The factorial ANOVA revealed a significant difference (ANOVA 
p<0.001) between males and females, with females having a slightly higher GSI than 





























Figure 11: GSI (%) of Atlantic salmon males and females during smoltification. Asterisks (*) 
indicates difference in time within gender group in relation to the first sampling. Differences between 
gender groups are represented by letters. Data is presented as mean ± s.e.m. Females: n = 8 – 10 for 
each sampling, Males: n = 10 – 12 for each sampling. 
3.1.5 Gill NKA activity 
Gill NKA activity remained stable for the first two samplings and then dropped 
significantly (ANOVA p<0.001) in the third sampling (fig. 12, appendix III). The 
activity level increased significantly for sampling 4 in relation to sampling 3 






































Figure 12: Gill NKA activity (µmol ADP mg-1 prot-1) of Atlantic salmon males and females 
during smoltification. Asterisks (*) indicates difference in time within gender group in relation to the 
first sampling. Data is presented as mean ± s.e.m. Females: n = 8 – 10 for each sampling, Males: n = 10 
– 12 for each sampling. 
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 3.1.6 Gill NKAα1b gene expression 
The relative NKAα1b gene expression level decreased in both males and females 
from sampling 1 to 3, but not significantly (fig. 13). A factorial ANOVA revealed a 
significant difference among samplings (ANOVA p<0.05, appendix III) and the post 
hoc test found that difference to be between females in the first sampling and between 
males in the 3rd sampling (appendix III). The NKAα1b gene expression in both 
genders seemed to reached the lowest point in sampling 3 and increased slightly for 


































Figure 13: Gill NKAα1b gene expression of Atlantic salmon males and females during 
smoltification. Data is presented as mean ± s.e.m., Females: n = 6 for each sampling, Males: n = 6 for 
each sampling. No differences in relation to samplings 1 was found within each gender, but a 









 3.1.6 Gill NKAα1a gene expression 
The expression of NKAα1a remained low throughout sampling 1 to 2 and increased 
significantly for males and females in sampling 3, before a decrease was observed at 
sampling 4 (fig. 14). A factorial ANOVA revealed significant differences between 
samplings (ANOVA p<0.0001) and the following post hoc test found the expression 
level of NKAα1a in males and females in sampling 3 to be significantly higher than in 
sampling 1 (fig 14, appendix III). No significant difference between genders was 


































Figure 14: Gill NKAα1a gene expression of Atlantic salmon males and females during 
smoltification. Asterisks (*) indicates difference in time within gender group in relation to the first 









3.2 Maturation stage  
The results from the maturation stage are divided into the three maturation categories: 
immature females (NF), immature males (NM) and mature males (MM) and are 
presented for each salinity/photoperiod combination (treatment group). As mentioned 
in section 2.11, only NF and MM were used for statistical analyses, due to a low n for 
NM in several of the treatment groups.  
3.2.1 Percentage of mature males 
As the tanks contained both males and females and no selections was done during 
sampling, was the gender of the sampled fish was completely random and this 
sometimes gave a low number of one of the genders. Following is an overview of the 
number of males sampled in each treatment group in each sampling (table 5). In 
general, the LL groups have a higher percentage of mature males, but almost all 
groups show a maturation percentage above 40. In sampling 8 almost all sampled 
males were mature (table 5). 
 
Table 5: Sampled males. The table shows the number of sampled males and the percentage of mature 
males within each group. 
Sampling Treatment No. of males No. of mature males % Mature males 
5 SWLL 5 5 100.0 
5 SWLD 10 5 50.0 
5 FWLL 10 9 90.0 
5 FWLD 11 3 27.3 
6 SWLL 10 9 90.0 
6 SWLD 7 4 57.1 
6 FWLL 9 4 44.4 
6 FWLD 10 8 80.0 
7 SWLL 11 11 100.0 
7 SWLD 10 7 70.0 
7 FWLL 6 3 50.0 
7 FWLD 9 4 44.4 
8 SWLL 17 15 88.2 
8 SWLD 17 16 94.1 
8 FWLL 18 17 94.4 
8 FWLD 24 17 70.8 
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3.2.2 Fork length sampling 5-8 
SWLL 
The fork length increased significantly for both NF and MM in SWLL throughout the 
maturation stage (fig. 15). The length remained stable in both NM and MM and no 
major peaks or lows were observed (fig. 15). The factorial ANOVA found a 
significant difference between samplings (ANOVA p<0.001), but not between 
maturation groups (appendix III). Two NM were found in sampling 8 and they 




























Figure 15: Fork length of Atlantic salmon SWLL during maturation. The fish are divided into the 
three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. No 
difference between NM and MM were found. Data is presented as mean ± s.e.m. NF: n = 8-15 in 
samplings 5-7 and 23 in sampling 8. MM: n = 5 in sampling 5 and n = 9 in sampling 6, n = 11 in 







The fork length of NF was significantly longer in sampling 7 and 8 compared to 
sampling 1 (ANOVA p<0.0001, fig. 16, appendix III). The length of MM increased 
significantly between sampling 5 and 6 and was significantly higher in sampling 6 
compared to NF (ANOVA p<0.0001, appendix III, fig. 16). However, the length of 
































Figure 16: Fork length of Atlantic salmon SWLD during maturation. The fish are divided into the 
three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. 
Differences between NF and MM in a sampling are marked with letters. Data is presented as mean ± 
s.e.m. NF: n = 8-15 in samplings 5-7 and 23 in sampling 8. MM: n = 10 for sampling 5, n = 7 in 








The fork length increased significantly for MM and NF in FWLL throughout the 
experiment (fig. 17). NF and MM displayed similar growth curves, but MM was 
significantly longer in sampling 5 (fig. 17, appendix III). A factorial ANOVA 
revealed significant differences between samplings (ANOVA p<0.0001), NF and MM 
(ANOVA p<0.05) and in the interaction between samplings and MM and NF 
(ANOVA p< 0.05) (fig. 17, appendix III). The growth curves of NF and MM did not 

































Figure 17: Fork length of Atlantic salmon in FWLL during maturation. The fish are divided into 
the three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. 
Differences between NF and MM in a sampling are marked with letters. Data is presented as mean ± 
s.e.m. NF: n = 8-15 in samplings 5-7 and 22 in sampling 8. MM: n = 10 for sampling 5, n = 9 in 






The fork length increased significantly for NF in FWLD throughout the study, but not 
for MM (fig. 18). The length increased significantly between sampling 5 and 6 for 
NF, but not for MM (fig. 18). The MM was significantly longer than NF in sampling 
5 and since MM did not increase significantly between sampling 5 and 6, NF and MM 
had the same mean length inn sampling 6 (fig. 18).  
The fork length decreased in all maturation groups in the seventh sampling (fig. 18). 
The curve of MM showed the same trend as NF and NM, but did not display as 
distinct peaks. A factorial ANOVA revealed differences between samplings (ANOVA 
p<0.0001), and in the interaction between samplings and NF and MM (ANOVA 
p<0.0001), but not between NF and MM alone (fig. 18, appendix III). NF is 































Figure 18: Fork length of Atlantic salmon in FWLD during maturation. The fish are divided into 
the three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. 
Differences between NF and MM in a sampling are marked with letters. Data is presented as mean ± 
s.e.m. NF: n = 8-15 in samplings 5-7 and 16-in sampling 8. MM: n = 11 for sampling 5, n = 10 in 




3.2.3 Body weight sampling 5-8 
SWLL 
The weight increased significantly in both MM and NF through the maturation period 
(fig. 19, appendix III). Just as in fork length of MM in SWLL, there was an even 
increase in body weight, without any major peaks or lows.  
The weight of NF increased steady throughout the maturation stage and NF was 
significantly heavier in sampling 8 than in sampling 5 (fig. 19, appendix III). A 
factorial ANOVA revealed a significant difference between samplings (ANOVA 
p<0.001) and between NF and MM (ANOVA p<0.05), but the following post hoc test 
showed no significant differences between MM and NF within specific samplings 


























Figure 19: Body weight of Atlantic salmon in SWLL during maturation. The fish are divided into 
the three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. Data 
is presented as mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8.MM: n = 5 in 





The weight curve of SWLD is similar to the fork length curve of SWLD, in which 
MM peaks at sampling 6 and was significantly heavier than NF (fig. 16 and 20). NF 
grows steady, and was significantly larger in sampling 8 than they were in sampling 5 
(fig. 20, appendix III). The same can not be said for MM, which all in all did not 
increase significantly in weight. The factorial ANOVA found significant differences 
between samplings (ANOVA p<0.0001) and in the interaction between maturation 
groups and samplings as males and females differed in sampling 6 and 8 (ANOVA 































Figure 20: Body weight of Atlantic salmon in SWLD during maturation. The fish are divided into 
the three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. 
Differences between NF and MM in a sampling are marked with letters. Data is presented as mean ± 
s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. MM: n = 10 for sampling 5, n = 7 in 







Both NF and MM showed a significant increase in weight throughout the maturation 
stage and the factorial ANOVA revealed a significant difference in body weight 
between NF and MM in FWLL (ANOVA p<0.001, fig. 21, appendix III). MM was 
slightly higher than NF until sampling 8, where NF was equally heavy as MM. As 
with fork length in FWLL, there was no specific peaks or lows in the weight curve 






























Figure 21: Body weight of Atlantic salmon in FWLL during maturation. The fish are divided into 
the three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. 
Differences between NF and MM in a sampling are marked with letters. Data is presented as mean ± 
s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. MM: n = 10 for sampling 5, n = 9 in 








Just as in SWLL and SWLD, the weight of MM was higher than the weight of NF in 
sampling 5 (fig 22). The weight of MM peaked slightly in sampling 6, but flattened 
out and ended up significantly lower than NF in sampling 8 (fig. 22, appendix III). A 
factional ANOVA revealed a significant difference between samplings (ANOVA p< 
0.0001), but not between NF and MM, although the post hoc test found differences 































Figure 22: Body weight of Atlantic salmon in FWLD during maturation. The fish are divided into 
the three maturation groups; immature females (NF), immature males (NM) and mature males (MM). 
Asterisks (*) indicates difference in time within maturation group in relation to the first sampling. 
Differences between NF and MM in a sampling are marked with letters. Data is presented as mean ± 
s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. MM: n = 11 for sampling 5, n = 10 in 






3.2.4 Gonadosomatic index sampling 5-8 
As the mature and immature individuals are separated by a GSI of 0.5, all immature 
fish will have a GSI below 0.5 and the difference between NF and MM will always be 
significant. The GSI is therefore presented for MM, with all treatment groups in one 
graph (fig 23).  
The GSI of SWLL and SWLD was significantly higher than FWLL in sampling 5, but 
the GSI of FWLD did not differ from any of the other treatment groups. In the 
following samplings it was the treatments with the same light regime that had the 
most similar development (fig. 23). The GSI peaked at sampling 6 for SWLD and 
FWLD, whereas the peak for SWLL and FWLL was observed sampling 7 (fig. 23). 
The GSI of SWLL and FWLL remained elevated after the peak, but the GSI of 
FWLD and SWLD decreased a great deal after peaking at sampling 6 (fig. 23). A 
factorial ANOVA showed significant differences between treatment groups (ANOVA 
p<0.05) and samplings (ANOVA p<0.0001) and in the interaction between them 


































Figure 23: GSI of Atlantic salmon MM in all treatment groups during maturation. Asterisks (*) 
indicates difference in time within maturation group in relation to the first sampling. Differences 
between treatments in a sampling are marked with letters. Data is presented as mean ± s.e.m. NF: n = 
8-15 in samplings 5-7 and 16-23 in sampling 8. MM: for n see table 5. 
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3.2.5 Condition factor sampling 5-8 
SWLL 
The condition factor of MM was quite high in sampling 5 and remained stable 
throughout the experiment, with no significant changes (fig. 24) (appendix III). The 
condition factor of NF started out significantly lower, but increased until sampling 7, 
remaining stable (fig. 24). A factorial ANOVA showed significant differences 
between NF and MM (ANOVA p<0.001) and between samplings (ANOVA p<0.01) 


































Figure 24: Condition factor of Atlantic salmon in SWLL during maturation. The fish are divided 
into the three maturation groups; immature females (NF), immature males (NM) and mature males 
(MM). Asterisks (*) indicates difference in time within maturation group in relation to the first 
sampling. Differences between NF and MM in a sampling are marked with letters. Data is presented as 
mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. MM: n = 5 in sampling 5 and n 






The condition factor was quite high for MM in this treatment group and remained 
relative stable throughout the experiment (fig. 25). However, there was a slight 
decline in sampling 8, causing MM to be significantly lower than NF in sampling 8 
(fig. 25). The condition factor of NF was lower than MM until sampling 7, where NF 
went above MM. A factorial ANOVA revealed significant differences between 






























Figure 25: Condition factor of Atlantic salmon in SWLD during maturation. The fish are divided 
into the three maturation groups; immature females (NF), immature males (NM) and mature males 
(MM). Asterisks (*) indicates difference in time within maturation group in relation to the first 
sampling. Differences between NF and MM in a sampling are marked with letters. Data is presented as 
mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. MM: n = 10 for sampling 5, n = 









The distance between the condition factor in MM and NF in sampling 5 was greater 
here than in the other treatments and the gap remained large until sampling 8 (fig. 26). 
Unlike in treatment SWLD and FWLD, did the NF line never cross and go above the 
MM line (fig. 26). In addition, the pattern of the lines resembles the pattern seen in 
SWLL. A factorial ANOVA revealed significant differences between MM and NF 

































Figure 26: Condition factor of Atlantic salmon in FWLL during maturation. The fish are divided 
into the three maturation groups; immature females (NF), immature males (NM) and mature males 
(MM). Asterisks (*) indicates difference in time within maturation group in relation to the first 
sampling. Differences between NF and MM in a sampling are marked with letters. Data is presented as 
mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. MM: n = 10 for sampling 5, n = 







Once more, the condition factor of MM is above NF in sampling 5, but as seen in 
SWLL and SWLD, MM remained quite stable as NF increases (fig. 24, 25, 27). 
Nevertheless, there was a significant increase in condition factor for MM between 
sampling 5 and 6, not seen in the other treatments (fig, 27). A factorial ANOVA 
revealed no significant difference between MM and NF, but a difference between 


































Figure 27: Condition factor of Atlantic salmon in FWLD during maturation. The fish are divided 
into the three maturation groups; immature females (NF), immature males (NM) and mature males 
(MM). Asterisks (*) indicates difference in time within maturation group in relation to the first 
sampling. Differences between NF and MM in a sampling are marked with letters. Data is presented as 
mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. MM: n = 11 for sampling 5, n = 






3.2.5 Gill NKA activity sampling 5-8 
SWLL 
The gill NKA activity was similar for MM and NF in sampling 5, but was 
significantly different between groups in sampling 6, since the NKA activity 
increased in NF, while it dropped in MM (fig. 28) (appendix III). Even though 
enzyme activity in NF increased in sampling 6, it followed MM and dropped at 
sampling 7. The NKA activity for both NF and MM reached their lowest level in 
sampling 7, as the activity level for both increased at sampling 8 (fig. 28). The 
factorial ANOVA found significant difference between samplings (ANOVA 









































Figure 28: Gill NKA activity (µmol ADP mg-1 prot-1) of Atlantic salmon in SWLL during 
maturation. The fish are divided into the three maturation groups; immature females (NF), immature 
males (NM) and mature males (MM). Asterisks (*) indicates difference in time within maturation 
group in relation to the first sampling. Differences between NF and MM in a sampling are marked with 
letters. Data is presented as mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. 





The Gill NKA activity level peaked in both NF and MM at sampling 6 followed by a 
decrease in sampling 7, and increased again for sampling 8 (fig. 29). The enzyme 
activity level in NM seemed to follow the same trend as NF, but there was a greater 
variation in activity within each sampling, probably due to low n. A factorial ANOVA 
found significant differences between samplings (ANOVA p<0.0001) and maturation 









































Figure 29: Gill NKA activity (µmol ADP mg-1 prot-1) of Atlantic salmon in SWLD during 
maturation. The fish are divided into the three maturation groups; immature females (NF), immature 
males (NM) and mature males (MM). Asterisks (*) indicates difference in time within maturation 
group in relation to the first sampling. Differences between NF and MM in a sampling are marked with 
letters. Data is presented as mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. 








The activity level in FWLL resembled the activity level seen in FWLD. As in the 
other treatment groups, the activity level of NF was significantly higher than in MM 
(fig. 30) (appendix III).  The peaks and lows were not as prominent here as in the 
other groups, but the activity level in both NF and MM in sampling 7 were 
significantly lower compared to the first sampling (fig. 30, appendix III). NM is the 
group that stands out, with very high activity in sampling 6 and very low activity in 
sampling 7 (fig. 30). The factorial ANOVA revealed significant differences between 











































Figure 30: Gill NKA activity (µmol ADP mg-1 prot-1) of Atlantic salmon in FWLL during 
maturation. The fish are divided into the three maturation groups; immature females (NF), immature 
males (NM) and mature males (MM). Asterisks (*) indicates difference in time within maturation 
group in relation to the first sampling. Differences between NF and MM in a sampling are marked with 
letters. Data is presented as mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. 





There was a significant difference between the activity level of NF and MM in 
sampling 5 and the difference remained until sampling 8, except for sampling 7 where 
no significant difference was found (fig. 31) (appendix III). Compared to SWLL and 
SWLD, one can see a similar trend in activity level, but the levels were much lower in 
FWLD. Another thing that also differs from the SW groups is that only NF has an 
increased NKA activity level in sampling 8, while MM remained low. The NKA 
activity in NM was almost completely level with no apparent trend. The factorial 
ANOVA revealed significant differences between samplings (ANOVA p<0.0001) and 






































Figure 31: Gill NKA activity (µmol ADP mg-1 prot-1) of Atlantic salmon in FWLD during 
maturation. The fish are divided into the three maturation groups; immature females (NF), immature 
males (NM) and mature males (MM). Asterisks (*) indicates difference in time within maturation 
group in relation to the first sampling. Differences between NF and MM in a sampling are marked with 
letters. Data is presented as mean ± s.e.m. NF: n = 8-15 in samplings 5-7 and 16-23 in sampling 8. 
MM: n = 11 for sampling 5, n = 10 in sampling 6, n = 9 in sampling 7, n = 24 in sampling 8. 
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 3.2.6 Gill NKAα1b gene expression sampling 5-8 
SWLL 
The NKAα1b expression level in NF was stable trough the whole maturation period, 
(fig. 32). If one compares the expression level in sampling 5 to the α1b expression 
level in sampling 4 (fig. 13), it is clear that the expression level has dropped between 
these two samplings. No significant differences were found between maturation 
groups or between samplings (appendix III) although the expression level for MM 

































Figure 32: Gill NKAα1b gene expression of Atlantic salmon in SWLL during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 








The NKAα1b expression level of NF increased until sampling 7 where it peaked, 
before dropping at sampling 8 (fig. 33). The α1b level of MM remained fairly stable, 
but this also decreased slightly at sampling 8 (fig. 33). The expression level of NM 
seems different from the two other groups, with a low expression level in sampling, 
followed by a peak in α1b expression at sampling 7 (fig. 33). The factorial ANOVA 
revealed no significant differences between samplings nor between maturation groups 



































Figure 33: Gill NKAα1b gene expression of Atlantic salmon in SWLD during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 
mature males (MM). Data is presented as mean ± s.e.m. NF: n = 5-6 in all samplings. MM: n = 5-7 in 






The NKAα1b expression levels in MM in FWLL remained low during the entire 
experiment and thus seem to differ from all the other treatments (fig. 34). In contrast, 
the α1b expression level of NF followed a similar trend observed in SWLD and 
FWLD, with a significant peak in sampling 6 and then a steady decline till sampling 
8. The factorial ANOVA found the difference between NF and MM to be significant 
(ANOVA p<0.0001), and the following post hoc found the expression level for NF in 







































Figure 34: Gill NKAα1b gene expression of Atlantic salmon in FWLL during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 
mature males (MM). Asterisks (*) indicates difference in time within maturation group in relation to 
the first sampling (sampling 6 for MM). Differences between maturations groups in a sampling are 
marked with letters. Data is presented as mean ± s.e.m. NF: n = 5-6 in all samplings. MM: n = 2 in 






The NKAα1b expression levels in FWLD resembled the expression level in SWLD, 
with NKAα1b being expressed higher overall in NF than in MM. There were no 
specific peaks for NF and MM, but there was a slight increase in both groups at 
sampling 6, before they decline steadily until sampling 8 (fig. 35). It seemed that the 
NKAα1b levels of NM were at its highest in sampling 6, before it plunged down at a 
possible low in sampling 7 and then seemed to remained low throughout of the 
experiment (fig. 35). No significant differences were found between samplings or 


































Figure 35: Gill NKAα1b gene expression of Atlantic salmon in FWLD during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 
mature males (MM). Data is presented as mean ± s.e.m. NF: n = 5-6 in all samplings. MM: n = 4 in 
sampling 5 and n = 3 in sampling 7, n = 5-6 in sampling 6 and 8. 
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3.2.7 NKAα1a gene expression sampling 5-8 
SWLL 
The NKAα1a gene expression results for SWLL are affected by the great variation for 
NF in sampling 6 and for MM in sampling 8. The level of NF peaks in sampling 6 but 
is low in the other samplings (fig. 36). The expression level in MM stays low until 
sampling 8, where the mean level and variation increased. The factorial ANOVA 
found a significant difference between samplings (ANOVA p<0.05), but the 
following post hoc test could not detect which samplings that differed (appendix III). 

































Figure 36: Gill NKAα1a gene expression of Atlantic salmon in SWLL during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 








The expression level of MM increased significantly from sampling 6 through 7 and 8 
and was significantly higher than NF in sampling 7. Although the expression level in 
NF does not seem to increase all that much, did the post hoc test revealed a significant 
increase in sampling 7 and 8 compared to sampling 5 (fig. 37, appendix III). The 
factorial ANOVA revealed significant differences between samplings (ANOVA 









































Figure 37: Gill NKAα1a gene expression of Atlantic salmon in SWLD during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 
mature males (MM). Asterisks (*) indicates difference in time within maturation group in relation to 
the first sampling (sampling 6 for MM). Differences between maturations groups in a sampling are 
marked with letters. Data is presented as mean ± s.e.m. NF: n = 5-6 in all samplings. MM: n = 5-7 in 








The expression level of NF remains quite high throughout the experiment with a 
slightly lower expression in sampling 7 (fig. 38). The level of expression in NF is also 
significantly higher compared to MM in sampling 5 (fig. 38). The expression level in 
MM shows a steady increase from sampling 5 to sampling 8. The factorial ANOVA 
revealed significant differences between samplings (ANOVA p<0.01), maturation 








































Figure 38: Gill NKAα1a gene expression of Atlantic salmon in FWLL during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 
mature males (MM). Asterisks (*) indicates difference in time within maturation group in relation to 
the first sampling (sampling 6 for MM). Differences between maturations groups in a sampling are 
marked with letters. Data is presented as mean ± s.e.m. NF: n = 5-6 in all samplings. MM: n = 2 in 





Both NF and MM follow the same trend in this treatment group, with an expression 
that increases slightly for sampling 6, goes slightly down for sampling 7 before it 
peaks at sampling 8 (fig. 39). The factorial ANOVA found significant differences 
between samplings (ANOVA p<0.001), but revealed no significant difference 






































Figure 39: Gill NKAα1a gene expression of Atlantic salmon in FWLD during maturation. The 
fish are divided into the three maturation groups; immature females (NF), immature males (NM) and 
mature males (MM). Asterisks (*) indicates difference in time within maturation group in relation to 
the first sampling (sampling 6 for MM). Data is presented as mean ± s.e.m. NF: n = 5-6 in all 











Atlantic salmon go through several changes during smoltification, many of which 
occur when the salmon are still in FW. Some time after SW migration, the salmon 
will reach sexual maturation and migrate back to FW to spawn. Data from the current 
study give an insight to the osmoregulatory changes that take place during 
smoltification, SW transfer, desmoltification and maturation which will increase the 
understanding of osmoregulation and the expression of the NKAα1a and NKAα1b 
subunit isoforms in Atlantic salmon during these changes. The results from the 
present study will be discussed in the mentioned order. 
4.1 Smoltification 
Production of out of season smolts for intensive fish farming is widespread and the 
method has been perfected over many years. The parr are normally kept on LL for a 
period of time, before a LD photoperiod regime is initiated to induce smoltification 
(Sigholt et al., 1995), as changes in photoperiod are one of the main triggers for 
initiation of smoltification (McCormick et al., 1998). It is suggested that lack of 
photoperiod signals inhibit the development of the light-brain-pituitary axis and 
prevent smoltification through lack of endocrine control (Ebbesson et al., 2007). 
Several tests confirm this dependency on a period of short day length, as parr kept 
only on LL do not display increased NKA activity and fail to adapt to SW (Stefansson 
et al., 2007, Bjørnsson et al., 1989). Nevertheless, salmon from the present study 
showed several signs of a successful smoltification, which will be discussed below.  
As expected, males and females increased in both length and weight during the smolt 
period, but there was no significant growth between sampling 3 and 4. Sampling 3 
was conducted at the end of the artificial winter period (LD 12:12) and sampling 4 
was performed after reintroduction to LL. Salmon exposed to continuous light grow 
faster due to higher plasma GH levels compared to salmon held in LD or simulated 
natural photoperiods (SNP) (Bjørnsson et al., 2000, Krakenes et al., 1991, 
McCormick et al., 1995), but a LD period is necessary to induce smolting and to 
maintain rapid growth after SW transfer (Berge et al., 1995, Endal et al., 2000, Sigholt 
et al., 1995, Stefansson et al., 2007).  
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The slow growth during LD is reflected by a decrease in condition factor (CF) in the 
same period. The reduction in CF is expected during smoltification (Bjørnsson et al., 
1989, Sigholt et al., 1995) and is explained as a result of increased catabolism and 
growth in length unmatched by weight (McCormick and Saunders, 1987). The latter is 
explained as an ocean adaptive morphological change, giving the fish a more 
streamlined profile (Thorpe et al., 1982).  
The gonadosomatic index (GSI) was the only variable showing differences between 
males and females during smoltification. Immature females have a higher GSI than 
immature males, since they have larger gonads (Mattson, 1991). Contrary to what was 
seen in females, GSI in males increased significantly during smolting. A reduction in 
day length may induce precocious maturation in male parr (Skilbrei and Heino, 2011, 
King et al., 2003, Berrill et al., 2003) and the significant increase in GSI in sampling 3 
in males suggests that the males respond to the LD treatment and prepare for 
maturation. This could mean that the photoperiod regime used for production of 0+ 
smolt may induce puberty in large males (Skilbrei and Heino, 2011). Nevertheless, 
males never reached the GSI level of females during smoltification and no mature 
male parr was found.  
In the two first samplings, when fish were still on LL, NKA activity was fairly high, 
before it dropped significantly under LD 12:12 in sampling 3. Previous studies on 
underyearling smolts show a similar reduction in NKA activity after the 
commencement of LD (Berge et al., 1995). Gill NKA activity increased after 
reintroduction to LL, suggesting that smoltification was initiated as elevated NKA 
activity levels is strongly associated with SW adaptation (Boeuf and Prunet, 1985, 
McCormick et al., 1998, McCormick and Saunders, 1987). Gill NKA activity was 
equally high prior to LD as after, which might be related to the fact that the parr was 
larger than anticipated, preceding the LD treatment. Large parr adapt better to abrupt 
SW transfer than small parr signifying body mass as an important factor in SW 
acclimation (Bjerknes et al., 1992).  
The lowest point for gill NKAα1b expression was in sampling 3, the same as for gill 
NKA activity. This is in coherence with the previously found correlation between 
elevated levels of NKA activity and high NKAα1b protein (McCormick et al., 2009) 
and gene expression (Nilsen et al., 2007). Moreover, as NKA activity increased in 
sampling 4, enhanced gill NKAα1b expression was also expected since the NKAα1b 
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is related to NKA activity (Nilsen et al., 2007, Stefansson et al., 2007, Richards et al., 
2003). Although a slight increase is seen in NKAα1b expression, it is not significant 
nor is it as profound as the increase seen in NKA activity. This could suggest that 
NKAα1b mRNA already has been translated into protein, giving a higher NKA 
enzyme activity than NKAα1b expression. During smoltification there will be a high 
turnover of NKAα1b to increase NKA activity and prepare the salmon for SW 
transfer. After SW acclimation NKAα1b will return to a “steady state” of 
transcription, maintaining NKA activity at a stable level (Meyer et al., 2004). Nilsen 
et al. (2007) detected high NKA enzyme activity in smolts one month after SW 
transfer while NKAα1b transcription declined indicating that NKAα1b had reached 
the steady state of transcription necessary to maintain a high NKA activity.  
The expression of gill NKAα1a showed a significant peak in sampling 3, at a time 
when both gill NKAα1b expression and NKA activity were at their lowest. During 
smoltification, gill NKAα1a expression levels decline whilst gill NKAα1b expression 
and NKA activity levels rise (Nilsen et al., 2007). Previous studies of NKAα1a found 
changes in NKA isoforms as a response to salinity change in both rainbow trout (O. 
mykiss) (Richards et al., 2003) and Atlantic salmon (Bystriansky et al., 2006, Nilsen et 
al., 2007), but no data exist on NKA isoform alteration in relation to immediate 
changes in photoperiod. The hormonal alteration created by the change in light may 
contribute to NKA isoform change since there are often higher values of the FW 
adaptive hormone PRL and low amount of SW adaptive hormones like GH present 
during winter (McCormick, 2001, Nilsen et al., 2008, Prunet et al., 1989). 
Furthermore, the antagonistic relationship between NKAα1a and NKA activity 
supports the general understanding that a high NKA activity is more closely linked to 
the α1b isoform than the α1a isoform of NKA (Madsen et al., 2008, McCormick et 
al., 2009, Nilsen et al., 2007, Richards et al., 2003, Stefansson et al., 2007). Recently 
discovered structural and thermodynamic differences between NKAα1b and NKAα1a 
support hypothesis of NKAα1a as the main isoform for ion uptake while NKAa1b is 
the main isoform for ion excretion (Jorgensen, 2008) 
4.2 Post smolts 
After completion of smoltification the tanks were divided into FW and SW with either 
LL or LD light treatment. In the wild or in commercial farming, the smolts would at 
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this point migrate or be transferred to a marine environment. Consequently, immature 
females (NF) exposed to SW in this study follow a common SW adaptation process 
and are expected to show the characteristics of a post-smolt in SW.  
The significant increase in general body size through sampling 5-8 was seen in both 
LL and LD and they showed approximately the same development. Both LL and SW 
transfer is found to increase GH levels (Arnesen et al., 2003, Bjørnsson et al., 2000, 
Sakamoto et al., 1993), which consequently may affect the overall growth of the 
salmon. Although one thus might anticipate a more profound length and weight gain 
in the LL group compared to the LD group, prolonged exposure to LL treatment is 
also known to eventually reduce growth rate (Berge et al., 1995, Saunders et al., 
1985). The two known effects of LL might counterbalance each other, giving a 
similar growth for LL and LD treated salmon.  
Even though no differences were seen between the photoperiod treatments in relation 
to weight and length there seems to be a difference between light regimes in CF.  
The CF for NF in SWLD showed a steady increase throughout the SW acclimation 
period and showed no sign of flatting out, while CF for NF in SWLL stabilized 
between sampling 7 and 8 and never reached as high CF as NF in SWLD. It is 
possible that the mentioned negative effects of LL is displayed in the CF although no 
differences in seen in body size between the light treatments (Berge et al., 1995, 
Saunders et al., 1985). 
Two weeks after salinity change, neither NF from the SWLL treatment group nor 
from the SWLD group showed elevated levels of NKA activity compared to the 4th 
sampling. Madsen et al (2008) found elevated levels of NKA activity first after seven 
days in SW while Berge et al. (1995) found increased activity 96 h after introduction 
to SW. It seems there is great variation between different photoperiod treatments as to 
when the first signs of elevated NKA activity occur (Berge et al., 1995). Moreover, 
salmon that are transferred to SW after the initial NKA activity peak show a greater 
increase in NKA activity after SW transfer (Arnesen et al., 2003). The modest 
increase in NKA activity in this study may indicate that SW transfer was timed 
perfectly in relation to smolt status. After some time in SW, when the salmon is 
completely acclimatized the NKA activity level will stabilize (Singer et al., 2002) and 
the reduction in NKA activity in NF in SW groups after sampling 6 may indicate that 
the smolts are fully adapted to SW some time between sampling 6 and 7. 
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In coherence with pervious findings, there was an upregulation in gill NKAα1b 
expression in both SW groups after SW transfer (Madsen et al., 2008, McCormick et 
al., 2009, Nilsen et al., 2007, Bystriansky et al., 2006). Because of the variation within 
each point, few statistically significant changes were detected but a general trend can 
be seen. In both smolting salmon and in parr, amplification in relative NKAα1b gene 
expression was seen after SW transfer (McCormick et al., 2009, Nilsen et al., 2007). 
The effect of SW was more profound in these experiments than in the present results 
but some similarities can be seen. A drop in NKAα1b expression was seen in SWLD 
and may indicate that the smolts are adjusting to SW and high transcription of 
NKAα1b is no longer necessary to maintain a stable plasma osmolality. NKAα1b 
transcription has thus reached a steady state. A down-regulation of NKAα1b in SW 
acclimatized smolts was also noticed in Nilsen et al. (2007) and after one month in 
SW, NKAα1b expression level was equally high as in smolts kept in FW. The 
NKAα1b transcription level in SWLL remained high and did not decrease towards 
the end of the experiment. It can be hypothesized that elevated levels of GH in the LL 
treatment group may have stimulated NKAα1b transcription to remain high as GH is 
known to be involved in the proliferation and differentiation of SW-type CC 
(McCormick, 2001) and high levels of GH correlate with elevated NKAα1b 
transcription (Stefansson et al., 2007) 
Gill NKAα1a transcription in NF was on a steady decline in both SW groups after 
smoltification was initiated. NKAα1a is associated with FW adaptation and its 
transcription is expected to decline during SW adaptation (Madsen et al., 2008, 
McCormick et al., 2009, Nilsen et al., 2007, Stefansson et al., 2007). However, an 
increase in NKAα1a expression is registered for NF in SWLL in sampling 6 and there 
is also a significant increase in NKAα1a expression in NF for SWLD from sampling 
7 and onwards. Unlike previous findings the NKAα1a expression peak in SWLL 
seems to coincide with high expression of NKAα1b in the same group. When taking 
in to consideration the variation within NKAα1a expression in this particular 
sampling and the fact that all previous experiments of similar character contradicts 
this finding, one should be careful to interpret too much into the elevated levels of 
NKAα1a (Bystriansky et al., 2006, Madsen et al., 2008, McCormick et al., 2009, 
Nilsen et al., 2007, Stefansson et al., 2007). The small but significant increase in 
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NKAα1a in SWLD stands in relation to the decrease in NKAα1b and NKA activity 
and supports the previous description of the antagonistic relationship between these 
isoforms (Madsen et al., 2008, McCormick et al., 2009, Nilsen et al., 2007, Richards 
et al., 2003).   
To summarize, based on increased NKAα1b and NKA enzyme activity it seems like 
the smolt transfer to SW was timed perfectly in relation to smolt status and that the 
smolts had reached the steady state of NKAα1b transcription after sampling 6 and 
thus were acclimatized to SW. In addition, NKAα1a level is low in SW, but increases 
towards the end of the experiment.   
4.3 Desmoltification 
When smolts are prevented from reaching SW they go through a desmoltification 
process where they are partially readapted to FW through the loss of hypo-
osmoregulatory ability (Stefansson et al., 1998). Subsequently, in this study, NF 
smolts kept in FW are expected to show signs of desmoltification after several weeks. 
High temperatures (>14 °C) are known to accelerate desmoltification in salmon 
(Stefansson et al., 1998, Handeland et al., 2004), thus the high temperature (16°C) 
maintained during this trial is thought to speed up the desmoltification process. Just as 
for NF kept in SW, both FW groups grew steadily throughout the long-term FW 
phase although NF in FWLD did not increase in size between sampling 6 and 7. 
The condition factor also increased in the FW groups and CF did not seem to be 
affected by the slow growth between sampling 6 and 7 in the LD group. Handeland et 
al. (2004) reported of decreasing condition factor in desmolting salmon and while the 
condition factor in the present study increased, it seemed to stabilize and even 
decrease slightly for NF in FW after sampling 7.  
The gill NKA activity level was lower in the FW groups than the SW groups 
throughout sampling 5-8. NF in FWLL had a higher NKA activity in sampling 5 than 
FWLD. In addition the drop in NKA activity between sampling 6 and 7 was greater in 
FWLL than FWLD. Lowered NKA activity is a strong indication of desmoltification 
(Handeland et al., 2004, Stefansson et al., 1998) and thus is seems that 
desmoltification in FWLD already had begun in sampling 5, while desmoltification 
did not fully commence in FWLL before sampling 6. As both treatment groups were 
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kept at 16 °C the difference can only be explained by the different photoperiod 
treatments.  
As discussed above, lowered NKA activity is often in coherence with lowered 
transcription of gill NKAα1b (Nilsen et al., 2007, Madsen et al., 2008, McCormick et 
al., 2009, Stefansson et al., 2007). Consistent with these findings, NKAα1b 
expression seemed to be lower in FWLD than in FWLL throughout sampling 5 to 8 
and a drop in NKAα1b expression is seen in NF from sampling 6 and onwards in both 
FW groups. The higher NKA activity and NKAα1b expression level in LL can only 
be related to photoperiod treatment. It is possible that the elevated levels of GH in LL 
stimulate NKAα1b production and thus delay desmoltification (McCormick, 2001, 
Tipsmark and Madsen, 2009). In addition, NKAα1b, considered to be the SW specific 
isoform (Richards et al., 2003), is expressed lower in FW then in SW, giving support 
to this hypothesis.  
The high levels of NKAα1a were found in FW groups throughout the study and 
support the suggestion of NKAα1a as the FW adaptive isoform (Nilsen et al., 2007, 
McCormick et al., 2009, Shrimpton et al., 2005, Richards et al., 2003). While there 
was a significant increase in NKAα1a transcription in the LD photoperiod group, 
there were no significant changes in the LL group. The high expression of NKAα1a 
in sampling 8 for both groups indicates full FW adaptation and is consistent with the 
low NKAα1b transcription in the same sampling and with previous findings of the 
antagonistic relationship between NKAα1b and NKAα1a (Madsen et al., 2008, 
McCormick et al., 2009, Nilsen et al., 2007, Richards et al., 2003, Shrimpton et al., 
2005). 
Conclusively, based on gill NKA activity, gill NKAα1b and NKAα1a expression 
data, desmoltification seems to begin earlier in the FWLD group compared to the 
FWLL group, which may be caused by a elevated GH levels in LL (McCormick, 
2001, Bjørnsson et al., 2000). 
4.4 Osmoregulation in maturing male Atlantic salmon 
As presented in table 5, there were a high percentage of mature males in all treatment 
groups although there were slightly fewer in the LD groups than in the LL. A high 
percentage in the LD group was unexpected and is probably mainly connected to 
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large size of the smolts (see section 5.1). Consequently, few immature males were 
available and were thus not included in statistical analysis.  
In previous studies on osmoregulatory changes in maturing salmon Pacific salmon 
have been used and sampled individuals were always wild caught (Makino et al., 
2007, Shrimpton et al., 2005, Uchida et al., 1997). When comparing Atlantic and 
Pacific salmon one should always bear in mind that their salinity tolerance varies 
between genus in the salmon family and differences in lifecycle occur (Bystriansky et 
al., 2006, Gross, 1985). In addition, all wild caught individuals have been exposed to 
various environmental stimuli and one does not know the background for each fish. 
With that said, all are salmonids and similar changes in NKA subunits have been 
observed in Pacific and Atlantic salmon (Madsen et al., 2008, Nilsen et al., 2007, 
Richards et al., 2003, Shrimpton et al., 2005). 
Puberty and sexual maturation in salmon are mainly controlled trough photoperiod 
cues and the activation of the light-brain-pituitary-gonad axis (Schulz et al., 2010, 
Schulz et al., 2006, Taranger et al., 1999). Moreover, puberty in males will eventually 
lead to elevated levels of androgens and it is hypothesized that endocrine changes 
during maturation may have an direct effect on osmoregulation (Makino et al., 2007). 
Hormone data are not presented in this thesis, but blood plasma samples from 
samplings are available and will be analyzed at a later date. Elevated levels of 11-KT 
have been seen in male salmon with a GSI above 0.5 (Andersson E, Taranger G.L., 
Personal communication, (Campbell et al., 2003) thus MM in this study are 
considered to be under the influenced of androgens. 
The fork length of mature males increased significantly in the LL treatment groups 
but not in the LD groups, although a significant increase in length was seen in SWLD 
in sampling 6. These findings are consistent with previous observations where fish 
kept in LL were longer than fish kept on LD (Krakenes et al., 1991). Furthermore, in 
the 5th sampling, MM seems to be overall longer than NF, but only significantly so in 
the FW groups. The smolts that remained in FW were not exposed to the stress of a 
salinity change and it seemed like MM in the FW groups grew more between 
sampling 4 and 5 than NF in FW. This may have caused the significant difference in 
length between NF and MM in the FW groups in sampling 5. In addition, reduced 
growth has been observed in mature salmon (Saunders et al., 1982) and this is one of 
the reasons why mature fish are unwanted in commercial aquaculture (Taranger et al., 
1999). Thus, the difference in length may have been related to maturation. When 
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examining GSI data one clearly seen that the peak in GSI for LD treatment was in 
sampling 6 while it was in sampling 7 for LL. Maturation seemed to commence 
earlier in LD possibly resulting in low appetite and poor growth. In addition, negative 
effect of maturation on growth may be less prominent in salmon kept on LL due to the 
fact that growth is stimulated by LL (Bjørnsson et al., 2000). 
The pattern for growth in body weight reflects the changes in length growth with no 
significant weight gain for MM in the LD groups and significant growth in the LL 
groups. This is also in accordance with previous studies on photoperiod and growth 
(Saunders et al., 1989, Sigholt et al., 1995) although Duncan et al. (1999) reported of 
a higher weight gain in simulated natural photoperiod groups in comparison to LL.  
The large body size upheld by MM in the LL groups was reflected in the CF, as CF in 
MM stayed above NF throughout the sampling. However, this is not the case in LD 
were the CF for MM remained fairly stable, but is passed by NF in sampling 7 and 
end up being significantly lower in sampling 8 in SWLD. There seems to be a 
connection between light and gender/maturation in relation to CF. Perhaps MM in LD 
consumed less feed as CF and feed uptake are proven to be correlated (Austreng et al., 
1987, Kindschi, 1988). In addition, maturing grilse tend to cease feeding during the 
summer months, after growing rapidly in the spring (Kadri et al., 1997, Kadri et al., 
1996). This is unlike immature fish, which grow slow in spring, but tend to increase 
appetite in relation to elevated temperatures (Kadri et al., 1997, Saunders et al., 1994). 
If this were true for this study, we should have seen a decline in CF in MM, but it 
remained stable. This could suggest that the MM consumes enough feed to maintain a 
stable CF, but not enough feed to increase CF.  
There seems to be a correlation between photoperiodic treatment and when the GSI 
peak occurs. MM in both SWLD and FWLD reach their maximum GSI in sampling 6 
while MM in SWLL and FWLL peak in sampling 7. Photoperiod treatment has 
variable effects depending on when the treatment is initiated, duration and strength of 
photoperiod and the physiological state of the animal (Oppedal et al., 1999, Schulz et 
al., 2006, Taranger et al., 1999). In this particular study smolts exposed to LD became 
mature earlier than smolts in LL. Some male smolts may have during smoltification 
reached the internal threshold for commencing maturation. Since salmon spawn in 
autumn, males that already were ready to mature and put on LD may have accelerated 
maturation as the reduced day length made them believe autumn was approaching. 
When planning this study, a low degree of male maturation was expected in the LD 
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group, but instead they matured earlier. This illustrates how unpredictable the 
outcome of photoperiodic treatment can be and why more knowledge is needed when 
it comes to the role of preventing precocious maturation in male salmon (Taranger et 
al., 2010). 
NKA activity for MM seemed to follow the general pattern of NKA activity in NF but 
was lower in MM than NF in all treatment groups although not statistically lower in 
all samplings. In addition, NKA activity was lower in the FW groups, which is a 
common observation for NKA activity in smolts kept in FW (Bystriansky et al., 2006, 
McCormick et al., 2009, Nilsen et al., 2007, Stefansson et al., 1998). It may seem like 
MM prepare for FW with reduced NKA activity in a similar way that smolting parr 
prepare for SW by increasing NKA activity.  
Because of the variation within each point, few statistically significant changes were 
detected, however, a general trend can be seen where NKAα1b expression in MM in 
general was lower in the FW groups than in the SW groups and it also seemed to be 
lower in MM than in NF. In addition, NKAα1b expression for MM in SWLL was 
equally high as for NF throughout sampling 5-7 before a drop in expression was seen 
in sampling 8. Even though NKAα1b expression for MM in SWLD was not 
significantly different from NKAα1b expression in NF, the trend suggests a lower 
expression in MM. The same can be said for NKAα1b transcription in MM in FWLD. 
Moreover, NKAα1b transcription in MM in FWLL was different than in the other 
treatment groups as there was no up or down regulation of NKAα1b throughout the 
experiment and the expression level in MM was significantly different from that of 
NF. 
The lowered levels of NKAα1b in MM in relation to NF may indicate that elevated 
levels of maturation specific androgens like testosterone (T) and 11-ketotestosteron 
(11-KT) affect gill NKAα1b gene expression. An experiment done by Onuma et al. 
(2005) showed that sex steroids have a direct effect on the gene expression of PRL in 
masu salmon (O. masou) and PRL has been shown to reduce NKAα1b gene 
expression in Atlantic salmon (Tipsmark and Madsen, 2009).  
Both immunohistochemistry using specific antibodies of α1a and α1b (McCormick et 
al., 2009) and In Situ hybridization (Madsen et al., 2008) have been used to 
characterize the size, abundance and localization of NKAα1a and NKAα1b in gill 
tissue. Utilizing the latter method, PRL was found to have a negative effect on SW-
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type CC and especially NKAα1b (Tipsmark and Madsen, 2009). Consequently, the 
low NKAα1b expression seen in MM in relation to NF in this study may have been 
an indirect effect of elevated levels of androgens as NKAα1b expression in MM 
seemed to be lower at the end of maturation when the androgen level is high 
(Campbell et al., 2003).  
NKAα1a expression for MM in SWLL was low until sampling 8 where two 
individuals had high NKAα1a transcription, creating great variation within the 
sampling. Because of this variation it was difficult to draw any conclusions about the 
NKAα1a expression in this treatment group. Nevertheless, the high expression in 
some MM may suggest the start of increased NKAα1a transcription in MM. To 
answer this, one more sampling would have been required. In SWLD NKAα1a 
transcription in MM was low in sampling 5 and 6, before NKAα1a expression 
increased significantly in sampling 7 and 8. The NKAα1a levels in MM did not 
follow the same trend as NF and the two were significantly different in sampling 7. 
NKAα1a expression in both NF and MM followed the same trend in FWLD and 
expression was high and stable with a slight increase in sampling 8. In contrast, 
NKAα1a transcription for MM in FWLL was completely different from NF. While 
the expression of NKAα1a started low and increased significantly for MM no 
significant changes were seen between MM and NF. In general, when NM were 
present they seemed to follow the same trend as NF, indicating NF as a trustworthy 
control group. 
When Shrimpton et al. (2005) studied homing sockeye salmon (O. nerka) they found 
that gill NKAα1a expression increased while the salmon were still in SW and 
continued to rise while migrating up the river. The new discovery was not that 
NKAα1a transcription increases in FW, but that NKAα1a expression increased prior 
to FW transfer (Shrimpton et al., 2005). Furthermore, mature Chum salmon (O. keta) 
captured in SW just before river entry, failed to survive in SW for more than 5 days 
due to elevated plasma osmolality (Hirano et al., 1990, Uchida et al., 1997). Elevated 
plasma osmolality has been correlated with low NKAα1b expression and low NKA 
enzyme activity (Mackie et al., 2005, Bystriansky et al., 2006, Richards et al., 2003) 
suggesting that low NKAα1b transcription followed by low NKA activity in MM in 
SW may cause dehydration and death. Our results are consistent with these findings 
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as NKAα1a levels increase in MM kept in SWLD, suggesting a preparatory adaption 
for FW in mature salmon kept in SW. 
4.5 Conclusion and further perspectives 
The results from the present study support previous studies claiming NKAα1a to be 
the main isoform for FW adaptation (Madsen et al., 2008, McCormick et al., 2009, 
Nilsen et al., 2007, Richards et al., 2003, Stefansson et al., 2007) as NKAα1a 
expression decreased during preparatory SW adaptation and in smolts transferred to 
SW. In addition, NKAα1a increased in desmolting salmon and also in MM kept in 
FW and SW. The latter suggests that maturing salmon adapt to FW, which might lead 
to elevated plasma osmolality and death if they are kept in SW for a longer period of 
time after initiation of maturation (Hirano et al., 1990, Uchida et al., 1997).  
Furthermore, the hypothesis of NKAα1b being the SW adaptive isoform (McCormick 
et al., 2009, Nilsen et al., 2007, Richards et al., 2003) and the isoform with the 
strongest correlation to gill NKA enzyme activity (Nilsen et al., 2007, Richards et al., 
2003, Stefansson et al., 2007) has gained support. The NKAα1b expression increased 
during preparatory SW adaptation and continued to increase after SW transformation 
before SW acclimation was complete and NKAα1b transcription reached the level 
where it was able to maintain sufficient NKA activity to keep plasma osmolality 
stable. The lowered level of NKAα1b transcription in MM also suggest a 
preadaptation to FW in mature individuals, which may be fatal during prolonged 
exposure to SW.  
Further studies should be conducted to uncover all physiological changes during 
maturation in Atlantic salmon including influence of androgens on osmoregulation 
and the welfare consequences of keeping mature salmon in SW. Some of these 
questions might be answered when hormone and plasma samples taken during this 
experiment are analyzed and compared to the present results. 
Nevertheless, this study has given us new insight to salmon maturation and we can 
say that there are changes in the expression level of NKAα1b and NKAα1a during 





5.1 Experimental design 
The experiment started 29th of September with 16 tanks containing parr kept on LL. 
After smoltification were the fish divided into four treatment groups, where each 
treatment group consisted of four replica tanks. The use of replicates in an experiment 
is necessary to reduce variance and improve the significance of the result. Based on 
previous characterization of the post-smolt maturation model (Fjelldal, Hansen, in 
prep) it was unexpected to discover a considerable proportion of mature males in the 
LD groups during maturation. This may be explained by the extra body weight the 
fish gained during the three extra weeks, as larger individual are more likely to enter 
maturation (Taranger et al., 2010). Consequently, few immature males were available 
for analysis and statistically comparing immature males with the other 
gender/maturation groups could give untrustworthy results. The females remained 
immature and were thus representing a normal post-smolt. This made them suited to 
be compared to the mature males. 
5.2 RNA isolation and quality  
Good quality RNA is vital for successful and reliable gene expression analysis as the 
real-time RT-PCR need DNA-free, un-degraded RNA (Bustin and Nolan, 2004a, 
Pfaffl, 2004). RNA is vulnerable to degradation by RNase enzymes, which may result 
in shorter fragments of RNA occurring in samples. This may again lead to loss of or 
errors in gene expression results. To secure an adequate RNA quality, gill tissue was 
submerged in RNAlater (Ambion, Austin, TX, USA) immediately after dissection as 
RNAlater rapidly permeates most tissues and stabilize and protect RNA (Tröβe et al., 
2010).  The gills grew large during the course of the experiment. The size of the 
sampled gills was subsequently reduced to fit in the sample tubes in sampling 7 and 8. 
Applied Biosystems (Applied Biosystems, Carlsbad, CA, USA) recommend the use 
of 1 ml RNAlater per 50 mg of tissue so ensure that RNA enters the tissue 
completely. Gills are “designed” to have maximum contact with the surrounding 
environment, thus less RNAlater is required per mg to obtain full effect. Alternative 
tissue preservation for RNA isolation is freezing the tissue directly. This would be the 
preferred method if the same tissue were to be used for protein analysis, as RNAlater 
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may complicate such work. For RNA isolation, RNAlater considered to be the best 
preservation medium. 
When performing RNA isolation the tissue was cut from cartilage in a standardized 
manner and transferred to Trizol-reagent (Sigma-Aldrich, St. Louis, MO, USA) as 
quickly as possible. Following homogenization, Trizol dissolves the cell component 
and preserves the RNA integrity (Chomczynski and Sacchi, 1987). Even though 
precautions were taken to ensure good RNA quality, we should not disregard factors 
that may have affected RNA quality and the integrity of the RNA should always be 
examined (see below)  
The concentration and absorbance of isolated RNA were measured using a 
NanoDrop-1000 (Thermo Scientific, NC, USA). According to Bustin and Nolan 
(2004) is an A260/280 ratio greater than 1.8 is a sign of good RNA purity as it 
indicate a low protein contamination. However, a low A260/230 ratio suggested a 
residual contamination of organic compounds, such as phenol and alcohol (Bustin and 
Nolan, 2004a) from the RNA isolation protocol, which could affect downstream 
applications such as cDNA synthesis and quantitative PCR (Pfaffl, 2004) Preferably 
both ratios should be above 1.8, but this may be difficult to achieve and a ratio around 
1.7 still indicates sufficient RNA purity for the protocols used in the present study 
(Nilsen, personal communication).  
Although, the A260/280 and A260/230 reflects purity, it does not give information 
about the RNA integrity. To access the integrity the Agilent 2100 bioanalyzer 
(Agilent technologies, Santa Clara, CA, USA) were utilized, as it produces a RNA 
integrity number (RIN) based on the 18s and 28s ribosomal RNA bands (Bustin et al., 
2005). The software generates a RIN number ranging from 1 to 10, with 1 being the 
lowest integrity and 10 being the highest. A RIN value above 5 is recommended for a 
successful and reliable real-time RT-PCR quantification (Bustin and Nolan, 2004b). 
For this study, twelve random samples were checked for RIN values and the majority 
of samples had a high RIN value (table 6), indicating very good RNA quality. The 
one sample with low RIN value was monitored closely throughout the experiment, 
particularly for the reference gene, but no notable negative effects were observed 




Table 6: RNA Integrity Numbers (RIN). Values from randomly selected samples analyzed with the 
Agilent 2100 Bioanalyzer. Absorbance ratios from the NanoDrop are also included. 
Sample nr Sampling A260/280 A260/230 RIN value 
47 3 2.03 2.29 10 
6 1 2.05 2.30 10 
33 2 2.04 2.30 8.8 
31 2 2.04 2.33 9.9 
3 1 2.03 2.37 10 
71 4 2.01 2.32 4.4 
67 4 2.04 2.36 9.9 
77 4 2.04 2.31 8.3 
11 1 2.04 2.37 10 
22 2 2.06 2.26 10 
9 1 2.06 2.28 10 
75 4 2.02 2.31 8.3 
 
 
5.3 DNase treatment and cDNA synthesis 
As most RNA preparations may contain residual amounts of genomic DNA, gDNA, 
(Pfaffl, 2004), the isolated RNA was treated with DNase to remove all gDNA 
residues. Even the smallest DNA contamination may interfere with the desired 
“specific amplification” as the kinetic PCR have a tremendous amplification power 
(Pfaffl, 2004). This study used SYBR green as the staining dye, which bind to all 
double stranded DNA and emits a fluorescence signal. Thus it is important to remove 
all unwanted genomic DNA, as any contamination would give imprecise results 
(Bustin, 2005). With that said, treating RNA with DNase may result in RNA 
degradation and the DNase should always be removed and/or inactivated before any 
Reverse Transcriptase (RT) step (Pfaffl, 2004). The protocol used in this study 
includes an inactivation of the DNase enzyme. Moreover, the protocols for DNase 
treatment and cDNA synthesis are adjusted in a way they “dilute” the carryover 
contamination of residual proteins (DNase) into the cDNA synthesis step. 
As RNA cannot serve as a template for PCR, the formation of a DNA template is 
necessary and RNA is used as the template for the formation of single stranded (ss) 
complementary DNA (cDNA) through reverse transcriptase (Pfaffl, 2004). The RT 
step is the source of the most variability in a kinetic RT-PCR experiment (Pfaffl, 
2004) and it is crucial that all samples are treated in a standardized manner throughout 
the experiment. To minimize variation in the RT step, all reaction components were 
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added into one master mix, as described in the Material and Methods section, before 
aliquots of the master mix were added to the samples. This together with not changing 
manufacturer or batch number for reagents, primers and laboratory supply most likely 
minimized variation throughout the experiment.  
A random nonamer primer was used in this experiment. The primer binds to RNA and 
acts as a starting point for DNA synthesis and the random primers will synthesize 
cDNA from all RNA present in the sample, such as ribosomal RNA (rRNA), mRNA 
and transcription RNA (tRNA) (Bustin et al., 2005). If the amount of mRNA is low, 
will this give a low concentration of primed mRNA in proportion to primed rRNA 
and its subsequent amplification may not be quantitative (Bustin et al., 2005). Other 
primers such as Oligo-dT and target-specific primers will only bind and synthesize 
cDNA from mRNA, but the transcription may not reach the PCR target sequence if 
secondary structures are present (Bustin and Nolan, 2004b). The use of specific 
primers is thus not recommended if one suspects RNA degradation or fragmentation 
as they are dependent on the exact nucleotide sequences they are designed for (Bustin 
and Nolan, 2004b). Random primers are used in about 30% of all RT-PCR assays and 
may produce good results if the cDNA synthesis is carried out in a careful, competent 
manner (Bustin et al., 2005, Bustin and Nolan, 2004b). When assays used in the 
present study were made, they were optimized for use together with MGB Taq-Man 
probes. As previous experiences have shown that cDNA synthesis using Oligo-dt 
primers may lead to inconsistencies in qPCR reactions with Taq-man assays (Nilsen, 
personal communication). While we used SYBRgreen for this experiment, our cDNA 
aliquots will be transported to other collaborating laboratories that use Taq-man. 
Thus, cDNA was synthesized using random primers. 
5.4.1 Real-Time quantitative PCR, Quantification of gene expression 
Real Time qPCR was in this study used to measure the expression of NKAα1a and 
NKAα1b in Atlantic salmon gill tissue. Real time RT-PCR is the most sensitive, 
specific and reproducible method for quantification of mRNA and is therefore 
frequently used (Bustin, 2000, Bustin et al., 2005). However, the quality of the RT-
qPCR results is also dependent on the quality and consideration placed in the steps 
performed prior to qPCR. There are many potential pitfalls leading to variations and 
errors in qPCR.  Such variations could stem from assay design, equipment, PCR 
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reagents, unspecific products, primer-dimers, amplification efficiency, presence of 
inhibitors and human error, all problems inherent to the amplification of genes and 
may therefore contribute to insecure results (Pfaffl 2004; Bustin et al. 2005). 
Good lab routines and precision pipetting is also essential for preventing cumulative 
error and non-template control (NTC; sample well with water instead of cDNA 
template) samples should always be present on each qPCR plate (Bustin and Nolan, 
2004b). The presence of NTC samples are important to detect possible contamination 
and should ideally be negative (Wong and Medrano, 2005). In the present study, four 
NTC samples displayed amplification like curves, but Ct values were high (around 
35) and more than 10 Ct values from the actual samples, indicating low contamination 
levels. The amplification curves from the positive NTC differed from those of the 
actual samples. Hence, it was concluded that the four NTC wells that gave an 
amplification signal did not represent a potential problem for interpretation of our 
results.  
The PCR reaction has four main phases: The ground phase, were fluorescence has not 
reached above background noise, the early exponential phase where fluorescence is 
rising above background noise, the exponential phase where the amount of DNA 
doubles in each step and the plateau phase were reaction components becomes limited 
and the fluorescence intensity is no longer useful for data calculation (Wong and 
Medrano, 2005). In real-time qPCR the amplification of DNA is monitored during the 
course of the reaction by observing the fluorescence of the added marker (Bustin, 
2005). The registered quantity of fluoresces is proportional to the formed amount of 
double stranded DNA and the number of amplifications cycles required to achieve a 
specific amount of DNA is registered (Bustin, 2005). The more copies of the target 
there are at the beginning of the assay, the fewer amplification cycles are required for 
the fluorescence to reach the threshold level of detection (Bustin 2000; Bustin et al. 
2005; Wong and Medrano 2005). The number of cycles needed to reach the threshold 
is referred to as threshold cycle (Ct) and is defined as the cycle when sample 
fluorescence exceeds a chosen threshold above calculated background fluorescence 
(Wong and Medrano, 2005). The threshold is set manually and must always be within 
the exponential phase and above background noise (Bustin, 2005). In this study, 
NKAα1a and NKAα1b where set at 0.013 and at 0.012 for EF1a, which was within 
the exponential phase for all plates. 
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Several probes and dyes may be used to detect DNA amplification in real time, some 
bind to specific sections of the DNA, whereas others binds to DNA in general (Bustin, 
2000). For this study SYBRgreen (Applied Biosystems, Carlsbad, CA, USA) was 
chosen as the dye. SYBRgreen binds to the double stranded DNA and the bound dye 
emits a detectible fluoresce (Bustin, 2000). The amount of fluorescence will increase 
proportionally with the quantity of amplified DNA and is recorded in real-time 
(Bustin, 2000). As SYBRgreen binds to all dsDNA present, specific primers and low 
DNA contamination are required to ensure a reliable PCR result (Bustin, 2000). The 
isolated RNA was, as mentioned, treated with DNase and specific primers for 
NKAα1a, NKAα1b and EF1α were used in this study. High-quality results have been 
achieved using these assays and protocols in previous studies (Nilsen et al., 2007, 
Olsvik et al., 2005).  
The PCR efficiency may have considerable impact on the final qPCR results (Bustin, 
2005). It is therefore imperative that the efficiency is monitored during analysis in 
order to ensure accurate quantification results.  In the present study, triplicate ten-fold 
dilution series of cDNA were used to generate regression slopes for each plate (see 
Materials and Methods) (Wong and Medrano, 2005), which gave a wide linear range 
in Ct values for all three genes. All of the experimental samples were within the linear 
range of the dilution series, allowing accurate quantification (Bustin, 2000).  
All slopes for NKAα1a (fig 41) and EF1α (fig. 41) were found to be within a similar 
range. However one regression line for NKAα1b differed from the others. The 
efficiency was calculated using individual plates for NKAα1b and NKAα1a while the 
mean slope for all plates were used for EF1α (fig. 40). The NKAα1b plate that 
differed from the rest was closely monitored and no effect of plates was notable when 


















































































Figure 40: Efficiency curve for EF1α.  The graph shows the efficiency curves for EF1α created by 
plotting Ct values from the dilution series against the log of input cDNA. For regression line equations see 
appendix II. 
Figure 41: Efficiency curve for NKAα1a and NKAα1b. The graphs show the efficiency curves for 
NKAα1a and NKAα1b created by plotting Ct values from the dilution series against the log of input 
cDNA. For regression line equations see appendix II. 
 
Some variation was observed between the duplicates of the experimental samples and 
mean Ct value with a standard deviation raised to the second power above 0.05 were 
monitored (Pfaffl, 2004). The real-time RT-PCR is less reliable when Ct values are in 
the upper limit of dependability of qPCR (≥35 Ct values) (Bustin 2002), but 
differences in duplicates were found in both low and high Ct values. All irregular 
samples were thoroughly monitored. 
5.4.2 Normalization 
As pointed out, variation in sample-to-sample and run-to-run may easily arise due to 
differences in amount of starting material between samples, variation in RNA 
integrity, difference in amplification efficiencies and variation of cDNA present in 
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each sample (Bustin, 2000, Pfaffl, 2004). These types of variations easily arise when 
samples are from different individuals and taken over a period of time, as was the case 
for this study (Bustin, 2000). To minimize such errors, must the gene expression level 
of the target gene must be normalized and efficiency corrected using a reference gene, 
also called housekeeping gene (Bustin, 2005, Bustin, 2000, Pfaffl, 2004, Wong and 
cy 
Medrano, 2005). 
For this reason, this study uses relative gene expression as the quantification strategy, 
since this method is based on the expression level of a target gene compared to a 
reference gene (Pfaffl, 2004). The choice of reference gene depends on the tissue of 
interest (Olsvik et al., 2005), as the reference gene should be expressed at a stable 
level among different tissues of an organism and trough all stages of development and 
remain unaffected by the experimental treatments (Olsvik et al., 2005, Wong and 
Medrano, 2005, Bustin, 2000, Pfaffl et al., 2004, Pfaffl, 2004). Different endogenous 
control genes will behave differently in various tissues and experimental designs and 
one should thus test several potential reference genes for every examined tissue, under 
different treatments (Olsvik et al., 2005). The reference gene used for this study was 
Elongation factor 1a, a reference gene proven to be stable when tested on gill tissue 
and other organs in Atlantic salmon in the utilized laboratory (Nilsen et al., 2007, 
Olsvik et al., 2005).  Unfortunately, variations in EF1a gene expression were detected 
in this experiment. When facing such a problem, it is possible to use the mean of all 
EF1a Ct values as the reference value instead of a sample-to-sample efficien
correction (Pfaffl, 2004) in combination with the mean slope from all EF1a plates. 
Several mathematical methods are available for calculation of a target gene in relation 
to an adequate reference gene and two models are used for relative quantification 
(Pfaffl, 2004). The two models in question are the ΔΔCt and the efficiency-correlated 
Ct model (Pfaffl, 2001). As the ΔΔCt method should only be used for quick 
assessment of the data (Pfaffl, 2001), the efficiency correlated Ct model was used in 
this study. For this model, the relative expression of a target gene is calculated, based 
on its real-time PCR efficiencies and the Ct value difference of an unknown sample 
versus the reference gene (Pfaffl, 2004). The amplification efficiency is required for 
calculating the target quantity and therefore, the amplification efficiency for each 
plate was determined using the regression line slope from the dilution curves. As 
mentioned, some irregularities were found in the reference gene in this experiment. 
To reduce the influence of these variations the mean value of efficiency correlated Ct 
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values from NKAα1a and NKAα1b from sampling one were used as a calibrator for 
the other samplings. The efficiency-correlated data from sampling 1 were chosen as 
this sampling represents the biological initiation point for this experiment. The 
following equation was then used to calculate relative gene expression for NKAα1a 
and NKAα1b (Pfaffl, 2004): 
 
This method gave very good results and removed the chances for a false gene 
ions in the housekeeping gene.  regulation expression due to variat
5.4 Statistical analysis 
A two-way analysis of variance (ANOVA), followed by a Newman-Keuls test was 
chosen for analyzing the data of the present study. Since the ANOVA is a parametric 
test, it requires normally distributed data with an equal variance and this was tested 
using Normal probability plots with Shapiro-Wilks test and Levene’s test for 
homogeneity of variance. Normal probability plots provide a quick way to visually 
inspect the pattern of data and see if they follow a normal distribution. The selected 
variable is thus plotted in a scatterplot against the values "expected from the normal 
distribution." If the observed values (plotted on the x-axis) are normally distributed, then 
all values should fall onto a straight line in the plot. If the values are not normally 
distributed, they will deviate from the line (Statistica, StatSoft, Inc., Tulsa, USA). To 
more easily assess the data a Shapiro-Wilks test was added to the normality plot, as 
this test produces a p-value where a value below 0.05 was considered significant and 
a normal distribution is rejected. The Levene’s test was used, as it is a powerful way to 
check for homogeneity of variances. If the Levene’s test is statistically significant, then 
the hypothesis of homogeneous variances should be rejected. All data used was normally 
distributed, but some data gave a significant result when tested for homogeneity of 
variance. To reduce variance, the body weight and relative NKAα1b gene expression 
data from the smolting period and relative NKAα1a and NKAα1b gene expression 
and GSI values from the maturation period were log transformed (Zar, 1996). Also, 
outliers in the NKAα1b and NKAα1a data were removed using the method of 2 
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standard deviation as the limit for outliers. After log transformation, some test groups 
still gave a significant result in the Levene’s test (appendix III) and although 
nonparametric tests do not make assumptions about the nature of the distribution of the 
samples, parametric tests are more powerful than nonparametric ones as the latter will 
have a greater probability in committing a Type II error (Zar, 1996). Furthermore, the 
homogeneity of variances assumption is usually not as crucial as other assumptions for 
ANOVA (Zar, 1996). Thus, parametric tests were used for all groups, as commonly 
employed test as ANOVA are robust enough to allow us to disregard all but severe 
deviations from the theoretical assumptions (Zar, 1996). For GSI during the maturation 
 procedure. The 
antly different tanks in one of five 
sponse variables were not considered enough of a difference to discard all tanks 
om being one group during the smolting stage.  
 
 
stage, only MM were analyzed and differences between photoperiod/salinity groups were 
compared instead of gender/maturation differences.  
Newman-Keuls test was used following a two-way ANOVA to detect differences 
between NF and MM in each sampling and to detect differences in samplings in 
reference to the first sampling. The Newman-Keuls test was chosen over Tukey test 
since it tends to detect more significant differences than the Tukey
Newman-Keuls test is therefore considered more powerful, although statisticians dispute 
over the merit of these tests.  
Prior to the main analysis, a one-way ANOVA was performed on the mentioned 
response variables in materials and methods (section 2.11) within the sampled tanks 
from each sampling during the smolting stage. All tanks in the smolting stage were 
treated equally and the one-way ANOVA was utilized to detect potential differences 
between tanks in each sampling. Only one tank in sampling 1 and one tank in 
sampling 2 gave significant results in NKA activity and thus differed from the three 
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The Sørensen buffer consists of:  
24 g of Na2H2PO4 (Sigma-Aldrich, St. Louis, MO, USA) dissolved in 1000 ml H2O (solution 
1) and 27.2 g Na2HP2 (Sigma-Aldrich, St. Louis, MO, USA) in 1000 ml H2O (solution 2). 
28 ml of solution 1 is then mixed with 72 ml of solution 2, resulting in a 0.2 M solution. Mix 
500 ml of 0.2 M with 500 ml to get 1 L of 0.1 M Sørensen buffer. 
 
Sørensen buffer consist of: 
250 mM sucrose, 10 mM
Appendix II 
 Na2–EDTA, 50 mM Mimidazole at pH 7.3 
 
Efficiency data from the dilution series 
Table A.II.1: Efficiency data of the dilution series from each plate for EF1α. 
 
Plate no. Slope R2 Mean efficiency 
Plate 1 -3.627 0.998 1.964
Plate 2 -3.505 0.996 1.964
Plate 3 -3.299 0.992 1.964
Plate 4 -3.303 0.982 1.964
Plate 5 -3.235 0.998 1.964
Plate 6 -3.379 0.998 1.964
Plate 7 -3.430 0.998 1.964
Plate 8  -3.544 0.997 1.964
 
Table A.II.2: Efficiency data of the dilution series from each plate for NKAα1b 
 
Plate no. Slope R2 Efficiency 
Plate 1 -3.371 0.979 1.980
Plate 2 -3.724 0.996 1.856
Plate 3 -3.628 0.991 1.886
Plate 4 -3.685 0.985 1.868
Plate 5 -3.426 0.992 1.958
Plate 6 -3.490 0.996 1.934
Plate 7 -3.474 0.997 1.940
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Table A.II.3: Efficiency data of the dilution series from each plate for NKAα1a 
 
Plate no. Slope R2 Efficiency 
Plate 1 -3.270 0.994 2.022
Plate 2 -3.166 0.999 2.069
Plate 3 -3.155 0.998 2.075
Plate 4 -3.389 0.994 1.973
Plate 5 -3.661 0.995 1.876
Plate 6 -3.537 0.996 1.917




Test for homogeneity of variance sampling 1-4 
Table A.III.1: Levene's Test for Homogeneity of Variances for Fork length (cm) for males and females in 
sampling 1-4. Significant values (p<0.05) are highlighted in bold. 
 
Gender MS effect Ms error F p 
Males 8,675198 2,297765 3,775494 0,018737
Females 3,762528 0,772774 4,868861 0,006064
 
Table A.III.2: Levene's Test for Homogeneity of Variances for Fork length (cm) for each sampling. Significant 
values (p<0.05) are highlighted in bold. 
 




SS Error Df Error MS Error F p 
1 1,652836 1 1,652836 5,475984 18 0,304221 5,433004 0,031586
2 0,050000 1 0,050000 15,28200 18 0,849000 0,058893 0,810998
3 3,784500 1 3,784500 38,39600 18 2,133111 1,774169 0,199488
4 5,852083 1 5,852083 51,38542 18 2,854745 2,049949 0,169347
 
Table A.III.3: Levene's Test for Homogeneity of Variances for Log Body weight for males and females in 
sampling 1-4. Significant values (p<0.05) are highlighted in bold. 
 
Gender MS effect Ms error F p 
Males 0,018335 0,005184 3,536928 0,024152
Females 0,004768 0,001964 2,428316 0,081236
 
Table A.III.4: Levene's Test for Homogeneity of Variances for Log Body weight for each sampling. Significant 
values (p<0.05) are highlighted in bold. 
 




SS Error Df Error MS Error F p 
1 0,004489 1 0,004489 0,014748 18 0,000819 5,478459 0,030967
2 0,000161 1 0,000161 0,032774 18 0,001821 0,088389 0,769639
3 0,007012 1 0,007012 0,081874 18 0,004549 1,541544 0,230324
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4 0,023263 1 0,023263 0,127908 18 0,007106 3,273692 0,087131
 
Table A.III.5: Levene's Test for Homogeneity of Variances for GSI for males and females in sampling 1-4. 
Significant values (p<0.05) are highlighted in bold. 
 
Gender MS effect Ms error F p 
Males 0,000140 0,000060 2,333036 0,090364
Females 0,000137 0,000042 3,279801 0,031847
 
 
Table A.III.6: Levene's Test for Homogeneity of Variances for GSI for males and females in each sampling. 
Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df Error MS Error F p 
1 0,000199 1 0,000199 0,000515 18 0,000029 6,942465 0,016818
2 0,000222 1 0,000222 0,000699 18 0,000039 5,715081 0,027959
3 0,000001 1 0,000001 0,000861 18 0,000048 0,024640 0,877015
4 0,000031 1 0,000031 0,001590 18 0,000088 0,355134 0,558641
 
Table A.III.7: Levene's Test for Homogeneity of Variances for Condition factor for males and females in 
sampling 1-4. Significant values (p<0.05) are highlighted in bold. 
 
Gender MS effect Ms error F p 
Males 0,002307 0,002670 0,864030 0,468608
Females 0,000280 0,003316 0,084588 0,968018
 
Table A.III.8: Levene's Test for Homogeneity of Variances for Condition factor for males and females in each 
sampling. Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df Error MS Error F p 
1 0,000189 1 0,000189 0,046486 18 0,002583 0,073074 0,789987
2 0,000746 1 0,000746 0,024299 18 0,001350 0,552460 0,466906
3 0,000323 1 0,000323 0,043052 18 0,002392 0,135099 0,717489
4 0,007310 1 0,007310 0,037354 17 0,002197 3,327068 0,085777
 
Table A.III.9: Levene's Test for Homogeneity of Variances for NKA activity for males and females in 
sampling 1-4. Significant values (p<0.05) are highlighted in bold. 
 
Gender MS effect Ms error F p 
Males 1,544946 1,431214 1,079466 0,370070
Females 0,112376 28,46134 0,138193 0,936509
 
Table A.III.10: Levene's Test for Homogeneity of Variances for NKA activity for males and females in each 
sampling. Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df Error MS Error F p 
1 2,026868 1 2,026868 31,18766 18 1,732648 1,169809 0,293718
2 0,007015 1 0,007015 16,79023 18 0,932790 0,007520 0,931853
3 0,215421 1 0,215421 10,03808 18 0,557671 0,386287 0,542050
4 1,241090 1 1,241090 21,96908 17 1,292299 0,960374 0,340834
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Table A.III.11: Levene's Test for Homogeneity of Variances for Log NKA1b for males and females in 
sampling 1-4. Significant values (p<0.05) are highlighted in bold. 
 
Gender MS effect Ms error F p 
Males 92,77396 4,882840 0,824139 0,496711
Females 10,28135 3,551550 2,894890 0,062073
 
Table A.III.12: Levene's Test for Homogeneity of Variances for Log NKA1b for males and females in each 
sampling. Significant values (p<0.05) are highlighted in bold. 
 
 




SS Error Df Error MS Error F p 
1 4,811988 1 4,811988 17,83419 10 1,783419 2,698181 0,131493
2 3,641917 1 3,641917 8,806350 9 0,978483 3,722002 0,085776
3 0,258794 1 0,258794 93,98040 9 10,44227 0,024783 0,878384
4 1,515986 1 1,515986 39,63247 10 3,963247 0,382511 0,550089
 
Table A.III.13: Levene's Test for Homogeneity of Variances for NKA1a for males and females in sampling 1-4. 
Significant values (p<0.05) are highlighted in bold. 
 
 MS MS F p 
Gender Effect Error     
Males 0,602387 0,279776 2,153106 0,125437
Females 0,080182 0,035896 2,233729 0,117398
 
Table A.III.14: Levene's Test for Homogeneity of Variances for NKA1a for males and females in each 
sampling. Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df Error MS Error F p 
1 0,022516 1 0,022516 0,266994 10 0,026699 0,843327 0,380064
2 0,026528 1 0,026528 0,341812 9 0,037979 0,698479 0,424927
3 0,544923 1 0,544923 4,001200 10 0,400120 1,361900 0,270283
4 0,897861 1 0,897861 1,667537 10 0,166754 5,384356 0,042742
Test for homogeneity of variance sampling 5-8 
Table A.III.15: Levene's Test for Homogeneity of Variances for Fork length (cm) in sampling 5-8. Significant 
values (p<0.05) are highlighted in bold. 
 
Sampling SS df MS SS df MS F p 
5 2,904771 2 1,452385 125,5128 76 1,651484 0,879443 0,419194
6 15,79527 2 7,897633 263,4321 76 3,466212 2,278463 0,109397
7 4,331948 2 2,165974 172,1379 77 2,235557 0,968874 0,384088
8 0,782911 2 0,391455 415,8075 156 2,665432 0,146864 0,863531
 
Table A.III.16: Levene's Test for Homogeneity of Variances for Fork length (cm) for immature females (NF), 
immature males (NM) and mature males (MM) divided into the four treatment groups (SWLL, SWLD, FWLL 
and FWLD). Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df 
Error 
MS Error F p 
SWLL-NF 31,91821 3 10,63940 156,3051 53 2,949152 3,607614 0,019090
SWLL-MM 15,59443 3 5,198143 69,84767 32 2,182740 2,381476 0,087847
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SWLD-NF 15,36644 3 5,122146 79,33959 52 1,525761 3,357109 0,025643
SWLD-MM 5,002303 3 1,667434 30,65694 25 1,226278 1,359753 0,277881
FWLL-NF 5,566308 3 1,855436 144,4670 53 2,725792 0,680696 0,567765
FWLL-MM 4,136557 3 1,378852 56,48129 29 1,947631 0,707964 0,555085
FWLD-NF 23,56311 3 7,854369 70,29944 41 1,714620 4,580821 0,007413
FWLD-MM 10,39025 3 3,463417 60,62380 34 1,783053 1,942409 0,141321
 
Table A.III.17: Levene's Test for Homogeneity of Variances for Body weight (g) in sampling 5-8. Significant 
values (p<0.05) are highlighted in bold. 
 
 SS df MS SS df MS F p 
Sampling 5 17465,12 2 8732,560 315068,1 76 4145,632 2,106448 0,128717
Sampling 6 18099,79 2 9049,897 871426,1 77 11317,22 0,799657 0,453180
Sampling 7 33545,95 2 16772,98 840077,8 77 10910,10 1,537381 0,221468
Sampling 8 47885,80 2 23942,90 2129804 157 13565,63 1,764967 0,174572
 
Table A.III.18: Levene's Test for Homogeneity of Variances for Body weight (g) for immature females (NF), 
immature males (NM) and mature males (MM) divided into the four treatment groups (SWLL, SWLD, FWLL 
and FWLD). Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df 
Error 
MS Error F p 
SWLL-NF 173165,4 3 57721,82 657875,7 53 12412,75 4,650204 0,005859
SWLL-MM 51073,60 3 17024,53 289273,0 33 8765,848 1,942143 0,141979
SWLD-NF 82644,60 3 27548,20 428804,0 52 8246,232 3,340702 0,026134
SWLD-MM 59847,33 3 19949,11 134127,9 26 5158,766 3,867031 0,020642
FWLL-NF 97441,66 3 32480,55 531581,3 53 10029,84 3,238393 0,029253
FWLL-MM 14461,39 3 4820,464 230324,1 29 7942,210 0,606942 0,615846
FWLD-NF 208161,7 3 69387,23 399218,2 41 9737,030 7,126118 0,000583
FWLD-MM 34123,18 3 11374,39 284523,5 34 8368,338 1,359217 0,271740
 
Table A.III.19: Levene's Test for Homogeneity of Variances for Log Gonadosomatic index in sampling 5-8. 
Significant values (p<0.05) are highlighted in bold. 
 
 SS df MS SS df MS F p 
Sampling 5 2,076043 2 1,038022 2,320874 77 0,030141 34,43861 0,000000
Sampling 6 0,072110 2 0,036055 0,856861 77 0,011128 3,240013 0,044562
Sampling 7 0,000348 2 0,000174 0,607541 77 0,007890 0,022077 0,978171
Sampling 8 0,176608 2 0,088304 1,599240 157 0,010186 8,668933 0,000268
 
Table A.III.20: Levene's Test for Homogeneity of Variances for Log Gonadosomatic index for immature 
females (NF), immature males (NM) and mature males (MM) divided into the four treatment groups (SWLL, 
SWLD, FWLL and FWLD). Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df 
Error 
MS Error F p 
SWLL-NF 0,046260 3 0,015420 0,479601 53 0,009049 1,704034 0,177321
SWLL-MM 0,011621 3 0,003874 0,074574 33 0,002260 1,714150 0,183139
SWLD-NF 0,014035 3 0,004678 0,166630 52 0,003204 1,460004 0,236182
SWLD-MM 0,008260 3 0,002753 0,089010 26 0,003423 0,804233 0,502901
FWLL-NF 0,011878 3 0,003959 0,305536 53 0,005765 0,686832 0,564082
FWLL-MM 0,084517 3 0,028172 0,116298 29 0,004010 7,025069 0,001083
FWLD-NF 0,033923 3 0,011308 0,103021 42 0,002453 4,609974 0,007073
FWLD-MM 0,144940 3 0,048313 0,246418 34 0,007248 6,666138 0,001162
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Table A.III.21: Levene's Test for Homogeneity of Variances for Conditon factor in sampling 5-8. Significant 
values (p<0.05) are highlighted in bold. 
 
 SS df MS SS df MS F p 
Sampling 5 0,007874 2 0,003937 0,242705 77 0,003152 1,248973 0,292544
Sampling 6 0,003785 2 0,001892 0,248806 76 0,003274 0,578015 0,563457
Sampling 7 0,057144 2 0,028572 0,450247 77 0,005847 4,886283 0,010050
Sampling 8 0,023620 2 0,011810 1,146473 156 0,007349 1,607010 0,203787
 
Table A.III.22: Levene's Test for Homogeneity of Variances for Condition Factor for immature females (NF), 
immature males (NM) and mature males (MM) divided into the four treatment groups (SWLL, SWLD, FWLL 
and FWLD). Significant values (p<0.05) are highlighted in bold. 
 




SS Error Df 
Error 
MS Error F p 
SWLL-NF 0,050600 3 0,016867 0,289025 53 0,005453 3,092905 0,034648
SWLL-MM 0,003797 3 0,001266 0,114168 33 0,003460 0,365812 0,778114
SWLD-NF 0,014801 3 0,004934 0,207587 52 0,003992 1,235868 0,306106
SWLD-MM 0,051000 3 0,017000 0,290290 26 0,011165 1,522618 0,232121
FWLL-NF 0,020664 3 0,006888 0,230389 53 0,004347 1,584566 0,203992
FWLL-MM 0,015231 3 0,005077 0,063814 29 0,002200 2,307184 0,097430
FWLD-NF 0,014346 3 0,004782 0,056442 42 0,001344 3,558508 0,022066
FWLD-MM 0,006326 3 0,002109 0,127019 34 0,003736 0,564404 0,642214
 
Table A.III.23: Levene's Test for Homogeneity of Variances for NKA activity in sampling 5-8. Significant 
values (p<0.05) are highlighted in bold. 
 
 SS df MS SS df MS F p 
Sampling 5 1,306487 1 1,306487 133,2556 67 1,988889 0,656893 0,420529
Sampling 6 11,73313 1 11,73313 177,5444 66 2,690067 4,361652 0,040618
Sampling 7 1,565574 1 1,565574 122,2275 67 1,824291 0,858182 0,357573
Sampling 8 19,58626 1 19,58626 378,1196 143 2,644193 7,407274 0,007304
 
Table A.III.24: Levene's Test for Homogeneity of Variances for NKA activity for immature females (NF) and 
mature males (MM) divided into the four treatment groups (SWLL, SWLD, FWLL and FWLD). Significant 
values (p<0.05) are highlighted in bold. 
 




SS Error Df 
Error 
MS Error F p 
SWLL-NF 18,78566 3 6,261887 129,4137 53 2,441767 2,564490 0,064333
SWLL-MM 5,183934 3 1,727978 25,43454 36 0,706515 2,445777 0,079668
SWLD-NF 7,933492 3 2,644497 85,29737 52 1,640334 1,612170 0,197751
SWLD-MM 4,325041 3 1,441680 28,29737 26 1,088360 1,324635 0,287730
FWLL-NF 0,928330 3 0,309443 48,19096 53 0,909263 0,340323 0,796241
FWLL-MM 4,494040 3 1,498013 8,601093 28 0,307182 4,876633 0,007488
FWLD-NF 4,791144 3 1,597048 12,76461 41 0,311332 5,129728 0,004183
FWLD-MM 0,450407 3 0,150136 9,858801 33 0,298752 0,502544 0,683152
 
Table A.III.25: Levene's Test for Homogeneity of Variances for Log NKA1b in sampling 5-8. Significant 
values (p<0.05) are highlighted in bold. 
 
 SS df MS SS df MS F p 
Sampling 5 0,081521 1 0,081521 1,788712 36 0,049686 1,640700 0,208420
Sampling 6 0,230852 1 0,230852 2,374802 41 0,057922 3,985572 0,052561
Sampling 7 0,164442 1 0,164442 1,926703 41 0,046993 3,499314 0,068544
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Sampling 8 0,000852 1 0,000852 1,037856 43 0,024136 0,035284 0,851885
 
 
Table A.III.26: Levene's Test for Homogeneity of Variances for Log NKA1b for immature females (NF) and 
mature males (MM) divided into the four treatment groups (SWLL, SWLD, FWLL and FWLD). Significant 
values (p<0.05) are highlighted in bold. 
 




SS Error Df 
Error 
MS Error F p 
SWLL-NF 0,079064 3 0,026355 0,448055 18 0,024892 1,058759 0,391085
SWLL-MM 0,687588 3 0,229196 0,892454 19 0,046971 4,879500 0,011097
SWLD-NF 0,075163 3 0,025054 0,363592 20 0,018180 1,378163 0,278264
SWLD-MM 0,072022 3 0,024007 0,780368 17 0,045904 0,522990 0,672268
FWLL-NF 0,156656 3 0,052219 0,243796 16 0,015237 3,427049 0,042590
FWLL-MM 0,024978 3 0,008326 0,204448 12 0,017037 0,488690 0,696568
FWLD-NF 0,259738 3 0,086579 0,324620 16 0,020289 4,267360 0,021512
FWLD-MM 0,214715 3 0,071572 0,336338 19 0,017702 4,043144 0,022169
 
Table A.III.27: Levene's Test for Homogeneity of Variances for Log NKA1a in sampling 5-8. Significant 
values (p<0.05) are highlighted in bold. 
 
 SS df MS SS df MS F p 
Sampling 5 0,102895 1 0,102895 16,25055 36 0,451404 0,227945 0,635938
Sampling 6 1,174613 1 1,174613 9,229181 41 0,225102 5,218138 0,027600
Sampling 7 0,202780 1 0,202780 5,612415 42 0,133629 1,517488 0,224853
Sampling 8 0,163618 1 0,163618 9,219186 44 0,209527 0,780893 0,381671
 
Table A.III.28: Levene's Test for Homogeneity of Variances for Log NKA1a for immature females (NF) and 
mature males (MM) divided into the four treatment groups (SWLL, SWLD, FWLL and FWLD). Significant 
values (p<0.05) are highlighted in bold. 
 




SS Error Df 
Error 
MS Error F p 
SWLL-NF 1,677023 3 0,559008 5,274615 18 0,293034 1,907653 0,164546
SWLL-MM 1,703041 3 0,567680 3,194033 20 0,159702 3,554631 0,032824
SWLD-NF 1,033000 3 0,344333 1,684961 20 0,084248 4,087138 0,020461
SWLD-MM 0,314422 3 0,104807 2,552919 17 0,150172 0,697917 0,566071
FWLL-NF 0,008807 3 0,002936 0,275224 17 0,016190 0,181339 0,907591
FWLL-MM 0,326583 3 0,108861 0,245066 12 0,020422 5,330530 0,014466
FWLD-NF 0,385390 3 0,128463 0,709037 17 0,041708 3,080060 0,055454
FWLD-MM 0,242144 3 0,080715 0,919493 18 0,051083 1,580068 0,228947
Test for normality, sampling 1- 4 
Normal probability plot of residual for Fork length of females in sampling 1, 2, 3 and 4: 
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Sampling 1






















 Length:  SW-W = 0,7242; p = 0,0042  
Sampling 2






















 Length:  SW-W = 0,942; p = 0,5757  
 
Sampling 3
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Sampling 4











































  Length:  SW-W = 0,9477; p = 0,6030 Length:  SW-W = 0,9587; p = 0,7711
 
Normal probability plot of residual for Log body weight of females in sampling 1, 2, 3 and 4: 
Sampling 1






















 Log Weight:  SW-W = 0,9467; p = 0,6782  
Sampling 2





















 Log Weight:  SW-W = 0,9507; p = 0,6773   
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Sampling 3






















 Log Weight:  SW-W = 0,953; p = 0,7040  
Sampling 4





















 Log Weight:  SW-W = 0,9619; p = 0,8099  
 
Normal probability plot of residual for Condition Factor of females in sampling 1, 2, 3 and 4: 
Sampling 1























 CF:  SW-W = 0,9384; p = 0,5954
Sampling 2























 CF:  SW-W = 0,9407; p = 0,5609  
 
Sampling 3























 CF:  SW-W = 0,8808; p = 0,1332  
Sampling 4























 CF:  SW-W = 0,9859; p = 0,9884  
 


























 GSI:  SW-W = 0,8537; p = 0,1039
Sampling 2






















 GSI:  SW-W = 0,9599; p = 0,7843  
Sampling 3























 GSI:  SW-W = 0,8697; p = 0,0992
Sampling 4






















 GSI:  SW-W = 0,9586; p = 0,7644  
Normal probability plot of residual for NKA activity of females in sampling 1, 2, 3 and 4: 
Sampling 1























 ATPase:  SW-W = 0,9408; p = 0,6189  
Sampling 2























 ATPase:  SW-W = 0,9647; p = 0,8382   
Sampling 3























 ATPase:  SW-W = 0,9244; p = 0,3952  
Sampling 4






















 ATPase:  SW-W = 0,9613; p = 0,7876  
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 Normal probability plot of residual for Log NKA1b of females in sampling 1, 2, 3 and 4: 
Sampling 1





























 LOG NKA1b:  SW-W = 0,96; p = 0,8196
Sampling 2





























 LOG NKA1b:  SW-W = 0,8828; p = 0,2821  
Sampling 3





























 LOG NKA1b:  SW-W = 0,972; p = 0,9059
Sampling 4





























 LOG NKA1b:  SW-W = 0,8377; p = 0,1588  
 
Normal probability plot of residual for NKA1a of females in sampling 1, 2, 3 and 4: 
Sampling 1
1,0 1,5 2,0 2,5 3,0 3,5 4,0 4,5 5,0 5,5 6,0
Sampling 2



























































































 Relative NKA1a mRNA(calibrator mean EF1a):  SW-W = 0,9602; p = 0,8213
Sampling 4






























 Relative NKA1a mRNA(calibrator mean EF1a):  SW-W = 0,9759; p = 0,9116  
 
Normal probability plot of residual for Fork length of males in sampling 1, 2, 3 and 4: 
 
Sampling 1























 Length:  SW-W = 0,8652; p = 0,0569
Sampling 2























 Length:  SW-W = 0,9469; p = 0,6315  
 
Sampling 3























 Length:  SW-W = 0,9689; p = 0,8807
Sampling 4























 Length:  SW-W = 0,8277; p = 0,0562  
 



























 Log Weight:  SW-W = 0,9131; p = 0,2339
Sampling 2























 Log Weight:  SW-W = 0,9688; p = 0,8795  
Sampling 3























 Log Weight:  SW-W = 0,9604; p = 0,7904
Sampling 4
























 Log Weight:  SW-W = 0,8272; p = 0,0555  
 
Normal probability plot of residual for Condition Factor of males in sampling 1, 2, 3 and 4: 
Sampling 1























 CF:  SW-W = 0,9444; p = 0,5570
Sampling 2























 CF:  SW-W = 0,9601; p = 0,7868  
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Sampling 3























 CF:  SW-W = 0,9011; p = 0,2253
Sampling 4























 CF:  SW-W = 0,972; p = 0,9135  
 
Normal probability plot of residual for GSI of males in sampling 1, 2, 3 and 4: 
 
Sampling 1
0,015 0,020 0,025 0,030 0,035 0,040 0,045 0,050
Sampling 2












































 Observed Value GSI:  SW-W = 0,9385; p = 0,4788  GSI:  SW-W = 0,9382; p = 0,5328
Sampling 4























 GSI:  SW-W = 0,9619; p = 0,8281  
Sampling 3
























 GSI:  SW-W = 0,9511; p = 0,6818
 
 
Normal probability plot of residual for NKA activity of males in sampling 1, 2, 3 and 4: 
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Sampling 1
5 6 7 8 9 10 11 12 13 14
Sampling 2












































 ATPase:  SW-W = 0,9794; p = 0,9617  Observed Value ATPase:  SW-W = 0,9098; p = 0,2119
Sampling 3















































 ATPase:  SW-W = 0,6919; p = 0,0018   ATPase:  SW-W = 0,928; p = 0,4289
 
Normal probability plot of residual for log NKA1b of males in sampling 1, 2, 3 and 4: 
Sampling 1





























 LOG NKA1b:  SW-W = 0,9305; p = 0,5843
Sampling 2






























































 LOG NKA1b:  SW-W = 0,8468; p = 0,1482
Sampling 4





















 LOG NKA1b:  SW-W = 0,9413; p = 0,6507  
Normal probability plot of residual for NKA1a of males in sampling 1, 2, 3 and 4: 
Test for normality sampling 5 - 8 
Normal probability plot of residual for fork length divided into samplings 5-8, treatment 
groups (SWLL, SWLD, FWLL and FWLD) and maturation category (NF and MM): 
 
Mature/non-mature=NF, Treatment=SWLL, Sampling=5
Normal Probability Plot of Length (cm)
 
Mature/non-mature=MM, Treatment=SWLL, Sampling=5
Normal Probability Plot of Length (cm)























































Normal Probability Plot of Length (cm) y Plot of Length (cm)





























 Length (cm):  SW-W = 0,9674; p = 0,8584























 Length (cm):  SW-W = 0,9778; p = 0,9521
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Mature/non-mature=MM, Treatment=FWLL, Sampling=5
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,8879; p = 0,1899
Mature/non-mature=NF, Treatment=FWLD, Sampling=5
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,9213; p = 0,4402
Mature/non-mature=MM, Treatment=FWLD, Sampling=5
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,9065; p = 0,3300
Mature/non-mature=NF, Treatment=SWLL, Sampling=6
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,9082; p = 0,2687  
Mature/non-mature=MM, Treatment=SWLL, Sampling=6
Normal Probability Plot of Length (cm)
























 Length (cm):  SW-W = 0,8676; p = 0,1428
Mature/non-mature=NF, Treatment=SWLD, Sampling=6
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,9028; p = 0,1463  
Mature/non-mature=MM, Treatment=SWLD, Sampling=6
Normal Probability Plot of Length (cm)

























 Length (cm):  SW-W = 0,9796; p = 0,7262
Mature/non-mature=MM, Treatment=FWLL, Sampling=6
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,75; p = 0.0000  
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Mature/non-mature=NF, Treatment=FWLL, Sampling=6
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,9652; p = 0,8347
Mature/non-mature=MM, Treatment=FWLD, Sampling=6
Normal Probability Plot of Length (cm)





















 Length (cm):  SW-W = 0,968; p = 0,8816  
Mature/non-mature=NF, Treatment=FWLD, Sampling=6
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,882; p = 0,1377
Mature/non-mature=MM, Treatment=SWLL, Sampling=7
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,9251; p = 0,3635
Mature/non-mature=NF, Treatment=SWLL, Sampling=7
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,9829; p = 0,9774
Mature/non-mature=NF, Treatment=SWLD, Sampling=7
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,9434; p = 0,5919
Mature/non-mature=MM, Treatment=SWLD, Sampling=7
Normal Probability Plot of Length (cm)



















 Length (cm):  SW-W = 0,835; p = 0,0891  
Mature/non-mature=NF, Treatment=FWLL, Sampling=7
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,932; p = 0,3256  
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Mature/non-mature=MM, Treatment=FWLL, Sampling=7
Normal Probability Plot of Length (cm)
























 Length (cm):  SW-W = 1; p = ---  
Mature/non-mature=NF, Treatment=FWLD, Sampling=7
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,9206; p = 0,3235   
Mature/non-mature=MM, Treatment=FWLD, Sampling=7
Normal Probability Plot of Length (cm)


























 Length (cm):  SW-W = 0,8634; p = 0,2725
Mature/non-mature=NF, Treatment=SWLL, Sampling=8
Normal Probability Plot of Length (cm)
























 Length (cm):  SW-W = 0,9757; p = 0,8224  
Mature/non-mature=MM, Treatment=SWLL, Sampling=8
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,93; p = 0,2728
Mature/non-mature=NF, Treatment=SWLD, Sampling=8
Normal Probability Plot of Length (cm)

























 Length (cm):  SW-W = 0,9085; p = 0,0380  
Mature/non-mature=MM, Treatment=SWLD, Sampling=8
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,8893; p = 0,0789
Mature/non-mature=MM, Treatment=FWLL, Sampling=8
Normal Probability Plot of Length (cm)






















 Length (cm):  SW-W = 0,9376; p = 0,3201   
 108
Mature/non-mature=NF, Treatment=FWLL, Sampling=8
Normal Probability Plot of Length (cm)

























 Length (cm):  SW-W = 0,9641; p = 0,5759  
Mature/non-mature=NF, Treatment=FWLD, Sampling=8
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,9351; p = 0,2928  
 
Mature/non-mature=MM, Treatment=FWLD, Sampling=8
Normal Probability Plot of Length (cm)























 Length (cm):  SW-W = 0,9416; p = 0,3090  
Normal probability plot of residual for Body length divided into samplings 5-8, treatment 
groups (SWLL, SWLD, FWLL and FWLD) and maturation category (NF and MM): 
Mature/non-mature=NF, Treatment=SWLL, Sampling=5
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,896; p = 0,0827   
Mature/non-mature=MM, Treatment=SWLL, Sampling=5
Normal Probability Plot of Weight (g)



























 Weight (g):  SW-W = 0,6572; p = 0,0033   
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Mature/non-mature=NF, Treatment=SWLD, Sampling=5
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,8841; p = 0,1455   
Mature/non-mature=MM, Treatment=SWLD, Sampling=5
Normal Probability Plot of Weight (g)





























 Weight (g):  SW-W = 0,8506; p = 0,1964   
Mature/non-mature=NF, Treatment=FWLL, Sampling=5
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,9623; p = 0,8122  
Mature/non-mature=MM, Treatment=FWLL, Sampling=5
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,829; p = 0,0436   
Mature/non-mature=NM, Treatment=FWLD, Sampling=5
Normal Probability Plot of Weight (g)
























 Weight (g):  SW-W = 0,8929; p = 0,3631  
Mature/non-mature=NF, Treatment=FWLD, Sampling=5
Normal Probability Plot of Weight (g)























 Weight (g):  SW-W = 0,9159; p = 0,3975  
Mature/non-mature=MM, Treatment=FWLD, Sampling=5
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,8846; p = 0,2084
Mature/non-mature=NF, Treatment=SWLL, Sampling=6
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,8774; p = 0,1218  
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Mature/non-mature=MM, Treatment=SWLL, Sampling=6
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,9801; p = 0,9647  
Mature/non-mature=NF, Treatment=SWLD, Sampling=6
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,9062; p = 0,1624  
Mature/non-mature=MM, Treatment=SWLD, Sampling=6
Normal Probability Plot of Weight (g)
























 Weight (g):  SW-W = 0,9854; p = 0,7690    
Mature/non-mature=MM, Treatment=FWLL, Sampling=6
Normal Probability Plot of Weight (g)

























 Weight (g):  SW-W = 0,9282; p = 0,4818  
Mature/non-mature=NF, Treatment=FWLL, Sampling=6
Normal Probability Plot of Weight (g)























 Weight (g):  SW-W = 0,9618; p = 0,7942  
Mature/non-mature=MM, Treatment=FWLD, Sampling=6
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,9687; p = 0,8880  
Mature/non-mature=NF, Treatment=FWLD, Sampling=6
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,8845; p = 0,1471  
Mature/non-mature=MM, Treatment=SWLL, Sampling=7
Normal Probability Plot of Weight (g)























 Weight (g):  SW-W = 0,9789; p = 0,9596  
 111
Mature/non-mature=NF, Treatment=SWLL, Sampling=7
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,9483; p = 0,6715  
Mature/non-mature=NF, Treatment=SWLD, Sampling=7
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,884; p = 0,1452  
Mature/non-mature=MM, Treatment=SWLD, Sampling=7
Normal Probability Plot of Weight (g)




















 Weight (g):  SW-W = 0,9374; p = 0,6152   
Mature/non-mature=NF, Treatment=FWLL, Sampling=7
Normal Probability Plot of Weight (g)























 Weight (g):  SW-W = 0,9814; p = 0,9819   
Mature/non-mature=MM, Treatment=FWLL, Sampling=7
Normal Probability Plot of Weight (g)

























 Weight (g):  SW-W = 0,9989; p = 0,9371   
Mature/non-mature=NF, Treatment=FWLD, Sampling=7
Normal Probability Plot of Weight (g)























 Weight (g):  SW-W = 0,8959; p = 0,1648  
Mature/non-mature=MM, Treatment=FWLD, Sampling=7
Normal Probability Plot of Weight (g)

























 Weight (g):  SW-W = 0,7317; p = 0,0257  
Mature/non-mature=NF, Treatment=SWLL, Sampling=8
Normal Probability Plot of Weight (g)
























 Weight (g):  SW-W = 0,9643; p = 0,5561  
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Mature/non-mature=MM, Treatment=SWLL, Sampling=8
Normal Probability Plot of Weight (g)





















 Weight (g):  SW-W = 0,9586; p = 0,6683
Mature/non-mature=NF, Treatment=SWLD, Sampling=8
Normal Probability Plot of Weight (g)























 Weight (g):  SW-W = 0,9549; p = 0,3678
Mature/non-mature=MM, Treatment=SWLD, Sampling=8
Normal Probability Plot of Weight (g)























 Weight (g):  SW-W = 0,9233; p = 0,2165
Mature/non-mature=MM, Treatment=FWLL, Sampling=8
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,9434; p = 0,3923
Mature/non-mature=NF, Treatment=FWLL, Sampling=8
Normal Probability Plot of Weight (g)
























 Weight (g):  SW-W = 0,9537; p = 0,3728   
Mature/non-mature=NF, Treatment=FWLD, Sampling=8
Normal Probability Plot of Weight (g)






















 Weight (g):  SW-W = 0,9548; p = 0,5701  
Sampling=8, Treatment=FWLD, Mature/non-mature=NF
Normal Probability Plot of Weight (g)



























Normal probability plot of residual for Log GSI divided into samplings 5-8, treatment groups 
(SWLL, SWLD, FWLL and FWLD) and maturation category (NF and MM): 
 
Mature/non-mature=NF, Treatment=SWLL, Sampling=5
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9575; p = 0,6482  
Mature/non-mature=MM, Treatment=SWLL, Sampling=5
Normal Probability Plot of LOG(GSI)



























 LOG(GSI):  SW-W = 0,8632; p = 0,2719     
Mature/non-mature=MM, Treatment=SWLD, Sampling=5
Normal Probability Plot of LOG(GSI)





























 LOG(GSI):  SW-W = 0,9221; p = 0,5437    
Mature/non-mature=MM, Treatment=FWLL, Sampling=5
Normal Probability Plot of LOG(GSI)






















 LOG(GSI):  SW-W = 0,9661; p = 0,8595     
Mature/non-mature=NF, Treatment=FWLD, Sampling=5
Normal Probability Plot of LOG(GSI)






















 LOG(GSI):  SW-W = 0,8659; p = 0,1110  
Mature/non-mature=MM, Treatment=FWLD, Sampling=5
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9345; p = 0,5579    
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Mature/non-mature=NF, Treatment=SWLL, Sampling=6
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9127; p = 0,3001  
Mature/non-mature=MM, Treatment=SWLL, Sampling=6
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9365; p = 0,5453  
Mature/non-mature=NF, Treatment=SWLD, Sampling=6
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9399; p = 0,4562  
Mature/non-mature=MM, Treatment=SWLD, Sampling=6
Normal Probability Plot of LOG(GSI)
























 LOG(GSI):  SW-W = 0,8763; p = 0,3136   
Mature/non-mature=NM, Treatment=FWLL, Sampling=6
Normal Probability Plot of LOG(GSI)





























 LOG(GSI):  SW-W = 0,7938; p = 0,0517  
Mature/non-mature=MM, Treatment=FWLL, Sampling=6
Normal Probability Plot of LOG(GSI)

























 LOG(GSI):  SW-W = 0,9563; p = 0,5980  
Mature/non-mature=NF, Treatment=FWLL, Sampling=6
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9739; p = 0,9228  
Mature/non-mature=MM, Treatment=FWLD, Sampling=6
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,7722; p = 0,0143   
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Mature/non-mature=NF, Treatment=FWLD, Sampling=6
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9801; p = 0,9658  
Mature/non-mature=MM, Treatment=SWLL, Sampling=7
Normal Probability Plot of LOG(GSI)






















 LOG(GSI):  SW-W = 0,7758; p = 0,0045  
Mature/non-mature=NF, Treatment=SWLL, Sampling=7
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,959; p = 0,7875  
Mature/non-mature=NF, Treatment=SWLD, Sampling=7
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,8775; p = 0,1221     
Mature/non-mature=NF, Treatment=FWLL, Sampling=7
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,8604; p = 0,0308   
Mature/non-mature=MM, Treatment=FWLL, Sampling=7









































 LOG(GSI):  SW-W = 0,9981; p = 0,9160   
Mature/non-mature=NF, Treatment=FWLD, Sampling=7
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,96; p = 0,7717  
Mature/non-mature=MM, Treatment=FWLD, Sampling=7
Normal Probability Plot of LOG(GSI)



























 LOG(GSI):  SW-W = 0,9759; p = 0,8777  
 116
Mature/non-mature=NF, Treatment=SWLL, Sampling=8
Normal Probability Plot of LOG(GSI)






















 LOG(GSI):  SW-W = 0,9275; p = 0,1556  
Mature/non-mature=MM, Treatment=SWLL, Sampling=8
Normal Probability Plot of LOG(GSI)






















 LOG(GSI):  SW-W = 0,9463; p = 0,4681   
Mature/non-mature=NF, Treatment=SWLD, Sampling=8









































 LOG(GSI):  SW-W = 0,9512; p = 0,3097  
Mature/non-mature=MM, Treatment=SWLD, Sampling=8
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9304; p = 0,2764  
Mature/non-mature=MM, Treatment=FWLL, Sampling=8
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9161; p = 0,1461  
Mature/non-mature=NF, Treatment=FWLL, Sampling=8
Normal Probability Plot of LOG(GSI)

























 LOG(GSI):  SW-W = 0,9608; p = 0,5317  
Mature/non-mature=NF, Treatment=FWLL, Sampling=8
Normal Probability Plot of LOG(GSI)
























 LOG(GSI):  SW-W = 0,9608; p = 0,5317  
Mature/non-mature=NF, Treatment=FWLL, Sampling=8
Normal Probability Plot of LOG(GSI)

























 LOG(GSI):  SW-W = 0,9608; p = 0,5317   
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Mature/non-mature=NF, Treatment=FWLD, Sampling=8
Normal Probability Plot of LOG(GSI)























 LOG(GSI):  SW-W = 0,9361; p = 0,3040  
Sampling=8, Treatment=FWLD, Mature/non-mature=MM
Normal Probability Plot of LOG(GSI)




























Normal probability plot of residual for Condition factor divided into samplings 5-8, treatment 
groups (SWLL, SWLD, FWLL and FWLD) and maturation category (NF and MM): 
 
Mature/non-mature=NF, Treatment=SWLL, Sampling=5
Normal Probability Plot of CF






















 CF:  SW-W = 0,9768; p = 0,9428   
Mature/non-mature=MM, Treatment=SWLL, Sampling=5
Normal Probability Plot of CF


























 CF:  SW-W = 0,9104; p = 0,4843   
Mature/non-mature=NF, Treatment=SWLD, Sampling=5
Normal Probability Plot of CF























 CF:  SW-W = 0,8587; p = 0,0736   
Mature/non-mature=MM, Treatment=SWLD, Sampling=5
Normal Probability Plot of CF




























 CF:  SW-W = 0,9033; p = 0,4284   
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Mature/non-mature=NF, Treatment=FWLL, Sampling=5
Normal Probability Plot of CF























 CF:  SW-W = 0,932; p = 0,4676  
Mature/non-mature=MM, Treatment=FWLL, Sampling=5
Normal Probability Plot of CF























 CF:  SW-W = 0,9715; p = 0,9070    
Mature/non-mature=NF, Treatment=FWLD, Sampling=5
Normal Probability Plot of CF






















 CF:  SW-W = 0,8402; p = 0,0581  
Mature/non-mature=MM, Treatment=FWLD, Sampling=5
Normal Probability Plot of CF






















 CF:  SW-W = 0,9802; p = 0,9638   
Mature/non-mature=NF, Treatment=SWLL, Sampling=6
Normal Probability Plot of CF






















 CF:  SW-W = 0,8777; p = 0,1227  
Mature/non-mature=MM, Treatment=SWLL, Sampling=6
Normal Probability Plot of CF























 CF:  SW-W = 0,9479; p = 0,6666  
Mature/non-mature=MM, Treatment=SWLD, Sampling=6
Normal Probability Plot of CF
























 CF:  SW-W = 0,926; p = 0,4738   
Mature/non-mature=NM, Treatment=FWLL, Sampling=6
Normal Probability Plot of CF





























 CF:  SW-W = 0,8156; p = 0,0808  
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Mature/non-mature=MM, Treatment=FWLL, Sampling=6
Normal Probability Plot of CF

























 CF:  SW-W = 0,925; p = 0,4701  
Mature/non-mature=NF, Treatment=FWLL, Sampling=6
Normal Probability Plot of CF






















 CF:  SW-W = 0,9472; p = 0,6088  
Mature/non-mature=MM, Treatment=FWLD, Sampling=6
Normal Probability Plot of CF






















 CF:  SW-W = 0,9492; p = 0,7028   
Mature/non-mature=NF, Treatment=FWLD, Sampling=6
Normal Probability Plot of CF























 CF:  SW-W = 0,9741; p = 0,9259  
Mature/non-mature=MM, Treatment=SWLL, Sampling=7
Normal Probability Plot of CF























 CF:  SW-W = 0,9284; p = 0,3950  
Mature/non-mature=NF, Treatment=SWLL, Sampling=7
Normal Probability Plot of CF






















 CF:  SW-W = 0,8897; p = 0,1980  
Mature/non-mature=NF, Treatment=SWLD, Sampling=7
Normal Probability Plot of CF
1,0 1,1 1,2 1,3 1,4 1,5 1,6
 
Mature/non-mature=MM, Treatment=SWLD, Sampling=7
Normal Probability Plot of CF










































Observed Value CF:  SW-W = 0,8598; p = 0,0759
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Mature/non-mature=NF, Treatment=FWLL, Sampling=7
Normal Probability Plot of CF






















 CF:  SW-W = 0,9379; p = 0,3923  
Mature/non-mature=MM, Treatment=SWLD, Sampling=7
Normal Probability Plot of CF




















 CF:  SW-W = 0,9109; p = 0,4018   
Mature/non-mature=NF, Treatment=FWLL, Sampling=7
Normal Probability Plot of CF






















 CF:  SW-W = 0,9379; p = 0,3923  
Mature/non-mature=MM, Treatment=FWLL, Sampling=7
Normal Probability Plot of CF
























 CF:  SW-W = 0,9974; p = 0,9023   
Mature/non-mature=NF, Treatment=FWLD, Sampling=7
Normal Probability Plot of CF






















 CF:  SW-W = 0,9729; p = 0,9144  
Mature/non-mature=MM, Treatment=FWLD, Sampling=7
Normal Probability Plot of CF


























 CF:  SW-W = 0,8952; p = 0,4075  
Mature/non-mature=NF, Treatment=SWLL, Sampling=8
Normal Probability Plot of CF

























 CF:  SW-W = 0,9316; p = 0,1183  
Mature/non-mature=MM, Treatment=SWLL, Sampling=8
Normal Probability Plot of CF























 CF:  SW-W = 0,9291; p = 0,2645   
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Mature/non-mature=NF, Treatment=SWLD, Sampling=8
Normal Probability Plot of CF

























 CF:  SW-W = 0,9512; p = 0,3096  
Mature/non-mature=MM, Treatment=SWLD, Sampling=8
Normal Probability Plot of CF























 CF:  SW-W = 0,8918; p = 0,0715  
Mature/non-mature=MM, Treatment=FWLL, Sampling=8
Normal Probability Plot of CF























 CF:  SW-W = 0,9182; p = 0,1579  
Mature/non-mature=NF, Treatment=FWLL, Sampling=8
Normal Probability Plot of CF

























 CF:  SW-W = 0,9595; p = 0,4796   
Mature/non-mature=NF, Treatment=FWLD, Sampling=8
Normal Probability Plot of CF























 CF:  SW-W = 0,8964; p = 0,0704  
Sampling=8, Treatment=FWLD, Mature/non-mature=MM
Normal Probability Plot of Condition-factor






















 Condition-factor:  SW-W = 0,9293; p = 0,1885  
 
 
Normal probability plot of residual for NKA activity divided into samplings 5-8, treatment 




Normal Probability Plot of Atpase
4 5 6 7 8 9 10 11
 
Mature/non-mature=MM, Treatment=SWLL, Sampling=5
Normal Probability Plot of Atpase


















































Observed Value Atpase:  SW-W = 0,9465; p = 0,4709
Mature/non-mature=NF, Treatment=SWLD, Sampling=5
Normal Probability Plot of Atpase
























 Atpase:  SW-W = 0,9793; p = 0,9611  
Mature/non-mature=MM, Treatment=SWLD, Sampling=5




























4 5 6 7 8 9 10 11
Observed Value    Atpase:  SW-W = 0,8648; p = 0,2459
Mature/non-mature=NF, Treatment=FWLL, Sampling=5
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,9329; p = 0,4766  
Mature/non-mature=MM, Treatment=FWLL, Sampling=5
Normal Probability Plot of Atpase























   Atpase:  SW-W = 0,8972; p = 0,2728
Mature/non-mature=NF, Treatment=FWLD, Sampling=5
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,9657; p = 0,8560  
Sampling=6, Treatment=SWLL, Mature/non-mature GSI 0.5=NF






















8 9 10 11 12 13 14
Observed Value   Atpase:  SW-W = 0,9419; p = 0,5740
 123
 Sampling=6, Treatment=SWLD, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,9667; p = 0,8520  
Sampling=6, Treatment=SWLD, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase

























 Atpase:  SW-W = 0,8504; p = 0,2415   
Sampling=6, Treatment=FWLL, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase



























 Atpase:  SW-W = 0,8486; p = 0,2216  
Sampling=6, Treatment=FWLL, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,8874; p = 0,1291  
Sampling=6, Treatment=FWLD, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,923; p = 0,4544  
Sampling=6, Treatment=FWLD, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,8634; p = 0,0837  
Sampling=7, Treatment=SWLL, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,8746; p = 0,0889  
Sampling=7, Treatment=SWLL, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase
























 Atpase:  SW-W = 0,8799; p = 0,1565  
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Sampling=7, Treatment=SWLD, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase






















Observed Value Atpase:  SW-W = 0,9767; p = 0,9453  
Sampling=7, Treatment=SWLD, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase






















 Atpase:  SW-W = 0,9325; p = 0,5720  
Sampling=7, Treatment=FWLL, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,9611; p = 0,7414  
Sampling=7, Treatment=FWLL, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase

























 Atpase:  SW-W = 0,9911; p = 0,8197  
Sampling=7, Treatment=FWLD, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,9662; p = 0,8461  
Sampling=7, Treatment=FWLD, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase



























 Atpase:  SW-W = 0,9331; p = 0,6125  
Sampling=8, Treatment=SWLL, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase

























 Atpase:  SW-W = 0,9507; p = 0,3026  
Sampling=8, Treatment=SWLL, Mature/non-mature GSI 0.5=MM
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Observed Value   Atpase:  SW-W = 0,9709; p = 0,8716
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Sampling=8, Treatment=SWLD, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase

























 Atpase:  SW-W = 0,9767; p = 0,8423  
Sampling=8, Treatment=SWLD, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase
























 Atpase:  SW-W = 0,9649; p = 0,7761  
Sampling=8, Treatment=FWLL, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,9632; p = 0,6919  
Sampling=8, Treatment=FWLL, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase


























 Atpase:  SW-W = 0,972; p = 0,7579  
Sampling=8, Treatment=FWLD, Mature/non-mature GSI 0.5=NF
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,9553; p = 0,6110
Sampling=8, Treatment=FWLD, Mature/non-mature GSI 0.5=MM
Normal Probability Plot of Atpase























 Atpase:  SW-W = 0,964; p = 0,7617  
 
 
Normal probability plot of residual for Log NKA1b divided into samplings 5-8, treatment 
groups (SWLL, SWLD, FWLL and FWLD) and maturation category (NF and MM): 
Treatment=SWLL, Sampling#=5, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b



























 LOG NKA1b:  SW-W = 0,9584; p = 0,7690
Treatment=SWLL, Sampling#=5, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,908; p = 0,4235  
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Treatment=SWLD, Sampling#=5, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9679; p = 0,8782
Treatment=SWLD, Sampling#=5, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9686; p = 0,8662
Treatment=FWLL, Sampling#=5, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9685; p = 0,8655
Treatment=FWLL, Sampling#=5, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b























 LOG NKA1b:  Bad numerical conditions for statistics
Treatment=FWLD, Sampling#=5, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9449; p = 0,6991
Treatment=FWLD, Sampling#=5, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b

























 LOG NKA1b:  SW-W = 0,9465; p = 0,5540
Treatment=SWLL, Sampling#=6, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,8827; p = 0,2815
Treatment=SWLL, Sampling#=6, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





















 LOG NKA1b:  SW-W = 0,8166; p = 0,0595
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Treatment=SWLD, Sampling#=6, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b

























 LOG NKA1b:  SW-W = 1; p = 0,9984
Treatment=SWLD, Sampling#=6, Mature/Non Mature0,5%=NF













































 LOG NKA1b:  SW-W = 0,8693; p = 0,2635
Treatment=FWLL, Sampling#=6, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b

























 LOG NKA1b:  SW-W = 0,99; p = 0,8083
Treatment=FWLL, Sampling#=6, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9097; p = 0,4343
Treatment=FWLD, Sampling#=6, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b























 LOG NKA1b:  SW-W = 0,8712; p = 0,1547
Treatment=FWLD, Sampling#=6, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9513; p = 0,7467
Treatment=SWLL, Sampling#=7, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b
-0,7 -0,6 -0,5 -0,4 -0,3 -0,2 -0,1 0,0 0,1 0,2
Treatment=SWLL, Sampling#=7, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b

























































Observed Value LOG NKA1b:  SW-W = 0,9687; p = 0,8839
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Treatment=SWLD, Sampling#=7, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9422; p = 0,6767
Treatment=SWLD, Sampling#=7, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





















 LOG NKA1b:  SW-W = 0,9298; p = 0,5490
Treatment=FWLL, Sampling#=7, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9429; p = 0,6864
Treatment=FWLL, Sampling#=7, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9572; p = 0,7880
Treatment=FWLD, Sampling#=7, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b

























 LOG NKA1b:  SW-W = 0,7641; p = 0,0314
Treatment=FWLD, Sampling#=7, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,939; p = 0,6585
Treatment=SWLL, Sampling#=8, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b Treatment=SWLL, Sampling#=8, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b



























 LOG NKA1b:  SW-W = 0,9842; p = 0,9259






























 LOG NKA1b:  SW-W = 0,9156; p = 0,4740
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Treatment=SWLD, Sampling#=8, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





















 LOG NKA1b:  SW-W = 0,9158; p = 0,4378
Treatment=SWLD, Sampling#=8, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,8502; p = 0,1579
Treatment=FWLL, Sampling#=8, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b



























 LOG NKA1b:  SW-W = 0,9625; p = 0,7945
Treatment=FWLL, Sampling#=8, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,8978; p = 0,3613
Treatment=FWLD, Sampling#=8, Mature/Non Mature0,5%=NF
Normal Probability Plot of LOG NKA1b





























 LOG NKA1b:  SW-W = 0,9491; p = 0,7328
Treatment=FWLD, Sampling#=8, Mature/Non Mature0,5%=MM
Normal Probability Plot of LOG NKA1b

































Normal probability plot of residual for Log NKA1a divided into samplings 5-8, treatment 
groups (SWLL, SWLD, FWLL and FWLD) and maturation category (NF and MM): 
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Treatment=SWLL, Sampling#=5, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a



























 LOG NKA1a:  SW-W = 0,8948; p = 0,4056
Treatment=SWLL, Sampling#=5, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9157; p = 0,4750
Treatment=SWLD, Sampling#=5, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9921; p = 0,9937
Treatment=SWLD, Sampling#=5, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,8298; p = 0,1387  
 
 
Treatment=FWLL, Sampling#=5, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9273; p = 0,5780
Treatment=FWLL, Sampling#=5, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a























 LOG NKA1a:  Bad numerical conditions for statistics  
Treatment=FWLD, Sampling#=5, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,885; p = 0,2930
Treatment=FWLD, Sampling#=5, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a



























 LOG NKA1a:  SW-W = 0,9214; p = 0,5451  
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Treatment=SWLL, Sampling#=6, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,8962; p = 0,3517
Treatment=SWLL, Sampling#=6, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





















 LOG NKA1a:  SW-W = 0,9076; p = 0,3792
Treatment=SWLD, Sampling#=6, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a

























 LOG NKA1a:  SW-W = 0,9622; p = 0,6263
Treatment=SWLD, Sampling#=6, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9469; p = 0,7151
Treatment=FWLL, Sampling#=6, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a
0,8 1,0 1,2 1,4 1,6 1,8 2,0 2,2
Treatment=FWLL, Sampling#=6, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





















































Observed Value LOG NKA1a:  SW-W = 0,9655; p = 0,6430
Treatment=FWLD, Sampling#=6, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,8065; p = 0,0914  
Treatment=FWLD, Sampling#=6, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a
























 LOG NKA1a:  SW-W = 0,9386; p = 0,5975
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Treatment=SWLL, Sampling#=7, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,8473; p = 0,1496
Treatment=SWLL, Sampling#=7, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9044; p = 0,4006
Treatment=SWLD, Sampling#=7, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,8254; p = 0,0982
Treatment=SWLD, Sampling#=7, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a






















 LOG NKA1a:  SW-W = 0,9106; p = 0,3997
Treatment=FWLL, Sampling#=7, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9962; p = 0,9962
Treatment=FWLL, Sampling#=7, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a






























 LOG NKA1a:  SW-W = 0,9352; p = 0,6322
Treatment=FWLD, Sampling#=7, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a

























 LOG NKA1a:  SW-W = 0,9865; p = 0,7773
Treatment=FWLD, Sampling#=7, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9406; p = 0,6641
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Treatment=SWLL, Sampling#=8, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,936; p = 0,6270
Treatment=SWLL, Sampling#=8, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,8918; p = 0,3665
Treatment=SWLD, Sampling#=8, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





















 LOG NKA1a:  SW-W = 0,9218; p = 0,4835
Treatment=SWLD, Sampling#=8, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,85; p = 0,1574
Treatment=FWLL, Sampling#=8, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9446; p = 0,6990
Treatment=FWLL, Sampling#=8, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9052; p = 0,4058  
Treatment=FWLD, Sampling#=8, Mature/Non Mature(GSI 0,5%)=NF
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,9168; p = 0,4827
Treatment=FWLD, Sampling#=8, Mature/Non Mature(GSI 0,5%)=MM
Normal Probability Plot of LOG NKA1a





























 LOG NKA1a:  SW-W = 0,8991; p = 0,4051  
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Analysis of variance (ANOVA) 
Fork length sampling 1-4 
Table A. III. 29: One-way ANOVA of Fork length between sampled tanks in sampling 1-4. Significant values 
(p<0.05) are highlighted in bold. 
 
  SS Degr. of MS F p 
Sampling 1 Intercept 10192,61 1 10192,61 7840,471 0,000000
 Tank nr 0,34 3 0,11 0,087 0,966405
 Error 20,80 16 1,30  
Sampling 2 Intercept 13676,45 1 13676,45 6288,023 0,000000
 Tank nr 1,75 3 0,58 0,268 0,847353
 Error 34,80 16 2,18  
Sampling 3 Intercept 17731,01 1 17731,01 4246,949 0,000000
 Tank nr 25,94 3 8,65 2,071 0,144461
 Error 66,80 16 4,18  
Sampling 4 Intercept 19313,11 1 19313,11 1819,846 0,000000
 Tank nr 21,84 3 7,28 0,686 0,573631
 Error 169,80 16 10,61  
 
 
Table A. III. 30: Factorial ANOVA of Fork length for females and males during smoltification (Sampling 1- 
4). Significant values (p<0.05) are highlighted in bold. 
 
 SS MS F p 
Intercept 58558,04 58558,04 13093,05 0,000000
Sampling 828,89 276,30 61,78 0,000000
Sex 2,46 2,46 0,55 0,460945
Sampling*Sex 17,72 5,91 1,32 0,274307
Error 322,02 4,47    
Total 1221,85     
Fork length sampling 5-8 
Table A. III. 31: Factorial ANOVA of Fork length for NF and MM in treatment group SWLL during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLL SS Degr. of MS F p 
Intercept 107455,2 1 107455,2 12973,60 0,000000
Sampling 329,0 3 109,7 13,24 0,000000
Mature/non-mature  22,4 1 22,4 2,70 0,103768
Sampling*Mature/non-mature  19,9 3 6,6 0,80 0,497532
Error 728,9 88 8,3  
 
Table A. III. 32: Factorial ANOVA of Fork length for NF and MM in treatment group SWLD during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
SWLD SS Degr. of MS F p 
Intercept 80902,92 1 80902,92 12843,35 0,000000
Sampling 229,80 3 76,60 12,16 0,000001
Mature/immature 19,31 1 19,31 3,07 0,083938
Sampling*Mature/immature 116,39 3 38,80 6,16 0,000828
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Error 485,04 77 6,30  
 
Table A. III. 33: Factorial ANOVA of Fork length for NF and MM in treatment group FWLD during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLD SS Degr. of MS F p 
Intercept 95917,68 1 95917,68 15314,18 0,000000
Sampling 286,09 3 95,36 15,23 0,000000
Mature/immature 7,20 1 7,20 1,15 0,287093
Sampling*Mature/immature 167,62 3 55,87 8,92 0,000041
Error 463,49 74 6,26  
 
Table A. III. 34: Factorial ANOVA of Fork length for NF and MM in treatment group FWLL during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLL SS Degr. of MS F p 
Intercept 88488,08 1 88488,08 11998,19 0,000000
Sampling 754,73 3 251,58 34,11 0,000000
Mature/immature 47,77 1 47,77 6,48 0,012803
Sampling*Mature/immature 60,21 3 20,07 2,72 0,049671
Error 604,76 82 7,38  
Body weight sampling 1-4 
Table A. III. 35: One-way ANOVA of Body weigh between sampled tanks in sampling 1-4. Significant values 
(p<0.05) are highlighted in bold. 
 
  SS Degr. of MS F p 
Sampling 1 Intercept 94,67522 1 94,67522 28273,81 0,000000
 Tank nr 0,00309 3 0,00103 0,31 0,819752
 Error 0,05358 16 0,00335  
Sampling 2 Intercept 111,8142 1 111,8142 21860,86 0,000000
 Tank nr 0,0014 3 0,0005 0,09 0,963388
 Error 0,0818 16 0,0051  
Sampling 3 Intercept 129,7340 1 129,7340 17556,57 0,000000
 Tank nr 0,0601 3 0,0200 2,71 0,079624
 Error 0,1182 16 0,0074  
Sampling 4 Intercept 130,3256 1 130,3256 5815,040 0,000000
 Tank nr 0,0542 3 0,0181 0,807 0,508355
 Error 0,3586 16 0,0224  
 
Table A. III. 36: Factorial ANOVA of Body weight for females and males during smoltification (Sampling 1- 
4). Significant values (p<0.05) are highlighted in bold. 
 
 SS MS F p 
Intercept 450,3882 450,3882 46626,95 0,000000
Sampling 1,8270 0,6090 63,05 0,000000
Sex 0,0059 0,0059 0,61 0,436554
Sampling*Sex 0,0384 0,0128 1,32 0,273321
Error 0,6858 0,0097    
Total 2,6419     
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Body weight sampling 5-8 
Table A. III. 37: Factorial ANOVA of body weight for NF and MM in treatment group SWLL during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLL SS Degr. of MS F p 
Intercept 40107037 1 40107037 1054,760 0,000000
Sampling 1381969 3 460656 12,115 0,000001
Mature/immature 232196 1 232196 6,106 0,015373
Sampling*Mature/immature 74995 3 24998 0,657 0,580411
Error 3384208 89 38025  
 
Table A. III. 38: Factorial ANOVA of body weight for NF and MM in treatment group SWLD during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLD SS Degr. of MS F p 
Intercept 29872733 1 29872733 1088,465 0,000000
Sampling 1398538 3 466179 16,986 0,000000
Mature/immature 44537 1 44537 1,623 0,206485
Sampling*Mature/immature 733346 3 244449 8,907 0,000038
Error 2140696 78 27445  
 
Table A. III. 39: Factorial ANOVA of body weight for NF and MM in treatment group FWLD during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLD SS Degr. of MS F p 
Intercept 40523772 1 40523772 1379,150 0,000000
Sampling 1508239 3 502746 17,110 0,000000
Mature/immature 10664 1 10664 0,363 0,548732
Sampling*Mature/immature 972517 3 324172 11,033 0,000005
Error 2174353 74 29383  
 
Table A. III. 40: Factorial ANOVA of body weight for NF and MM in treatment group FWLL during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLL SS Degr. of MS F p 
Intercept 37959606 1 37959606 1217,841 0,000000
Sampling 3488972 3 1162991 37,312 0,000000
Mature/immature 477922 1 477922 15,333 0,000186
Sampling*Mature/immature 264990 3 88330 2,834 0,043248
Error 2555906 82 31170  
Gonadosomatic Index sampling 1-4 
Table A. III. 41: One-way ANOVA of GSI between sampled tanks in sampling 1-4. Significant values (p<0.05) 
are highlighted in bold. 
 
  SS Degr. of MS F p 
Sampling 1 Intercept 0,050413 1 0,050413 75,40977 0,000000
 Tank nr 0,000728 3 0,000243 0,36313 0,780498
 Error 0,010696 16 0,000669  
Sampling 2 Intercept 0,082643 1 0,082643 139,9939 0,000000
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 Tank nr 0,003259 3 0,001086 1,8399 0,180568
 Error 0,009445 16 0,000590  
Sampling 3 Intercept 0,081913 1 0,081913 204,8639 0,000000
 Tank nr 0,001836 3 0,000612 1,5303 0,245048
 Error 0,006397 16 0,000400  
Sampling 4 Intercept 0,095040 1 0,095040 171,0170 0,000000
 Tank nr 0,001101 3 0,000367 0,6604 0,588278
 Error 0,008892 16 0,000556  
 
Table A. III. 42: Factorial ANOVA of GSI for females and males during smoltification (Sampling 1- 4). 
Significant values (p<0.05) are highlighted in bold. 
 
 SS MS F p 
Intercept 0,302986 0,302986 1699,569 0,000000
Sampling 0,001530 0,000510 2,860 0,042774
Sex 0,028664 0,028664 160,785 0,000000
Sampling*Sex 0,000808 0,000269 1,511 0,218884
Error 0,012836 0,000178  
Total 0,046281  
Gonadosomatic Index sampling 5-8 
Table A. III. 43: Factorial ANOVA of Log GSI for MM in all treatment groups during maturation (Sampling 5- 
8). Significant values (p<0.05) are highlighted in bold. 
 
MM all treatments SS Degr. of MS F p 
Intercept 30,36356 1 30,36356 861,5085 0,000000
Sampling 14,69447 3 4,89816 138,9760 0,000000
Treatment 0,39157 3 0,13052 3,7034 0,013571
Sampling*Treatment 2,70013 9 0,30001 8,5124 0,000000
Error 4,37034 124 0,03524  
Condition factor sampling 1-4 
Table A. III. 44: One-way ANOVA of Condition factor between sampled tanks in sampling 1-4. Significant 
values (p<0.05) are highlighted in bold. 
 
  SS Degr. of MS F p 
Sampling 1 Intercept 34,27399 1 34,27399 5267,440 0,000000
 Tank nr 0,01252 3 0,00417 0,642 0,599302
 Error 0,10411 16 0,00651  
Sampling 2 Intercept 33,86392 1 33,86392 9902,888 0,000000
 Tank nr 0,02864 3 0,00955 2,792 0,074024
 Error 0,05471 16 0,00342  
Sampling 3 Intercept 36,31222 1 36,31222 5192,248 0,000000
 Tank nr 0,01485 3 0,00495 0,708 0,561237
 Error 0,11190 16 0,00699  
Sampling 4 Intercept 29,38360 1 29,38360 2826,962 0,000000
 Tank nr 0,04593 3 0,01531 1,473 0,259507
 Error 0,16630 16 0,01039  
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Table A. III. 45: Factorial ANOVA of Condition factor for females and males during smoltification (Sampling 
1- 4). Significant values (p<0.05) are highlighted in bold. 
 
 SS MS F p 
Intercept 129,9070 129,9070 17457,70 0,000000
Sampling 0,1846 0,0615 8,27 0,000086
Sex 0,0001 0,0001 0,02 0,899982
Sampling*Sex 0,0104 0,0035 0,47 0,705872
Error 0,5283 0,0074    
Total 0,7277     
Condition factor sampling 5-8 
Table A. III. 46: Factorial ANOVA of Condition factor for NF and MM in treatment group SWLL during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLL SS Degr. of MS F p 
Intercept 149,4509 1 149,4509 10142,02 0,000000
Sampling 0,1763 3 0,0588 3,99 0,010260
Mature/immature 0,2178 1 0,2178 14,78 0,000227
Sampling*Mature/immature 0,0649 3 0,0216 1,47 0,228774
Error 1,3115 89 0,0147  
 
Table A. III. 47: Factorial ANOVA of Condition factor for NF and MM in treatment group SWLD during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLD SS Degr. of MS F p 
Intercept 111,8603 1 111,8603 7219,434 0,000000
Sampling 0,4358 3 0,1453 9,376 0,000023
Mature/immature 0,0001 1 0,0001 0,008 0,929111
Sampling*Mature/immature 0,3711 3 0,1237 7,985 0,000104
Error 1,2086 78 0,0155  
 
Table A. III. 48: Factorial ANOVA of Condition factor for NF and MM in treatment group FWLL during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLL SS Degr. of MS F p 
Intercept 102,2706 1 102,2706 9867,940 0,000000
Sampling 0,2328 3 0,0776 7,488 0,000174
Mature/immature 0,3969 1 0,3969 38,294 0,000000
Sampling*Mature/immature 0,1438 3 0,0479 4,624 0,004896
Error 0,8395 81 0,0104  
 
Table A. III. 49: Factorial ANOVA of Condition factor for NF and MM in treatment group FWLD during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLD SS Degr. of MS F p 
Intercept 111,8603 1 111,8603 7219,434 0,000000
Sampling 0,4358 3 0,1453 9,376 0,000023
Mature/immature 0,0001 1 0,0001 0,008 0,929111
Sampling*Mature/immature 0,3711 3 0,1237 7,985 0,000104
Error 1,2086 78 0,0155  
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NKA activity sampling 1-4 
Table A. III. 50: One-way ANOVA of Condition factor between sampled tanks in sampling 1-4. Significant 
values (p<0.05) are highlighted in bold. 
 
NKA  SS Degr. of MS F p 
Sampling 1 Intercept 1725,056 1 1725,056 577,0208 0,000000
 Tank nr 36,724 3 12,241 4,0946 0,024648
 Error 47,833 16 2,990  
Sampling 2 Intercept 1860,375 1 1860,375 1292,914 0,000000
 Tank nr 17,043 3 5,681 3,948 0,027713
 Error 23,022 16 1,439  
Sampling 3 Intercept 424,4526 1 424,4526 221,3468 0,000000
 Tank nr 5,5899 3 1,8633 0,9717 0,430405
 Error 30,6814 16 1,9176  
Sampling 4 Intercept 1496,007 1 1496,007 363,1472 0,000000
 Tank nr 11,107 3 3,702 0,8987 0,464770
 Error 61,793 15 4,120  
 
Table A. III. 51: Factorial ANOVA of NKA activity for females and males during smoltification (Sampling 1- 
4). Significant values (p<0.05) are highlighted in bold 
 
 SS MS F p 
Intercept 5168,506 5168,506 1736,794 0,000000
Sampling 336,972 112,324 37,745 0,000000
Sex 10,462 10,462 3,516 0,064902
Sampling*Sex 12,538 4,179 1,404 0,248649
Error 211,288 2,976    
Total 567,895     
NKA activity sampling 5-8 
Table A. III. 52: Factorial ANOVA of Log NK1b for NF and MM in treatment group SWLL during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLL SS Degr. 
of 
MS F p 
Intercept 5069,330 1 5069,330 962,2044 0,000000
Sampling 230,631 3 76,877 14,5919 0,000000
Mature/non-mature GSI 0.5 72,430 1 72,430 13,7479 0,000363
Sampling*Mature/non-mature GSI 0.5 38,511 3 12,837 2,4366 0,069882
Error 468,892 89 5,268  
 
Table A. III. 53: Factorial ANOVA of Log NK1b for NF and MM in treatment group SWLD during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLD SS Degr. 
of 
MS F p 
Intercept 4356,296 1 4356,296 1066,476 0,000000
Sampling 96,041 3 32,014 7,837 0,000123
Mature/non-mature GSI 0.5 30,544 1 30,544 7,478 0,007729
Sampling*Mature/non-mature GSI 0.5 22,817 3 7,606 1,862 0,142939
Error 318,611 78 4,085  
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Table A. III. 54: Factorial ANOVA of Log NK1b for NF and MM in treatment group FWLD during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLD SS Degr. 
of 
MS F p 
Intercept 486,6613 1 486,6613 527,2418 0,000000
Sampling 22,9681 3 7,6560 8,2944 0,000079
Mature/non-mature GSI 0.5 30,3987 1 30,3987 32,9335 0,000000
Sampling*Mature/non-mature GSI 0.5 2,9647 3 0,9882 1,0707 0,366841
Error 68,3044 74 0,9230  
 
 
Table A. III. 55: Factorial ANOVA of Log NK1b for NF and MM in treatment group FWLL during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLL SS Degr. 
of 
MS F p 
Intercept 1103,906 1 1103,906 523,9387 0,000000
Sampling 55,303 3 18,434 8,7493 0,000043
Mature/non-mature GSI 0.5 105,793 1 105,793 50,2119 0,000000
Sampling*Mature/non-mature GSI 0.5 3,439 3 1,146 0,5441 0,653530
Error 170,662 81 2,107  
NKAα1b gene expression sampling 1-4 
Table A. III. 56: Factorial ANOVA of NKA1b gene expression for females and males during smoltification 
(Sampling 1- 4). Significant values (p<0.05) are highlighted in bold 
 
 SS MS F p 
Intercept 0,60542 0,605423 1,461868 0,233912
Sampling 6,56246 2,187488 5,281956 0,003738
Gender 1,16964 1,169640 2,824239 0,100845
Sampling*Gender 0,07843 0,026143 0,063124 0,978980
Error 16,15159 0,414143    
NKAα1b gene expression sampling 5-8 
Table A. III. 57: Factorial ANOVA of Log NK1b for NF and MM in treatment group SWLL during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
SWLL SS Degr. of MS F p 
Intercept 5,646870 1 5,646870 39,60549 0,000000
Sampling 0,179311 3 0,059770 0,41921 0,740271
Mature/Non Mature 0,142265 1 0,142265 0,99780 0,324331
Sampling*Mature/Non Mature 0,338604 3 0,112868 0,79162 0,506349
Error 5,275384 37 0,142578    
 
Table A. III. 58: Factorial ANOVA of Log NK1b for NF and MM in treatment group SWLD during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
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 SS Degr. of MS F p 
Intercept 8,614652 1 8,614652 78,59564 0,000000
Mature/Non Mature 0,565545 1 0,565545 5,15974 0,029025
Sampling 0,921695 3 0,307232 2,80302 0,053183
Mature/Non Mature*Sampling 0,040787 3 0,013596 0,12404 0,945315
Error 4,055468 37 0,109607  
 
Table A. III. 59: Factorial ANOVA of Log NK1b for NF and MM in treatment group FWLD during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
 SS Degr. of MS F p 
Intercept 31,02641 1 31,02641 318,8047 0,000000
Sampling 0,93291 3 0,31097 3,1953 0,035275
Mature/Non Mature 0,66750 1 0,66750 6,8587 0,012951
Sampling*Mature/Non Mature 0,18830 3 0,06277 0,6449 0,591356
Error 3,40624 35 0,09732  
 
Table A. III. 60: Factorial ANOVA of Log NK1b for NF and MM in treatment group FWLL during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
FWLL SS Degr. of MS F p 
Intercept 16,78453 1 16,78453 291,3217 0,000000
Sampling 0,40552 3 0,13517 2,3462 0,094221
Mature/Non Mature 2,46206 1 2,46206 42,7330 0,000000
Sampling*Mature/Non Mature 0,11696 3 0,03899 0,6767 0,573626
Error 1,61322 28 0,05762  
NKAα1a gene expression sampling 1-4 
Table A. III. 61: Factorial ANOVA of NKA1a for females and males during smoltification (Sampling 1- 4). 
Significant values (p<0.05) are highlighted in bold 
 
 SS MS F p 
Intercept 1701,090 1701,090 139,0569 0,000000
Sampling 632,306 210,769 17,2294 0,000000
Gender 5,081 5,081 0,4154 0,523131
Sampling*Gender 8,779 2,926 0,2392 0,868453
Error 464,856 12,233  
NKAα1a gene expression sampling 5-8 
Table A. III. 62: Factorial ANOVA of Log NKA1a for NF and MM in treatment group SWLL during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
 SS Degr. of MS F p 
Intercept 7,25294 1 7,252940 11,38486 0,001716
Sampling 7,47312 3 2,491038 3,91016 0,015790
Mature/Non Mature 0,07606 1 0,076059 0,11939 0,731604
Sampling*Mature/Non Mature 0,98110 3 0,327034 0,51334 0,675543
Error 24,20862 38 0,637069  
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Table A. III. 63: Factorial ANOVA of Log NKA1a for NF and MM in treatment group SWLD during 
maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
 SS Degr. of MS F p 
Intercept 0,43952 1 0,439519 1,16294 0,287838
Sampling 26,88120 3 8,960401 23,70858 0,000000
Mature/Non Mature 3,59910 1 3,599099 9,52296 0,003830
Sampling*Mature/Non Mature 1,72602 3 0,575339 1,52230 0,224814
Error 13,98375 37 0,377939  
 
Table A. III. 64: Factorial ANOVA of Log NK1a for NF and MM in treatment group FWLD during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
 
 SS Degr. of MS F p 
Intercept 102,1935 1 102,1935 793,7278 0,000000
Sampling 3,5130 3 1,1710 9,0950 0,000137
Mature/Non Mature 0,1161 1 0,1161 0,9014 0,348907
Sampling*Mature/Non Mature 0,4840 3 0,1613 1,2532 0,305407
Error 4,5063 35 0,1288  
 
Table A. III. 65: Factorial ANOVA of Log NK1a for NF and MM in treatment group FWLL during maturation 
(Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
 SS Degr. of MS F p 
Intercept 76,98966 1 76,98966 880,9135 0,000000
Sampling 1,23873 3 0,41291 4,7245 0,008369
Mature/Non Mature 0,67332 1 0,67332 7,7041 0,009546
Sampling*Mature/Non Mature 0,97317 3 0,32439 3,7116 0,022502
Error 2,53453 29 0,08740  
Post hoc tests 
Dunnett test 
Table A. III. 66: Dunnets test of difference in Gill NKA activity between tanks in sampling 1. Significant 
values (p<0.05) are highlighted in bold. 
 






Table A. III. 67: Dunnets test of difference in Gill NKA activity between tanks in sampling 2. Significant 
values (p<0.05) are highlighted in bold. 
 






 Newman-Keuls tests 
Fork length 
 
Table A. III. 68: Newman-Keuls test of difference in Fork length between samplings and gender during 
smoltification (Sampling 1- 4). Significant values (p<0.05) are highlighted in bold. 
 
 Sampling Gender {1} {2} {3} {4} {5} {6} {7} {8} 
1 1 F  0,728367 0,001126 0,000625 0,000124 0,000126 0,000123 0,000127
2 1 M 0,728367  0,001750 0,000688 0,000150 0,000127 0,000126 0,000124
3 2 F 0,001126 0,001750 1,000000 0,000585 0,001218 0,000124 0,000725
4 2 M 0,000625 0,000688 1,000000 0,001451 0,001918 0,000128 0,001318
5 3 F 0,000124 0,000150 0,000585 0,001451 0,963076 0,101162 0,814625
6 3 M 0,000126 0,000127 0,001218 0,001918 0,963076  0,042436 0,979300
7 4 F 0,000123 0,000126 0,000124 0,000128 0,101162 0,042436 0,098506
8 4 M 0,000127 0,000124 0,000725 0,001318 0,814625 0,979300 0,098506
 
Table A. III. 69: Newman-Keuls test of difference in Fork length between sampling and gender in SWLL 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,007251 0,064171 0,132832 0,101442 0,004584 0,001630 0,001689
2 5 MM 0,007251 0,387791 0,284126 0,253840 0,794060 0,781148 0,882955
3 6 NF 0,064171 0,387791 0,946176 0,896998 0,349289 0,220343 0,243032
4 6 MM 0,132832 0,284126 0,946176 0,707437 0,286379 0,191076 0,222009
5 7 NF 0,101442 0,253840 0,896998 0,707437 0,339871 0,271321 0,334068
6 7 MM 0,004584 0,794060 0,349289 0,286379 0,339871  0,683879 0,884404
7 8 NF 0,001630 0,781148 0,220343 0,191076 0,271321 0,683879 0,949303
8 8 MM 0,001689 0,882955 0,243032 0,222009 0,334068 0,884404 0,949303
 
Table A. III. 70: Newman-Keuls test of difference in Fork length between sampling and gender in SWLD 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF   0,109600 0,094214 0,000122 0,023119 0,056405 0,000149 0,006201
2 5 MM 0,109600  0,624032 0,000669 0,463512 0,605351 0,007338 0,260728
3 6 NF 0,094214 0,624032  0,002367 0,596297 0,642626 0,021831 0,419011
4 6 MM 0,000122 0,000669 0,002367  0,019753 0,007123 0,398497 0,047242
5 7 NF 0,023119 0,463512 0,596297 0,019753  0,613921 0,090108 0,572279
6 7 MM 0,056405 0,605351 0,642626 0,007123 0,613921   0,048520 0,533089
7 8 NF 0,000149 0,007338 0,021831 0,398497 0,090108 0,048520  0,121823
8 8 MM 0,006201 0,260728 0,419011 0,047242 0,572279 0,533089 0,121823  
 
 
Table A. III. 71: Newman-Keuls test of difference in Fork length between sampling and gender in FWLL 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,005880 0,014125 0,000942 0,000695 0,000151 0,000119 0,000123
2 5 MM 0,005880 0,967505 0,487989 0,512635 0,170810 0,001117 0,003492
3 6 NF 0,014125 0,967505 0,271852 0,375483 0,128395 0,000954 0,002787
4 6 MM 0,000942 0,487989 0,271852 0,813276 0,512925 0,020694 0,044027
5 7 NF 0,000695 0,512635 0,375483 0,813276 0,387333 0,025621 0,044397
6 7 MM 0,000151 0,170810 0,128395 0,512925 0,387333  0,115878 0,120961
7 8 NF 0,000119 0,001117 0,000954 0,020694 0,025621 0,115878 0,658138
8 8 MM 0,000123 0,003492 0,002787 0,044027 0,044397 0,120961 0,658138
 
Table A. III. 72: Newman-Keuls test of difference in Fork length between sampling and gender in FWLD 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,000523 0,000305 0,000149 0,001174 0,000523 0,000121 0,000313
2 5 MM 0,000523 0,869730 0,639387 0,977831 0,865020 0,009272 0,838580
3 6 NF 0,000305 0,869730 0,566963 0,784828 0,893746 0,025981 0,895130
4 6 MM 0,000149 0,639387 0,566963 0,557590 0,734157 0,041019 0,759818
5 7 NF 0,001174 0,977831 0,784828 0,557590 0,628795 0,007523 0,701073
6 7 MM 0,000523 0,865020 0,893746 0,734157 0,628795  0,021836 0,750308
7 8 NF 0,000121 0,009272 0,025981 0,041019 0,007523 0,021836 0,033384
8 8 MM 0,000313 0,838580 0,895130 0,759818 0,701073 0,750308 0,033384
 
Body weight 
Table A. III. 73: Newman-Keuls test of difference in Body weight between samplings and gender during 
smoltification (Sampling 1- 4). Significant values (p<0.05) are highlighted in bold. 
 
Sampling Gender {1} {2} {3} {4} {5} {6} {7} {8} 
1 F 0,852473 0,000342 0,000234 0,000127 0,000126 0,000123 0,000124
1 M 0,852473  0,000307 0,000198 0,000124 0,000127 0,000126 0,000150
2 F 0,000342 0,000307 0,952762 0,000778 0,000428 0,000154 0,003507
2 M 0,000234 0,000198 0,952762 0,001186 0,000512 0,000164 0,007959
3 F 0,000127 0,000124 0,000778 0,001186 0,669073 0,495125 0,403542
3 M 0,000126 0,000127 0,000428 0,000512 0,669073  0,481972 0,416773
4 F 0,000123 0,000126 0,000154 0,000164 0,495125 0,481972 0,206360
4 M 0,000124 0,000150 0,003507 0,007959 0,403542 0,416773 0,206360
 
 
Table A. III. 74: Newman-Keuls test of difference in Body weight between sampling and gender in SWLL 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,016061 0,094576 0,041545 0,063105 0,002513 0,002255 0,001056
2 5 MM 0,016061 0,435250 0,740127 0,500476 0,477826 0,681422 0,664978
3 6 NF 0,094576 0,435250 0,443079 0,682723 0,180684 0,186724 0,123370
4 6 MM 0,041545 0,740127 0,443079 0,949344 0,469884 0,515923 0,420061
5 7 NF 0,063105 0,500476 0,682723 0,949344 0,350726 0,434011 0,369889
6 7 MM 0,002513 0,477826 0,180684 0,469884 0,350726  0,902032 0,903914
7 8 NF 0,002255 0,681422 0,186724 0,515923 0,434011 0,902032 0,761270
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8 8 MM 0,001056 0,664978 0,123370 0,420061 0,369889 0,903914 0,761270
 
Table A. III.75: Newman-Keuls test of difference in Body weight between sampling and gender in SWLD 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,097063 0,122675 0,000125 0,007274 0,025775 0,000121 0,002585
2 5 MM 0,097063 0,761073 0,000872 0,281450 0,455319 0,000305 0,174788
3 6 NF 0,122675 0,761073 0,001635 0,299363 0,372467 0,000533 0,220626
4 6 MM 0,000125 0,000872 0,001635 0,041592 0,015697 0,636884 0,046746
5 7 NF 0,007274 0,281450 0,299363 0,041592 0,552396 0,022055 0,658024
6 7 MM 0,025775 0,455319 0,372467 0,015697 0,552396  0,006105 0,553248
7 8 NF 0,000121 0,000305 0,000533 0,636884 0,022055 0,006105 0,038676
8 8 MM 0,002585 0,174788 0,220626 0,046746 0,658024 0,553248 0,038676
 
Table A. III. 76: Newman-Keuls test of difference in Body weight between samplings and gender in FWLL 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,003461 0,009784 0,000267 0,000988 0,000127 0,000123 0,000119
2 5 MM 0,003461 0,479901 0,448475 0,544887 0,117729 0,001305 0,001813
3 6 NF 0,009784 0,479901 0,226259 0,389375 0,031712 0,000252 0,000297
4 6 MM 0,000267 0,448475 0,226259 0,546450 0,301608 0,017383 0,030853
5 7 NF 0,000988 0,544887 0,389375 0,546450 0,232673 0,005616 0,008618
6 7 MM 0,000127 0,117729 0,031712 0,301608 0,232673  0,082005 0,185507
7 8 NF 0,000123 0,001305 0,000252 0,017383 0,005616 0,082005 0,991799
8 8 MM 0,000119 0,001813 0,000297 0,030853 0,008618 0,185507 0,991799
 
 
Table A. III. 77: Newman-Keuls test of difference in Body weight between sampling and gender in FWLD 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,002198 0,000323 0,000131 0,000641 0,000790 0,000121 0,000531
2 5 MM 0,002198 0,326134 0,185996 0,705654 0,799003 0,000479 0,572499
3 6 NF 0,000323 0,326134 0,651168 0,995948 0,999372 0,007804 0,982489
4 6 MM 0,000131 0,185996 0,651168 0,411323 0,218541 0,029894 0,538399
5 7 NF 0,000641 0,705654 0,995948 0,411323 0,969744 0,004465 0,948819
6 7 MM 0,000790 0,799003 0,999372 0,218541 0,969744  0,002667 0,994280
7 8 NF 0,000121 0,000479 0,007804 0,029894 0,004465 0,002667 0,005813
8 8 MM 0,000531 0,572499 0,982489 0,538399 0,948819 0,994280 0,005813
 
Gonadosomatic index 
Table A. III. 78: Newman-Keuls test of difference in GSI between samplings and gender during smoltification 
(Sampling 1- 4). Significant values (p<0.05) are highlighted in bold. 
 
 Sampling Gender {1} {2} {3} {4} {5} {6} {7} {8} 
1 1 F  0,000124 0,293999 0,000150 0,482396 0,000131 0,704003 0,000168
2 1 M 0,000124  0,000123 0,152341 0,000127 0,046870 0,000126 0,021969
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3 2 F 0,293999 0,000123 0,000126 0,536828 0,000127 0,333411 0,000124
4 2 M 0,000150 0,152341 0,000126 0,000124 0,333511 0,000127 0,296410
5 3 F 0,482396 0,000127 0,536828 0,000124 0,000152 0,925338 0,000121
6 3 M 0,000131 0,046870 0,000127 0,333511 0,000152  0,000126 0,599570
7 4 F 0,704003 0,000126 0,333411 0,000127 0,925338 0,000126 0,000163
8 4 M 0,000168 0,021969 0,000124 0,296410 0,000121 0,599570 0,000163
 
Table A. III. 79: Newman-Keuls test of difference in Log GSI between samplings and gender in SWLL during 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,000119 0,753466 0,000123 0,510211 0,000118 0,885902 0,000122
2 5 MM 0,000119 0,000107 0,000114 0,000145 0,000145 0,000114 0,000107
3 6 NF 0,753466 0,000107 0,000145 0,954966 0,000123 0,992709 0,000119
4 6 MM 0,000123 0,000114 0,000145 0,000119 0,272448 0,000107 0,272353
5 7 NF 0,510211 0,000145 0,954966 0,000119 0,000122 0,997663 0,000123
6 7 MM 0,000118 0,000145 0,000123 0,272448 0,000122  0,000119 0,656520
7 8 NF 0,885902 0,000114 0,992709 0,000107 0,997663 0,000119 0,000145
8 8 MM 0,000122 0,000107 0,000119 0,272353 0,000123 0,656520 0,000145
 
Table A. III. 80: Newman-Keuls test of difference in Log GSI between samplings and gender in SWLD during 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,000113 0,991817 0,000122 0,747188 0,000147 0,378905 0,000109
2 5 MM 0,000113 0,000109 0,000147 0,000147 0,000109 0,000122 0,000113
3 6 NF 0,991817 0,000109 0,000125 0,474711 0,000122 0,251820 0,000147
4 6 MM 0,000122 0,000147 0,000125 0,000124 0,000115 0,000121 0,000109
5 7 NF 0,747188 0,000147 0,474711 0,000124 0,000125 0,380911 0,000122
6 7 MM 0,000147 0,000109 0,000122 0,000115 0,000125  0,000124 0,000150
7 8 NF 0,378905 0,000122 0,251820 0,000121 0,380911 0,000124 0,000125
8 8 MM 0,000109 0,000113 0,000147 0,000109 0,000122 0,000150 0,000125
 
 
Table A. III. 81: Newman-Keuls test of difference in Log GSI between samplings and gender in FWLL during 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,000108 0,903312 0,000146 0,704991 0,000124 0,813400 0,000121
2 5 MM 0,000108 0,000121 0,000115 0,000146 0,000146 0,000115 0,000108
3 6 NF 0,903312 0,000121 0,000124 0,960452 0,000119 0,909317 0,000123
4 6 MM 0,000146 0,000115 0,000124 0,000121 0,000108 0,000108 0,000125
5 7 NF 0,704991 0,000146 0,960452 0,000121 0,000123 0,811313 0,000124
6 7 MM 0,000124 0,000146 0,000119 0,000108 0,000123  0,000121 0,150858
7 8 NF 0,813400 0,000115 0,909317 0,000108 0,811313 0,000121 0,000146
8 8 MM 0,000121 0,000108 0,000123 0,000125 0,000124 0,150858 0,000146
 
Table A. III. 82: Newman-Keuls test of difference in Log GSI between sampling and gender in FWLD during 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,000114 0,554626 0,000123 0,902649 0,000148 0,959840 0,000109
2 5 MM 0,000114 0,000123 0,000148 0,000109 0,000109 0,000148 0,000114
3 6 NF 0,554626 0,000123 0,000121 0,459882 0,000125 0,299524 0,000126
4 6 MM 0,000123 0,000148 0,000121 0,000126 0,629585 0,000125 0,000127
5 7 NF 0,902649 0,000109 0,459882 0,000126 0,000123 0,881106 0,000148
6 7 MM 0,000148 0,000109 0,000125 0,629585 0,000123  0,000126 0,000154
7 8 NF 0,959840 0,000148 0,299524 0,000125 0,881106 0,000126 0,000123
8 8 MM 0,000109 0,000114 0,000126 0,000127 0,000148 0,000154 0,000123
 
Condition factor 
Table A. III. 83: Newman-Keuls test of difference in Condition factor between samplings during 
smoltification (Sampling 1- 4). Significant values (p<0.05) are highlighted in bold.  
 
 Sampling Gender {1} {2} {3} {4} {5} {6} {7} {8} 
1 1 F  0,764971 0,612874 0,882269 0,905514 0,564136 0,037395 0,056039
2 1 M 0,764971  0,849526 0,970466 0,845777 0,426563 0,098494 0,106889
3 2 F 0,612874 0,849526 0,971875 0,805562 0,423674 0,095116 0,121134
4 2 M 0,882269 0,970466 0,971875 0,912065 0,497421 0,061798 0,047508
5 3 F 0,905514 0,845777 0,805562 0,912065 0,368571 0,035871 0,057668
6 3 M 0,564136 0,426563 0,423674 0,497421 0,368571  0,003005 0,005811
7 4 F 0,037395 0,098494 0,095116 0,061798 0,035871 0,003005 0,775689
8 4 M 0,056039 0,106889 0,121134 0,047508 0,057668 0,005811 0,775689
 
Table A. III. 84: Newman-Keuls test of difference in Condition factor between samplings and gender in 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,026364 0,328197 0,038454 0,045893 0,014115 0,038211 0,011112
2 5 MM 0,026364 0,101123 0,982228 0,982525 0,943900 0,932248 0,895197
3 6 NF 0,328197 0,101123 0,260332 0,263346 0,150256 0,195290 0,118631
4 6 MM 0,038454 0,982228 0,260332 0,846850 0,855218 0,955491 0,597936
5 7 NF 0,045893 0,982525 0,263346 0,846850 0,886005 0,925498 0,750421
6 7 MM 0,014115 0,943900 0,150256 0,855218 0,886005  0,923489 0,996996
7 8 NF 0,038211 0,932248 0,195290 0,955491 0,925498 0,923489 0,846227
8 8 MM 0,011112 0,895197 0,118631 0,597936 0,750421 0,996996 0,846227
 
Table A. III. 85: Newman-Keuls test of difference in Condition factor between samplings and gender in 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,084827 0,149261 0,062957 0,005876 0,005900 0,000125 0,062625
2 5 MM 0,084827 0,484552 0,851114 0,501285 0,438788 0,009685 0,709452
3 6 NF 0,149261 0,484552 0,601002 0,205176 0,187430 0,001397 0,531398
4 6 MM 0,062957 0,851114 0,601002 0,542021 0,337840 0,020735 0,867526
5 7 NF 0,005876 0,501285 0,205176 0,542021 0,924753 0,060807 0,611814
6 7 MM 0,005900 0,438788 0,187430 0,337840 0,924753  0,119524 0,497442
7 8 NF 0,000125 0,009685 0,001397 0,020735 0,060807 0,119524 0,020271
8 8 MM 0,062625 0,709452 0,531398 0,867526 0,611814 0,497442 0,020271
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Table A. III. 86: Newman-Keuls test of difference in Condition factor between samplings and gender in 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,000121 0,002057 0,000123 0,002017 0,000125 0,000194 0,000120
2 5 MM 0,000121 0,054302 0,942692 0,067020 0,894698 0,284562 0,965436
3 6 NF 0,002057 0,054302 0,050193 0,744566 0,059251 0,290528 0,045342
4 6 MM 0,000123 0,942692 0,050193 0,081670 0,846216 0,499975 0,886949
5 7 NF 0,002017 0,067020 0,744566 0,081670 0,086007 0,239407 0,079703
6 7 MM 0,000125 0,894698 0,059251 0,846216 0,086007  0,450609 0,939307
7 8 NF 0,000194 0,284562 0,290528 0,499975 0,239407 0,450609 0,534979
8 8 MM 0,000120 0,965436 0,045342 0,886949 0,079703 0,939307 0,534979
 
Table A. III. 87: Newman-Keuls test of difference in Condition factor between sampling and gender in FWLD 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,008259 0,002415 0,000126 0,000121 0,000125 0,000127 0,001595
2 5 MM 0,008259 0,444280 0,024543 0,002804 0,030740 0,017649 0,512538
3 6 NF 0,002415 0,444280 0,121327 0,022044 0,107678 0,083387 0,736251
4 6 MM 0,000126 0,024543 0,121327 0,422168 0,927391 0,994540 0,168647
5 7 NF 0,000121 0,002804 0,022044 0,422168 0,642896 0,695454 0,039316
6 7 MM 0,000125 0,030740 0,107678 0,927391 0,642896  0,717595 0,091291
7 8 NF 0,000127 0,017649 0,083387 0,994540 0,695454 0,717595 0,102140
8 8 MM 0,001595 0,512538 0,736251 0,168647 0,039316 0,091291 0,102140
 
NKA activity 
Table A. III. 88: Newman-Keuls test of difference in NKA activity between samplings and gender during 
smoltification (Sampling 1- 4). Significant values (p<0.05) are highlighted in bold. 
 
 Sampling Gender {1} {2} {3} {4} {5} {6} {7} {8} 
1 1 F  0,780698 0,882553 0,865414 0,000150 0,000115 0,198232 0,750128
2 1 M 0,780698  0,892026 0,816382 0,000125 0,000152 0,261560 0,792919
3 2 F 0,882553 0,892026 0,824561 0,000126 0,000129 0,260570 0,642231
4 2 M 0,865414 0,816382 0,824561 0,000128 0,000126 0,276434 0,770510
5 3 F 0,000150 0,000125 0,000126 0,000128 0,237380 0,000117 0,000123
6 3 M 0,000115 0,000152 0,000129 0,000126 0,237380  0,000313 0,000126
7 4 F 0,198232 0,261560 0,260570 0,276434 0,000117 0,000313 0,137681
8 4 M 0,750128 0,792919 0,642231 0,770510 0,000123 0,000126 0,137681
 
Table A. III. 89: Newman-Keuls test of difference in NKA activity between samplings and gender in SWLL 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,877470 0,002814 0,857965 0,291958 0,002996 0,295366 0,970437
2 5 MM 0,877470 0,002899 0,940367 0,349308 0,002910 0,245232 0,937351
3 6 NF 0,002814 0,002899 0,002246 0,000137 0,000118 0,049058 0,001975
4 6 MM 0,857965 0,940367 0,002246 0,187402 0,002798 0,300102 0,976108
5 7 NF 0,291958 0,349308 0,000137 0,187402 0,039455 0,018240 0,413966
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6 7 MM 0,002996 0,002910 0,000118 0,002798 0,039455  0,000132 0,003224
7 8 NF 0,295366 0,245232 0,049058 0,300102 0,018240 0,000132 0,128470
8 8 MM 0,970437 0,937351 0,001975 0,976108 0,413966 0,003224 0,128470
 
Table A. III. 90: Newman-Keuls test of difference in NKA activity between samplings and gender in SWLD 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,434546 0,001110 0,586560 0,761849 0,456943 0,504840 0,617881
2 5 MM 0,434546 0,000134 0,181017 0,417499 0,625352 0,100971 0,123674
3 6 NF 0,001110 0,000134 0,010605 0,002073 0,000213 0,018073 0,007137
4 6 MM 0,586560 0,181017 0,010605 0,496184 0,312374 0,683630 0,903226
5 7 NF 0,761849 0,417499 0,002073 0,496184 0,546614 0,521247 0,682055
6 7 MM 0,456943 0,625352 0,000213 0,312374 0,546614  0,211879 0,265473
7 8 NF 0,504840 0,100971 0,018073 0,683630 0,521247 0,211879 0,983439
8 8 MM 0,617881 0,123674 0,007137 0,903226 0,682055 0,265473 0,983439
 
Table A. III. 91: Newman-Keuls test of difference in NKA activity between samplings and gender in FWLD 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,021502 0,152386 0,316913 0,018562 0,000610 0,850276 0,001237
2 5 MM 0,021502 0,000400 0,229189 0,915499 0,358657 0,023277 0,296668
3 6 NF 0,152386 0,000400 0,024554 0,000382 0,000123 0,237184 0,000130
4 6 MM 0,316913 0,229189 0,024554 0,125707 0,026960 0,208577 0,041155
5 7 NF 0,018562 0,915499 0,000382 0,125707 0,453090 0,016961 0,482087
6 7 MM 0,000610 0,358657 0,000123 0,026960 0,453090  0,000817 0,746333
7 8 NF 0,850276 0,023277 0,237184 0,208577 0,016961 0,000817 0,001576
8 8 MM 0,001237 0,296668 0,000130 0,041155 0,482087 0,746333 0,001576
 
Table A. III. 92: Newman-Keuls test of difference in NKA activity between samplings and gender in FWLL 




{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,004470 0,066552 0,120269 0,035645 0,000145 0,542832 0,000209
2 5 MM 0,004470 0,000129 0,235867 0,384557 0,250960 0,017513 0,237991
3 6 NF 0,066552 0,000129 0,001405 0,000245 0,000120 0,040824 0,000123
4 6 MM 0,120269 0,235867 0,001405 0,447655 0,014680 0,170640 0,029709
5 7 NF 0,035645 0,384557 0,000245 0,447655 0,071473 0,087114 0,104036
6 7 MM 0,000145 0,250960 0,000120 0,014680 0,071473  0,000316 0,681224
7 8 NF 0,542832 0,017513 0,040824 0,170640 0,087114 0,000316 0,000723
8 8 MM 0,000209 0,237991 0,000123 0,029709 0,104036 0,681224 0,000723
 
Relative NKA1b gene expression  
Table A. III. 93: Newman-Keuls test of difference in Log NKA1b between samplings and gender during 
smoltification (Sampling 1- 4). Significant values (p<0.05) are highlighted in bold. 
 
 Sampling Gender {1} {2} {3} {4} {5} {6} {7} {8} 
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1 1 F  0,421081 0,360246 0,340329 0,105542 0,018749 0,401891 0,126031
2 1 M 0,421081  0,573173 0,706547 0,359010 0,106643 0,725818 0,426798
3 2 F 0,360246 0,573173 0,868516 0,577843 0,257519 0,844354 0,683238
4 2 M 0,340329 0,706547 0,868516 0,441309 0,337069 0,759034 0,699839
5 3 F 0,105542 0,359010 0,577843 0,441309 0,629414 0,527637 0,975687
6 3 M 0,018749 0,106643 0,257519 0,337069 0,629414  0,280439 0,378036
7 4 F 0,401891 0,725818 0,844354 0,759034 0,527637 0,280439 0,680823
8 4 M 0,126031 0,426798 0,683238 0,699839 0,975687 0,378036 0,680823
 
 
Table A. III. 94: Newman-Keuls test of difference in Log NKA1b between samplings and gender in SWLL 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,712022 0,917609 0,827248 0,706528 0,868577 0,806413 0,904014
2 5 MM 0,712022 0,971022 0,825275 0,672668 0,933369 0,859708 0,853660
3 6 NF 0,917609 0,971022 0,885071 0,997435 0,979474 0,995122 0,841920
4 6 MM 0,827248 0,825275 0,885071 0,740027 0,840678 0,796592 0,835942
5 7 NF 0,706528 0,672668 0,997435 0,740027 0,984674 0,921823 0,736046
6 7 MM 0,868577 0,933369 0,979474 0,840678 0,984674  0,945511 0,801111
7 8 NF 0,806413 0,859708 0,995122 0,796592 0,921823 0,945511 0,769087
8 8 MM 0,904014 0,853660 0,841920 0,835942 0,736046 0,801111 0,769087
 
Table A. III. 95: Newman-Keuls test of difference in Log NKA1b between samplings and gender in SWLD 





Sampling {1} {2} {3} {4} {5} {6} {7} {8} 
1 NF 5  0,472167 0,446847 0,958705 0,488476 0,964726 0,915493 0,735351
2 NF 6 0,472167 0,846753 0,361719 0,198130 0,384458 0,319873 0,224405
3 NF 7 0,446847 0,846753 0,405215 0,170935 0,385070 0,458843 0,187574
4 NF 8 0,958705 0,361719 0,405215 0,763321 0,817625 0,712609 0,841112
5 MM 5 0,488476 0,198130 0,170935 0,763321 0,738789 0,663477 0,960163
6 MM 6 0,964726 0,384458 0,385070 0,817625 0,738789  0,819024 0,856285
7 MM 7 0,915493 0,319873 0,458843 0,712609 0,663477 0,819024 0,727460
8 MM 8 0,735351 0,224405 0,187574 0,841112 0,960163 0,856285 0,727460
 
Table A. III. 96: Newman-Keuls test of difference in Log NKA1b between samplings and gender in FWLD 
during maturation (Sampling 5- 8). Significant values (p<0.05) are highlighted in bold. 
 
 Sampling Mature/Non 
Mature 
{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,108919 0,649752 0,953921 0,262385 0,934927 0,963001 0,945786
2 5 MM 0,108919 0,044836 0,216764 0,007474 0,209275 0,217867 0,220981
3 6 NF 0,649752 0,044836 0,577105 0,431991 0,603917 0,393606 0,625712
4 6 MM 0,953921 0,216764 0,577105 0,289192 0,900403 0,886743 0,842029
5 7 NF 0,262385 0,007474 0,431991 0,289192 0,246027 0,235136 0,285419
6 7 MM 0,934927 0,209275 0,603917 0,900403 0,246027  0,937292 0,814792
7 8 NF 0,963001 0,217867 0,393606 0,886743 0,235136 0,937292 0,936860
8 8 MM 0,945786 0,220981 0,625712 0,842029 0,285419 0,814792 0,936860
 
 151
Table A. III. 97: Newman-Keuls test of difference in Log NKA1b between samplings and gender in FWLL 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,125294 0,043936 0,191930 0,279068 0,132080 0,430818 0,172177
2 5 MM 0,125294 0,000440 0,669591 0,006304 0,831006 0,030360 0,807538
3 6 NF 0,043936 0,000440 0,002656 0,229453 0,000563 0,133414 0,001062
4 6 MM 0,191930 0,669591 0,002656 0,034383 0,630844 0,100543 0,612278
5 7 NF 0,279068 0,006304 0,229453 0,034383 0,008106 0,453029 0,015770
6 7 MM 0,132080 0,831006 0,000563 0,630844 0,008106  0,036034 0,685116
7 8 NF 0,430818 0,030360 0,133414 0,100543 0,453029 0,036034 0,059679
8 8 MM 0,172177 0,807538 0,001062 0,612278 0,015770 0,685116 0,059679
 
Relative NKA1a gene expression 
Table A. III. 98: Newman-Keuls test of difference in Log NKA1a between sampling and gender during 
Smoltification (Sampling 1- 4). Significant values (p<0.05) are highlighted in bold. 
 
 Sampling Gender {1} {2} {3} {4} {5} {6} {7} {8} 
1 1 F  0,918728 0,850899 0,901797 0,000559 0,001847 0,578477 0,924462
2 1 M 0,918728  0,954163 0,949607 0,000527 0,001857 0,611536 0,949463
3 2 F 0,850899 0,954163 0,808331 0,000693 0,002188 0,571608 0,902312
4 2 M 0,901797 0,949607 0,808331 0,000928 0,002734 0,550031 0,851836
5 3 F 0,000559 0,000527 0,000693 0,000928 0,573574 0,005453 0,000997
6 3 M 0,001847 0,001857 0,002188 0,002734 0,573574  0,008866 0,002455
7 4 F 0,578477 0,611536 0,571608 0,550031 0,005453 0,008866 0,393883
8 4 M 0,924462 0,949463 0,902312 0,851836 0,000997 0,002455 0,393883
 
Table A. III. 99: Newman-Keuls test of difference in Log NKA1a between sampling SWLL during maturation 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,989999 0,200256 0,257037 0,186066 0,320292 0,394552 0,091850
2 5 MM 0,989999 0,395007 0,382481 0,226228 0,418205 0,476597 0,110123
3 6 NF 0,200256 0,395007 0,766848 0,813317 0,902885 0,961904 0,638997
4 6 MM 0,257037 0,382481 0,766848 0,860487 0,895409 0,981031 0,725406
5 7 NF 0,186066 0,226228 0,813317 0,860487 0,791711 0,552840 0,648737
6 7 MM 0,320292 0,418205 0,902885 0,895409 0,791711  0,957076 0,684151
7 8 NF 0,394552 0,476597 0,961904 0,981031 0,552840 0,957076 0,545437
8 8 MM 0,091850 0,110123 0,638997 0,725406 0,648737 0,684151 0,545437
 
Table A. III. 100: Newman-Keuls test of difference in Log NKA1a between sampling in SWLD during 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,918686 0,618596 0,065042 0,047505 0,000165 0,000811 0,000146
2 5 MM 0,918686 0,407804 0,054825 0,034054 0,000160 0,000761 0,000151
3 6 NF 0,618596 0,407804 0,179533 0,084668 0,000458 0,004604 0,000320
4 6 MM 0,065042 0,054825 0,179533 0,968156 0,017838 0,076985 0,016067
5 7 NF 0,047505 0,034054 0,084668 0,968156 0,029190 0,164701 0,022412
6 7 MM 0,000165 0,000160 0,000458 0,017838 0,029190  0,297095 0,781035
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7 8 NF 0,000811 0,000761 0,004604 0,076985 0,164701 0,297095 0,383687
8 8 MM 0,000146 0,000151 0,000320 0,016067 0,022412 0,781035 0,383687
 
Table A. III. 101: Newman-Keuls test of difference in Log NKA1a between sampling in FWLD during 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,043284 0,012577 0,011383 0,017876 0,016497 0,000793 0,001668
2 5 MM 0,043284 0,586203 0,521141 0,436134 0,544366 0,125097 0,207528
3 6 NF 0,012577 0,586203 0,924971 0,902158 0,910871 0,438503 0,394472
4 6 MM 0,011383 0,521141 0,924971 0,826375 0,753033 0,547904 0,608271
5 7 NF 0,017876 0,436134 0,902158 0,826375 0,786723 0,404965 0,539785
6 7 MM 0,016497 0,544366 0,910871 0,753033 0,786723  0,475903 0,584801
7 8 NF 0,000793 0,125097 0,438503 0,547904 0,404965 0,475903 0,708554
8 8 MM 0,001668 0,207528 0,394472 0,608271 0,539785 0,584801 0,708554
 
Table A. III. 102: Newman-Keuls test of difference in Log NKA1a between sampling in FWLL during 





{1} {2} {3} {4} {5} {6} {7} {8} 
1 5 NF  0,001178 0,530396 0,620754 0,825508 0,700932 0,856299 0,776223
2 5 MM 0,001178 0,004115 0,003895 0,002511 0,004079 0,000561 0,000787
3 6 NF 0,530396 0,004115 0,861159 0,972768 0,863775 0,651745 0,630901
4 6 MM 0,620754 0,003895 0,861159 0,580057 0,815496 0,465060 0,538845
5 7 NF 0,825508 0,002511 0,972768 0,580057 0,959791 0,731551 0,780754
6 7 MM 0,700932 0,004079 0,863775 0,815496 0,959791  0,668885 0,695110
7 8 NF 0,856299 0,000561 0,651745 0,465060 0,731551 0,668885 0,808197
8 8 MM 0,776223 0,000787 0,630901 0,538845 0,780754 0,695110 0,808197
 
